methamphetamine has been researched along with Disease Models, Animal in 418 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (4.55) | 18.7374 |
1990's | 22 (5.26) | 18.2507 |
2000's | 124 (29.67) | 29.6817 |
2010's | 210 (50.24) | 24.3611 |
2020's | 43 (10.29) | 2.80 |
Authors | Studies |
---|---|
Dai, J; Jiang, R; Jiang, S; Li, C; Li, Q; Liu, J; Liu, Y; Meng, F; Sun, Z; Wang, W; Wu, M | 1 |
Danda, H; Končická, M; Kuchař, M; Lhotková, E; Mazoch, V; Olejníková, L; Páleníček, T; Pinterová-Leca, N; Šíchová, K; Štefková-Mazochová, K; Syrová, K | 1 |
Kline, HL; Yamamoto, BK | 1 |
Mihalčíková, L; Ochozková, A; Šlamberová, R; Yamamotová, A | 1 |
Erives, VH; Hamed, MF; Hernandez, H; Manepalli, S; Martinez, LR; Munzen, ME; Nguyen, LN; Nosanchuk, JD; Zamith-Miranda, D | 1 |
Chang, MH; Chiou, LC; Cook, J; Knutson, DE; Kubota, H; Lee, HJ; Lee, MT; Mihovilovic, M; Mouri, A; Nabeshima, T; Sieghart, W; Wu, CY | 1 |
Arai, T; Matsumoto, M; Yamazaki, M; Yarimizu, J | 1 |
Achim, C; Deben, D; Geyer, MA; Grant, IE; Kenton, JA; Milienne-Petiot, M; Minassian, A; Perry, W; Young, JW | 1 |
Berling, KL; Broderick, MR; Gieske, MG; Nelson, MR; Osborn, E; Wright, MR; Yates, JR | 1 |
Chen, LC; Chen, MC; Chou, D; Hsieh, MC; Lai, CY; Lee, CS; Li, Z; Lin, TB; Peng, HY; Wu, HF | 1 |
Anderson, EM; Matuszewich, L; McFadden, LM | 1 |
Deng, B; Li, S; Li, Y; Wang, Y; Yan, J | 1 |
Brannock, C; Cadet, JL; Daiwile, AP; Jayanthi, S; Ladenheim, B; McCoy, MT; Schroeder, J | 1 |
Ichitani, Y; Takahashi, K; Toyoshima, M; Yamada, K | 1 |
Abdollahifar, MA; Aliaghaei, A; Anarkooli, IJ; Barfi, E; Boroujeni, ME; Fridoni, MJ; Golsorkhdan, SA; Nejatbakhsh, R; Ramezanpour, A | 1 |
Chen, F; Dai, Y; Shen, S; Wang, K; Zhao, J | 1 |
Eshaq, RS; Harris, NR; Lee, M; Leskova, W | 2 |
Chen, Y; Hall, FS; Saber, YH; Tran, HTN | 1 |
Shaham, Y; Venniro, M | 1 |
Giovanetti, SM; Lesscher, HMB; Messing, RO; Ramsey, LA; Richie, CT; Russell, TI; Shaham, Y; Venniro, M | 1 |
Ding, J; He, Y; Hu, S; Huang, J; Li, C; Meng, Y; Qiu, P | 1 |
Huckans, M; Hudson, R; Lattal, KM; Loftis, JM; Navis, T; Person, U; Shirley, R; Taylor, J; Vandenbark, AA | 1 |
Cortes, LR; Dwyer, MR; Gulley, JM; Westbrook, SR | 1 |
Eikermann, M; Grabitz, SD; Hill, KP; Leonard, MZ; Miczek, KA; Rostin, P | 1 |
Chen, JC; Liao, IM | 1 |
Brewin, LW; Brown, CN; Bryant, CD; Coelho, MA; Fultz, EK; Kippin, TE; Page, A; Shab, G; Stailey, N; Szumlinski, KK | 1 |
Dong, GM; Guo, LK; Han, X; Li, J; Ma, CM; Song, R; Wang, ZY; Wu, N | 1 |
Baracz, SJ; Carey, HA; Cornish, JL; Everett, NA | 1 |
Fu, X; Hao, W; Liu, T; Xiang, X; Yang, BZ; Yang, C; Zhang, X | 1 |
Ebrahimi-Ghiri, M; Khakpai, F; Zarrindast, MR | 1 |
Cadet, JL; Chojnacki, MR; Jayanthi, S | 1 |
Jang, WJ; Jeong, CH; Lee, S; Ryu, IS; Son, T; Song, SH | 1 |
Chesworth, R; Karl, T; Rosa-Porto, R; Yao, S | 1 |
Galaj, E; Xi, ZX | 1 |
Barrett, ST; Bevins, RA; Chou, S; Duque, JF; Li, M; Loh, O; Murawski, NJ; Pittenger, ST | 1 |
Fu, L; Li, SQ; Pei, W; Yu, Y | 1 |
Chow, D; Gucwa, AL; Hamed, MF; Hernandez-Santini, AC; Martinez, LR; Mitha, AN; Vaval, V | 1 |
Baker, W; Cambow, D; Gogerty, D; Herlihy, B; Leda, AR; Park, M; Pavlenko, D; Toborek, M; Van Den Nieuwenhuizen, S | 1 |
Dalton, CF; Fachim, H; Iamjan, SA; Nudmamud-Thanoi, S; Reynolds, GP; Thanoi, S; Watiktinkorn, P | 1 |
Gao, B; Li, T; Liang, M; Liu, X; Qian, H; Shang, Q; Wang, J; Xi, Z; Xiao, J | 1 |
Bing, G; Dang, DK; Hwang, Y; Jang, CG; Jeong, JH; Kim, HC; Nabeshima, T; Nah, SY; Nguyen, BT; Sharma, N; Shin, EJ | 1 |
Cao, Y; Deng, H; Li, Z; Liu, K; Qi, Y; Song, C; Zhang, H | 1 |
Greig, NH; Kim, PP; Lu, T; Luo, Y | 1 |
Babinska, Z; Micale, V; Ruda-Kucerova, J; Stark, T | 1 |
Cotter, AR; Garcia, R; Leslie, K; Neisewander, JL; Olive, MF | 1 |
Fultz, EK; Hudson, CN; Kippin, TE; Martin, DL; Szumlinski, KK | 1 |
Al-Harthi, L; Hu, XT; Narasipura, SD; Richards, MH; Yamamoto, B; Yu, C | 1 |
Beckstead, MJ; Sharpe, AL; Varela, E | 1 |
Jablonski, SA; Vorhees, CV; Williams, MT | 1 |
Hrebíčková, I; Macúchová, E; Ševčíková, M; Šlamberová, R | 1 |
Batten, SR; Beckmann, JS | 1 |
Lattal, KM; Navis, TM; Pizzimenti, CL | 1 |
Angoa-Perez, M; Anneken, JH; Crich, D; Kuhn, DM; Sati, GC | 1 |
Ahmadiani, A; Beirami, E; Dargahi, L; Oryan, S; Seyedhosseini Tamijani, SM | 1 |
Bernaskova, K; Slamberova, R; Tomkova, S | 1 |
Baumann, MH; Elmore, JS; Janowsky, A; Miner, NB; Phillips, TJ | 1 |
Ando, K; Inoue, R; Kawai, K; Nishime, C; Nishinaka, E; Tsutsumi, H; Urano, K | 1 |
Johnson, BN; Li, JX; Siemian, JN; Xue, Z; Zhang, Y | 1 |
Cong, B; Gou, HY; Li, F; Li, J; Su, RB; Sun, X; Wang, ZY; Wu, N | 1 |
Cadet, JL; Jayanthi, S; McCoy, MT; Torres, OV | 1 |
Aungier, J; Cuesta, M; Morton, AJ; Ouk, K | 1 |
Feng, J; Jia, M; Liu, J; Wen, X; Zhang, G; Zhang, W | 1 |
Istin, M; Jaafari, N; Nicolas, C; Sikora, M; Solinas, M; Thiriet, N | 1 |
Chen, Z; Dolan, SB; Gatch, MB; Huang, R | 1 |
Huang, ET; Huckans, M; Hudson, R; Loftis, JM; Phillips, TJ; Wilhelm, CJ | 1 |
Capuani, C; Corsi, M; Harada, A; Kimura, H; Suzuki, H; Suzuki, K; Ugolini, A | 1 |
Bardo, MT; Crooks, PA; Dwoskin, LP; Lee, NR; Zheng, G | 1 |
Gutierrez, A; Vorhees, CV; Williams, MT | 1 |
Battisti, UM; Baumann, MH; Eltit, JM; Glennon, RA; Harris, A; Negus, SS; Ruchala, I; Sakloth, F; Sitta, R; Walther, D | 1 |
Górska, A; Gołembiowska, K; Kajta, M; Kamińska, K; Kreiner, G; Noworyta-Sokołowska, K; Rzemieniec, J; Wnuk, A; Wojtas, A | 1 |
Inada, K; Ishigooka, J; Kawano, M; Kawano, T; Muraoka, H; Nishimura, K; Oshibuchi, H; Tsutsumi, T; Yamada, M | 1 |
Ares-Santos, S; Granado, N; Moratalla, R; Tizabi, Y | 1 |
Bergman, J; de Moura, FB; Kohut, SJ | 1 |
Harless, N; Mitchell, CM; Natarajan, R; Yamamoto, BK | 1 |
Chen, TZ; Deng, YZ; Guo, LB; Jiang, HF; Jiao, DL; Ju, YY; Liu, JG; Wu, XQ; Zan, GY; Zhao, M | 1 |
Peters, J; Reichel, CM; Scofield, MD | 1 |
Beloate, LN; Coolen, LM; Dupuy, BM; Kuiper, LB | 1 |
Ghimire, B; Hellmuth, L; Houlton, SK; Mojica, E; Phillips, TJ; Schmidt, B; Shabani, S | 1 |
Bai, Y; Chao, J; Du, L; Hu, G; Shen, K; Yao, H; Zhang, Y | 1 |
Chen, L; Li, C; Li, Y; Ru, Q; Tian, X; Xiao, H; Xiong, Q; Zhou, M | 1 |
Dong, YX; Fan, XY; Hou, Y; Liu, S; Wu, CF; Yang, JY | 1 |
Abdollahifar, MA; Ahmadiani, A; Aliaghaei, A; Eskandarian Boroujeni, M; Peirouvi, T; Shaerzadeh, F | 1 |
Liu, H; Liu, R; Nie, Z; Pu, X; Sun, Y; Xu, J; Zhang, Z; Zhao, X | 1 |
Dargahi, L; Haghparast, A; Karimi-Haghighi, S | 1 |
Bernardi, A; Bisagno, V; Cadet, JL; García-Rill, E; Gomez, N; González, B; Jayanthi, S; Sosa, MH; Torres, OV; Urbano, FJ | 1 |
Darrow, AL; Marcinko, MC; Shohet, RV; Tuia, AJ | 1 |
Bonci, A; Cadet, JL; Gu, H; Hu, Y; Krasnova, IN; Lu, H; Salmeron, BJ; Stein, EA; Yang, Y | 1 |
Kimura, H; Kunugi, A; Suzuki, A; Suzuki, M; Suzuki, N; Tanaka, M | 1 |
Anholt, RRH; Baker, BM; Highfill, CA; Mackay, TFC; Stevens, SD | 1 |
Arab, A; Drazanova, E; Khairnar, A; Minsterova, A; Rektorova, I; Ruda-Kucerova, J; Starcuk, Z; Szabó, N | 1 |
Balan, S; Esaki, K; Fujita, Y; Hashimoto, K; Hayashi-Takagi, A; Hino, M; Hisano, Y; Iwayama, Y; Kakita, A; Kunii, Y; Maekawa, M; Mataga, N; Matsumoto, J; Nagaoka, A; Nozaki, Y; Ohba, H; Ohnishi, T; Shimamoto-Mitsuyama, C; Tan, Y; Toyoshima, M; Watanabe, A; Yabe, H; Yoshikawa, T | 1 |
Abdelhady, S; El Hayek, S; Fakih, C; Haidar, M; Hasan, H; Kobeissy, FH; Mondello, S; Shaito, A | 1 |
Cimbro, R; Davis, IR; Li, X; Lofaro, OM; Rubio, FJ; Zhang, J | 1 |
Miyamoto, Y; Muramatsu, S; Nabeshima, T; Nitta, A; Ozawa, K; Yamada, K; Yan, Y | 1 |
Aparicio, MB; Engelmann, AJ; Grant, Y; Kim, A; Mandyam, CD; Sobieraj, JC; Yuan, CJ | 1 |
Liu, JF; Lu, L; Shi, J; Sun, LL; Wang, J; Xue, YX; Zhang, Y; Zhao, LY; Zhu, WL | 1 |
Bu, Q; Cen, X; Deng, P; Li, Y; Lv, L; Wang, Y; Yan, G; Yang, Y; Zhou, J | 1 |
Chaki, S; Iijima, M; Koike, H | 1 |
Chen, YW; Kao, HY; Lai, WS; Min, MY | 1 |
Afanador, L; Angulo, JA; Baker, L; Diaz, C; Mexhitaj, I; Ordonez, D | 1 |
Colantuoni, C; Furukori, K; Harada, K; Hiyama, H; Hookway, C; Huang, B; Jaaro-Peled, H; Kano, SI; Kondo, MA; Matsuoka, N; Ni, K; Pevsner, J; Pou, S; Sawa, A; Seshadri, S; Tajinda, K | 1 |
Northrop, NA; Yamamoto, BK | 1 |
Adair, JE; Barnes, C; Becker, KG; Brannock, C; Cadet, JL; Chiflikyan, M; Gold, MS; Goldberg, SR; Jayanthi, S; Justinova, Z; Kobeissy, FH; Krasnova, IN; Ladenheim, B; Lehrmann, E; McCoy, MT; Quintero, C | 1 |
Jenner, P; Kadowaki Horita, T; Kanda, T; Kobayashi, M; Mori, A | 1 |
Fukunari, A; Kajii, Y; Kano, S; Kondo, MA; Miwa, K; Ohzeki, H; Okada, K; Sakaue, M; Sawa, A; Takemoto, K; Tamura, M; Tezuka, T; Yasumatsu, H | 1 |
Cordero, RJ; DeLeon-Rodriguez, CM; Desai, GM; Eugenin, EA; Frases, S; Martinez, LR; Nosanchuk, JD; Patel, D | 1 |
Ishige, K; Ito, Y; Kosuge, Y; Osada, N | 1 |
Bamba, T; Bando, K; Fukusaki, E; Horie, H; Ishii, A; Katagi, M; Miyawaki, I; Sato, T; Shima, N; Suzuki, K; Tatsuno, M; Tsuchihashi, H; Zaitsu, K | 1 |
Cornett, EM; Goeders, NE | 1 |
Bernášková, K; Matějovská, I; Šlamberová, R | 1 |
Brooks, DM; Hutchinson, J; Kothiwal, AS; Poulsen, AJ; Poulsen, DJ; Rau, TF; Rhoderick, JF; Rova, AR | 1 |
Ji-Au, W; Maneesri-le Grand, S; Saengjaroentham, C; Srikiatkhachorn, A; Supornsilpchai, W | 1 |
Davies, KP; Martinez, LR; Nosanchuk, JD; Tar, MT | 1 |
Kiguchi, N; Kishioka, S; Kobayashi, Y; Nishiue, H; Saika, F; Wakida, N | 1 |
Arezoomandan, R; Attarzadeh-Yazdi, G; Haghparast, A | 1 |
Brannock, C; Cadet, JL; Jayanthi, S; Krasnova, IN | 1 |
Kanazawa, M; Kubota, H; Mori, T; Rahmadi, M; Shibasaki, M; Suzuki, T | 1 |
Baumann, MH; Kim, AH; Kiyatkin, EA; Shaham, Y; Wakabayashi, KT | 1 |
Anglin, JM; Conrad, CD; Olive, MF; Paode, PR; Riggert, AG; Taylor, SB | 1 |
Harper, DN; Harrow, CC; Macaskill, AC | 1 |
Kelly, JP; McDonnell-Dowling, K | 3 |
Bossert, JM; Kambhampati, S; Li, X; Shaham, Y; Zeric, T | 1 |
Kesby, JP; Markou, A; Semenova, S | 1 |
Frank, JC; Gentry, WB; Hambuchen, MD; Hendrickson, HP; Laurenzana, EM; Owens, SM; Stevens, MW; White, SJ; Williams, DK | 1 |
Akiyama, K; Arime, Y; Fukumura, R; Gondo, Y; Mekada, K; Miura, I; Wakana, S; Yoshiki, A | 1 |
Caprioli, D; Thorndike, EB; Venniro, M; Zeric, T | 1 |
Baum, LL; Graves, SM; Mahmood, F; Mata, MM; Napier, TC; Raeisi, S | 1 |
Kato, K; Kunugi, H; Ogawa, S; Ota, M; Wakabayashi, C | 1 |
Davidson, C; Hutchinson, CV; Prados, J | 1 |
Adhikary, S; Bossert, JM; Caprioli, D; Li, X; Lucantonio, F; Madangopal, R; Marchant, NJ; Schoenbaum, G; Shaham, Y; Venniro, M; Zeric, T | 1 |
Ago, Y; Hara, Y; Hashimoto, H; Higashino, K; Katashiba, K; Matsuda, T; Takano, E; Takuma, K; Taruta, A | 1 |
Bubeníková-Valešová, V; Fialová, M; Šírová, J; Šlamberová, R | 1 |
Bailey, A; Georgiou, P; Hourani, SM; Kitchen, I; Ledent, C; Winsky-Sommerer, R; Wright, SR; Yoo, JH; Zanos, P | 1 |
Cadet, JL; Godino, A; Jayanthi, S | 1 |
Macúchová, E; Nohejlová, K; Pometlová, M; Šlamberová, R; Stuchlík, A; Valeš, K | 1 |
Hernandez, R; Lewis, CR; Manning, T; Olive, MF; Staudinger, K; Tomek, SE | 1 |
Kato, K; Kunugi, H; Masuda, C; Ogawa, S; Ota, M | 1 |
Blouin, AM; Briggs, SB; Cameron, MD; Lin, L; Miller, CA; Rumbaugh, G; Sillivan, SE; Young, EJ | 1 |
Cory-Slechta, DA; McConnell, SE; O'Banion, MK; Olschowka, JA; Opanashuk, LA | 1 |
Ramkissoon, A; Wells, PG | 1 |
Amchova, P; Babinska, Z; Dusek, L; Merhautova, J; Ruda-Kucerova, J; Sulcova, A | 1 |
Gao, Y; Gong, Z; Jin, X; Liu, S; Mi, G; Yan, H; Yang, H; Yang, Z; Ye, E | 1 |
Amchova, P; Babinska, Z; Havlickova, T; Jerabek, P; Kacer, P; Ruda-Kucerova, J; Sulcova, A; Sustkova-Fiserova, M; Syslova, K | 1 |
Halberstadt, AL; Manning, EE; van den Buuse, M | 1 |
Adedeji, A; Huber, R; Imeh-Nathaniel, A; Nathaniel, TI | 1 |
Brownell, AL; Choi, JK; Hattori, S; Ishii, S; Jenkins, BG; Kil, KE; Miyakawa, T; Takagi, T; Zhu, A | 1 |
Hashimoto, K; Ma, M; Ren, Q; Yang, C; Yao, W; Zhang, JC | 1 |
Eugenin, EA; Fries, BC; Guimaraes, AJ; Ham Lee, H; Martinez, LR; Mihu, MR; Nguyen, LN; Nosanchuk, JD; Roman-Sosa, J; Shah, BP; Varshney, AK | 1 |
Balleine, BW; Corbit, LH; Furlong, TM; Killcross, S; Supit, AS | 1 |
Barrett, ST; Bevins, RA; Chou, S; Pittenger, ST | 2 |
Furlong, TM; Keefe, KA; Leavitt, LS; Son, JH | 1 |
Batra, V; Goeders, NE; Guerin, GF; Wilden, JA | 1 |
Cadet, JL; Justinova, Z; Krasnova, IN | 1 |
Bailey, A; Garcia-Carmona, JA; Georgiou, P; Hourani, S; Kitchen, I; Laorden, ML; Zanos, P | 1 |
Istin, M; Solinas, M; Thiriet, N | 1 |
Halpin, LE; Northrop, NA; Yamamoto, BK | 1 |
Adhikary, S; Bossert, JM; Caprioli, D; Kallenberger, P; Shaham, Y; Venniro, M | 1 |
Chen, Y; Fang, M; Jiang, M; Kang, Q; Li, C; Lin, Y; Liu, W; Mo, Z; Peng, Q; Yung, KK | 1 |
Mark, GP; Murphy, SJ; Raber, J; Wang, J; Weber, S; Zuloaga, DG | 1 |
Mootz, JR; Phillips, TJ; Reed, C | 1 |
Bortell, N; Bustamante, EA; Fox, HS; Marcondes, MC; Morsey, B; Najera, JA; Ravasi, T | 1 |
Cenna, JM; Fernandes, NC; Gofman, L; Potula, R; Ramirez, SH; Sriram, U | 1 |
Fannon, MJ; Head, BP; Mandyam, CD; Somkuwar, SS | 1 |
Janphet, S; Nudmamud-Thanoi, S; Thanoi, S | 1 |
Nudmamud-Thanoi, S; Reynolds, GP; Thanoi, S; Veerasakul, S | 1 |
Cao, S; Chao, H; Ji, J; Liu, Y; Xu, X | 1 |
Amchova, P; Babinska, Z; Drago, F; Micale, V; Ruda-Kucerova, J; Stark, T; Sulcova, A | 1 |
Dimatelis, JJ; Kellaway, LA; Mpeta, B; Russell, VA; Stein, DJ; Womersley, JS | 1 |
Batra, V; Caputo, J; Goeders, NE; Guerin, GF; Tran, TL; Wilden, J | 1 |
Bai, Y; Chao, J; Gan, G; Hu, G; Hua, J; Huang, R; Lv, X; Nguyen, LK; Shen, K; Yao, H; Zhang, W; Zhang, Y | 1 |
Bischoff-Grethe, A; Brown, GG; Grant, I; Kesby, JP; Minassian, A; Morgan, EE; Soontornniyomkij, V | 1 |
Alter, SP; Cliburn, RA; Dunn, AR; Guillot, TS; Lohr, KM; Miller, GW; Stout, KA | 1 |
Mateo, M; Mendoza, J; Salaberry, NL | 1 |
Aungier, J; Morton, AJ; Ouk, K | 1 |
Baldwin, HA; Harvey, BK; Koivula, PP; Necarsulmer, JC; Whitaker, KW | 1 |
Cenna, JM; Fernandes, NC; Gofman, L; Haldar, B; Hill, BL; Potula, R; Sriram, U | 1 |
Carvalho, F; Carvalho, RA; Cunha, RA; Fonseca, R; Fontes Ribeiro, CA; Jarak, I; Köfalvi, A; Lemos, C; Pereira, FC; Pita, IR; Prediger, RD; Sequeira, AC; Silva, CD | 1 |
Akinyeke, T; Baker, EJ; Daunais, JB; Davenport, AT; Raber, J; Weber, SJ | 1 |
Canales, JJ; Loxton, D | 1 |
Grill, WM; McConnell, GC; So, RQ | 1 |
Bremer, PT; Creehan, KM; Ducime, A; Janda, KD; Kisby, BR; Nguyen, JD; Taffe, MA | 1 |
Coolen, LM; Frohmader, KS; Kuiper, LB | 1 |
Brocker, DT; Grill, WM; Gross, RE; So, RQ; Swan, BD; Turner, DA | 1 |
Biała, G; Budzynska, B; Frankowska, M; Kaszubska, K; Michalak, A | 1 |
Angulo, JA; Grinman, E; Hazan, A; Liu, Q | 1 |
Dolan, SB; Forster, MJ; Gatch, MB | 1 |
Chang, A; Kesby, JP; Markou, A; Semenova, S | 1 |
Cadet, JL; Jayanthi, S; Krasnova, IN; Ladenheim, B; McCoy, MT; Torres, OV | 1 |
Ago, Y; Arikawa, S; Matsuda, T; Nakamura, S; Yata, M | 1 |
Chou, J; Ebendal, T; Harvey, BK; Hoffer, B; Wang, Y | 1 |
Emson, PC; Guillot, TS; Li, Y; Miller, GW; Richardson, JR; Shepherd, KR; Wang, MZ | 1 |
Braseth, SN; Buford, MC; Holian, A; Hutchison, JD; Wells, SM | 1 |
Fukuda, T; Hiranita, T; Kira, J; Kitaichi, K; Miyakawa, T; Nakayama, KI; Sakae, N; Tatsumi, Y; Yamada, M; Yamamoto, T; Yamasaki, N; Yoshikawa, H | 1 |
Abe, H; Ebihara, K; Hashiguchi, H; Ishida, Y; Kawai, K; Magata, Y; Matsuo, H; Nishimori, T; Odagiri, K; Takeda, R; Yoshimoto, M | 1 |
Kishimoto, K; Kitamura, Y; Minamino, H; Shibaike, T; Shimohama, S; Takata, K; Takeuchi, H; Taniguchi, T; Tsushima, J; Yanagida, T; Yasui, H | 1 |
Hrubá, L; Pometlová, M; Rokyta, R; Schutová, B; Slamberová, R | 1 |
Chen, GS; Huang, LT; Huang, YN; Lin, TC; Wang, JY | 1 |
Iida, A; Inoue, N; Kakiuchi, T; Kondo, Y; Muramatsu, S; Nakano, I; Nakayama, T; Okuno, T; Ono, F; Suzuki, Y; Takino, N; Terao, K; Tsukada, H | 1 |
Fu, Y; Fujita, Y; Hirayama, M; Ichihara, M; Ito, M; Kajita, Y; Maesawa, S; Masuda, A; Ohno, K; Ohsawa, I; Ohta, S; Suzuki, Y | 1 |
Bourque, M; Di Paolo, T; Dluzen, DE | 1 |
Francescutti-Verbeem, DM; Kuhn, DM; Thomas, DM | 3 |
Cadet, JL; Cesena, A; Hodges, AB; Hohmann, CF; Ivanova, E; Krasnova, IN; Ladenheim, B; Phillip, CG; Rhoades, R | 1 |
Kuczenski, R; Lacan, G; McCunney, SJ; Melega, WP; Segal, DS | 1 |
Bubenikova-Valesova, V; Hruba, L; Janovsky, M; Kacer, P; Rambousek, L; Schutova, B; Slamberova, R; Syslova, K | 1 |
Burkhart-Kasch, S; Cunningham, CL; Franken, FH; Hashimoto, JG; Janowsky, A; Li, N; Phillips, TJ; Reed, C; Scibelli, AC; Wheeler, JM; Wiren, KM | 1 |
Deng, C; Li, Z; Xu, J; Zhang, H; Zhang, Y; Zhou, XL | 1 |
Belcher, AM; Cazares, VA; Chen, J; Izquierdo, A; Malvaez, M; Marshall, JF; O'Dell, SJ; Scott, L; Wu, T | 1 |
Daniels, WM; Faure, JJ; Hattingh, SM; Stein, DJ | 1 |
Ake, C; Kaul, M; Maung, R; Roberts, AJ; Sejbuk, NE | 1 |
Biezonski, DK; Meyer, JS | 1 |
Brembs, B; van Swinderen, B | 1 |
Charalampidis, D; Lord, KC; Lucchesi, PA; McIlwain, E; Shenouda, SK; Varner, KJ | 1 |
Kitanaka, J; Kitanaka, N; Morita, Y; Nishiyama, N; Takemura, M; Tanaka, K; Tatsuta, T; Watabe, K | 1 |
Kurokawa, K; Ohkuma, S; Shibasaki, M | 1 |
Reichel, CM; See, RE | 1 |
Cole, JB; Dawes, DM; Falvey, DG; Ho, JD; Lundin, EJ; Miner, JR; Reardon, RF; Terwey, KS | 1 |
Bini, V; Bortolato, M; Castelli, MP; Collu, M; Ennas, MG; Frau, R; Gessa, GL; Loriga, R; Luesu, W | 1 |
Duenas, VJ; Garzon-Muvdi, T; Mahajan, R; Quiñones-Hinojosa, A; Shah, A | 1 |
Nagai, T; Yamada, K | 1 |
Darvas, M; Hatzidimitriou, G; McCann, UD; Palmiter, RD; Ricaurte, GA; Sotak, B; Yuan, J | 1 |
Chen, JY; Chen, KB; Kuo, CT; Tao, PL; Wen, YR; Yeh, GC | 1 |
Akamine, S; Fang, X; Namba, H; Sugiyama, K; Sun, W | 1 |
Abekawa, T; Inoue, T; Ito, K; Koyama, T; Nakato, Y | 1 |
Bernásková, K; Matejovská, I; Rokyta, R; Schutová, B; Slamberová, R | 1 |
Ayoub, G; Raffa, RB; Rawls, SM; Shah, H | 1 |
Buchanan, M; Gold, MS; Kobeissy, FH; Sadasivan, S; Wang, KK; Zhang, Z | 1 |
Abekawa, T; Ito, K; Koyama, T; Nakagawa, S; Nakato, Y | 2 |
Chiang, YH; Harvey, BK; Pick, CG; Shen, H; Wang, Y | 1 |
Choi, D; Hoffman, W; Huckans, MS; Loftis, JM | 1 |
Ahn, HS; Cheong, JH; Choi, JY; dela Peña, I; Ryu, JH; Shin, CY | 1 |
Ibi, D; Kamei, H; Mizoguchi, H; Nagai, T; Sato, J; Takase, F; Takuma, K; Toth, E; Yamada, K | 1 |
Abekawa, T; Ito, K; Koyama, T; Nakato, Y | 1 |
Hrubá, L; Pometlová, M; Schutová, B; Slamberová, R | 1 |
Herrold, AA; Napier, TC; Voigt, RM | 1 |
Good, RL; Liang, LP; Patel, M; Radcliffe, RA | 1 |
Allen, SC; Andrenyak, DM; Chu, PW; Conrad, KM; Ellis, JD; Fleckenstein, AE; German, CL; Gibb, JW; Hadlock, GC; Hanson, GR; Hoonakker, AJ; McFadden, LM; Vieira-Brock, PL; Webb, KM; Wilkins, DG | 1 |
Aungier, J; Cuesta, M; Morton, AJ | 1 |
Andersen, ML; Arent, CO; da-Rosa, DD; Dal-Pizzol, F; Ferreira, CL; Lopes-Borges, J; Mariot, E; Quevedo, J; Steckert, AV; Valvassori, SS; Varela, RB | 1 |
Ares-Santos, S; Cuadrado, A; Granado, N; Lastres-Becker, I; Martin, E; Moratalla, R; Oliva, I | 1 |
Hrubá, L; Schutová, B; Šlamberová, R | 1 |
Crystal, RG; De, BP; Hicks, MJ; Janda, KD; Kaminsky, SM; Koob, GF; Moreno, AY; Rosenberg, JB; Wee, S | 1 |
Irvine, RJ; Majumder, I; White, JM | 1 |
Chapman, DE; Keefe, KA; Pastuzyn, ED; Wilcox, KS | 1 |
Ma, T; Park, SW; Roman, R; Shen, X; Tien, LT | 1 |
Dusek, L; Kucerova, J; Pistovcakova, J; Sulcova, A; Vrskova, D | 1 |
Blesa, J; Jackson-Lewis, V; Przedborski, S | 1 |
Masuo, Y; Rakwal, R; Shibato, J | 1 |
Mitchell, SH; Moschak, TM; Phillips, TJ; Stang, KA | 1 |
Cheong, JH; dela Peña, I; Lee, HC; Lee, HL; Lee, JC; Sohn, AR; Woo, TS | 1 |
Hensleigh, E; Lynch, S; Pritchard, LM | 1 |
Andersen, ML; da-Rosa, DD; Dal-Pizzol, F; Ferreira, CL; Lopes-Borges, J; Ornell, F; Quevedo, J; Steckert, AV; Valvassori, SS; Varela, RB | 1 |
Chuturgoon, AA; Daniels, WM; Mabandla, MV; Phulukdaree, A; Subiah, CO | 1 |
Cheer, JF; Glick, SD; Morra, JT | 1 |
Engleman, EA; Musselman, HN; Nass, R; Neal-Beliveau, B | 1 |
Breger, LS; Dunnett, SB; Lane, EL; Smith, GA | 1 |
Napier, TC; Riddle, JL; Rokosik, SL | 1 |
Bowyer, JF; Kelly, KA; Miller, DB; O'Callaghan, JP | 1 |
Bergman, J; Blaylock, BL; Nader, MA; Newman, AH; Sibley, DR; Skolnick, P | 1 |
Bäckman, CM; Brusco, A; Cadet, JL; Diaz-Ruiz, O; Hoffman, AF; Ladenheim, B; Lupica, CR; Malik, N; Shan, L; Tagliaferro, A; Zhang, Y | 1 |
Bourne, N; Bubar, MJ; Cunningham, KA; Milligan, G; Valencia, F | 1 |
Hansen, R; Kaushal, N; Matsumoto, RR; McCurdy, CR; Seminerio, MJ; Zhang, HT | 1 |
Halpin, LE; Yamamoto, BK | 1 |
Andersen, ML; Bavaresco, DV; Feier, G; Morais, MO; Quevedo, J; Resende, WR; Scaini, G; Streck, EL; Valvassori, SS; Varela, RB | 1 |
den Hollander, B; Korpi, ER; Linden, AM; Ojanperä, I; Rozov, S; Uusi-Oukari, M | 1 |
Kobayashi, K; Mishina, M; Miyazaki, M; Mouri, A; Nabeshima, T; Noda, Y; Yamada, K | 1 |
Hubbard, DT; Kesby, JP; Markou, A; Semenova, S | 1 |
Killinger, B; Liu, B; Moszczynska, A; Schneider, B; Traini, R | 1 |
Fujikawa, DG; Ke, X; Shinmei, SS; Trinidad, RB; Wu, A | 1 |
Teitelbaum, SL | 1 |
Benkovic, SA; Miller, DB; O'Callaghan, JP; Sriram, K | 1 |
Hishida, S; Kinoshita, H; Minami, T; Nishiguchi, M; Ouchi, H; Taniguchi, T; Utsumi, T | 1 |
Alessandrí, MG; Fornai, F; Geppert, M; Jahn, R; Schlüter, OM; Südhof, TC; Takamori, S | 1 |
Aihara, N; Hida, H; Imamura, N; Ishida, K; Kanda, Y; Nishino, H; Yamada, K | 1 |
Kita, T; Nakashima, T; Wagner, GC | 1 |
Capobianco, L; De Blasi, A; Ferrucci, M; Fornai, F; Iacovelli, L; Lazzeri, G; Lenzi, P; Picascia, A | 1 |
Barr, MC; Chang, L; Cloak, CC; Ernst, T; Henriksen, S; Huitron-Resendiz, S; Phillips, TR; Sanchez-Alavez, M | 1 |
Matuszewich, L; Yamamoto, BK | 1 |
Hasegawa, T; He, J; Kim, HC; Kitaichi, K; Mamiya, T; Miyamoto, Y; Mizuno, M; Nabeshima, T; Nagai, T; Nakajima, A; Nitta, A; Saito, K; Seishima, M; Sekikawa, K; Seto, A; Tran, MH; Uchiyama, T; Yamada, K; Yamada, Y; Yoshimura, M | 1 |
Ando, N; Morimoto, K; Ninomiya, T; Suwaki, H; Watanabe, T | 1 |
Matsuoka, N; Mutoh, S; Shirakawa, K; Tada, M | 1 |
Itoh, H; Kurachi, M; Sumiyoshi, C; Sumiyoshi, T; Tanaka, K; Tsunoda, M; Uehara, T | 1 |
Endo, S; Ishibashi, S; Katsumata, N; Kuroiwa, T; Mizusawa, H; Yuan, SL | 1 |
Ikemoto, S; Yui, K | 1 |
Geyer, MA; Kuczenski, R; Lohr, JB; Niculescu, AB; Ogden, CA; Paulus, MP; Rich, ME; Schork, NJ | 1 |
Chen, GJ; Chou, J; Harvey, BK; Hoffer, BJ; Mark, A; Wang, Y | 1 |
Ishido, M; Masuo, Y; Morita, M; Niki, E; Oka, S | 1 |
Flynn, CT; Fox, HS; Henriksen, SJ; Katner, SN; Madden, LJ; May, M; Parsons, LH; Zandonatti, MA | 1 |
Marshall, JF; O'Dell, SJ | 1 |
Anderson, LI; Dluzen, DE; Leipheimer, RE | 1 |
Bannai, M; Kondoh, T; Nishino, H; Torii, K | 1 |
Inoue, K; Koizumi, S; Miyatake, M; Narita, M; Shibasaki, M; Suzuki, T; Tsuda, M; Yajima, Y | 1 |
Mancusková, M; Pometlová, M; Slamberová, R; Syllabová, L | 1 |
Hagino, Y; Hara, Y; Ikeda, K; Imai, K; Kamegaya, E; Kishida, M; Koga, H; Shimada, K; Sora, I; Takamatsu, Y; Yamamoto, H; Yamamoto, T | 1 |
Bagorda, F; Lehmann, K; Teuchert-Noodt, G | 1 |
Brady, AM; Glick, SD; O'Donnell, P | 1 |
Hayashi, K; Inden, M; Inoue, K; Kim, DH; Kitamura, Y; Nishimura, K; Qi, M; Shimohama, S; Sumi, S; Takata, K; Taniguchi, T; Tsuchiya, D; Yanagisawa, D; Yoshimoto, K | 1 |
Itoh, H; Kurachi, M; Seeman, P; Sumiyoshi, T; Tsunoda, M; Uehara, T | 1 |
Kuczenski, R; Segal, DS | 1 |
Gold, MS; Hayes, RL; Kobeissy, FH; Liu, MC; Wang, KK; Warren, MW | 1 |
Chiu, CT; Ho, IK; Ma, T | 1 |
Gotohda, T; Ishigami, A; Kitamura, O; Kubo, S; Tokunaga, I | 1 |
Byrnes-Blake, KA; Gentry, WB; Landes, RD; Laurenzana, EM; Owens, SM | 1 |
Cadet, JL; Sokolov, BP | 1 |
Hashimoto, K; Ishikura, H; Iyo, M; Kishimoto, T; Ozawa, K; Shimizu, E | 1 |
Johnson, MA; Miller, CE; Rajan, V; Wightman, RM | 1 |
Kruzich, PJ; Xi, J | 1 |
Angulo, JA; Xu, W; Zhu, JP | 1 |
Akita, H; Hoka, S; Jitsuki, S; Ogata, M; Ogura, T; Oh-Nishi, A; Saji, M | 1 |
Ishii, S; Ito, T; Kaneko, Y; Kashiwa, A; Nishikawa, T; Umino, A | 1 |
Achat-Mendes, C; Anderson, KL; Itzhak, Y | 1 |
Cass, WA; Maragos, WF; Nath, A; Steiner, J; Theodore, S; Young, K | 1 |
Dluzen, DE; Liu, B | 1 |
Fujimoto, Y; Hashimoto, K; Iyo, M; Kitaichi, K; Nakayama, H; Shimizu, E; Zhang, L | 1 |
Carroll, ME; Newman, JL | 1 |
Barr, AM; Honer, WG; Lang, DJ; Lecomte, T; MacEwan, GW; Panenka, WJ; Thornton, AE | 1 |
Ali, S; Bowyer, JF | 1 |
Fukazawa, Y; Kiguchi, N; Kishioka, S; Maeda, T; Ozaki, M; Yamamoto, A | 1 |
Blake, BL; Breese, GR; Devine, DP; Egami, K; Jinnah, HA; Muehlmann, AM | 1 |
Melo, P; Rodrigues, LG; Silva, MC; Tavares, MA | 2 |
Kalivas, PW; Melendez, RI; Murphy, TH; Pacchioni, AM; Shih, A; Vallone, J | 1 |
Fukuda, H; Kawakami, K; Morishita, R; Ogihara, T; Sata, M; Sato, N; Shimamura, M; Tomimatsu, T; Wakayama, K | 1 |
Brummelte, S; Neddens, J; Teuchert-Noodt, G | 1 |
Koob, GF; Pulvirenti, L; Wang, Z; Wee, S; Woolverton, WL | 1 |
Abekawa, T; Ito, K; Koyama, T; Nakagawa, S | 1 |
Clemens, KJ; Cornish, JL; Hunt, GE; McGregor, IS | 1 |
Itoh, H; Kurachi, M; Matsuoka, T; Sumiyoshi, T; Uehara, T | 1 |
Abekawa, T; Fang, YR; Ito, K; Koyama, T; Li, XB | 1 |
Ago, Y; Baba, A; Hashimoto, H; Matsuda, T; Nakamura, S; Takahashi, K | 1 |
Cho, AK; Fairbanks, LA; Jorgensen, MJ; Laćan, G; Melega, WP; Morton, G; Pham, J; Way, BM | 1 |
Gross, G; Groth, I; Jongen-Relo, A; Rex, A; Wicke, KM | 1 |
Flumerfelt, BA; Hrycyshyn, AW; Rajakumar, B; Rajakumar, N | 1 |
Geier, JE; Gold, MS; Jeung, JA; Kobeissy, FH; Warren, MW | 1 |
Harvey, DC; Laćan, G; Melega, WP; Way, BM | 1 |
Ali, S; Bowyer, JF; Robinson, B; Schmued, LC | 1 |
Mizoguchi, H; Nabeshima, T; Yamada, K | 1 |
Ago, Y; Baba, A; Matsuda, T; Nakamura, S | 1 |
Chung, YK; Ha, HJ; Jang, J; Jung, MW; Kim, YB | 1 |
Bratton, GR; Hart, N; Nation, JR; Rocha, A; Valles, R | 1 |
Hashimoto, K | 1 |
Brady, AM; Glick, SD; McCallum, SE; O'Donnell, P | 1 |
Andreas, K; Fischer, HD; Schmidt, J | 1 |
Kanaya, T; Sarai, K; Sera, H; Yonekawa, M | 1 |
Kunishima, C; Nabeshima, T; Shibuya, H; Toru, M; Yamada, K; Yoshikawa, T | 1 |
Brent, J; Kulig, K; McKinney, PE; Phillips, S; Tomaszewski, C | 1 |
Ellison, G; Switzer, RC | 1 |
Fuse, Y; Matsuoka, H; Numachi, Y; Sato, M; Yoshida, S | 1 |
Furukawa, H; Nabeshima, T; Noda, Y; Yamada, K | 1 |
Fukuda, A; Kumazaki, M; Kunimatsu, M; Nishino, H; Onizuka, K; Sasaki, M; Takaku, A | 1 |
Kikura, R; Mukai, T; Nakahara, Y; Yasuhara, M | 1 |
Abekawa, T; Ito, K; Koyama, T; Ohmori, T | 1 |
Yamamoto, J | 1 |
Hashiguchi, H; Ishida, Y; Ishizuka, Y; Kuwahara, I; Mitsuyama, Y; Nishimori, T; Todaka, K | 1 |
Carter, RJ; Morton, AJ; Reynolds, DS | 1 |
Ito, K | 1 |
Jodo, E; Kayama, Y; Matsuki, T; Niwa, S; Suzuki, Y; Takeuchi, S | 1 |
Green, S; Jakowec, MW; Petzinger, GM; Tolwani, RJ; Waggie, K | 1 |
Boonchoong, P; Boonyarat, C; Peungvicha, P; Toasaksiri, S; Vajragupta, O; Watanabe, H; Wongkrajang, Y | 1 |
Goldberg, SR; Munzar, P | 1 |
Kurachi, M; Sumiyoshi, T; Tanii, Y; Uehara, T | 1 |
Leung, LS; Ma, J | 1 |
Horikomi, K; Miwa, T; Takahashi, S | 1 |
Fleckenstein, AE; Hanson, GR; Kokoshka, JM; Wilkins, DG | 1 |
Goto, K; Ikemoto, S; Ishiguro, T; Yui, K | 1 |
Baumann, MH; Carroll, FI; Dersch, CM; Partilla, JS; Rice, KC; Rothman, RB | 1 |
Ali, SF; Imam, SZ; Islam, F; Itzhak, Y; Slikker, W | 1 |
Ali, SF; Miller, DB; O'Callaghan, JP | 1 |
Kato, K; Kobayashi, M; Niwa, S; Ono, M; Shishido, K; Shishido, T | 1 |
Bell, KP; Choi, PK; Clarkson, ED; Esplen, JE; Freed, CR; Heidenreich, KA; Zawada, WM | 1 |
Cho, AK; Kuczenski, R; Melega, WP; Segal, DS | 1 |
Edgar, DM; Mignot, E; Nishino, S; Sora, I; Uhl, GH; Wisor, JP | 1 |
Borlongan, C; Chang, CF; Chiang, YH; Hayashi, T; Lin, SZ; Su, TP; Tsao, LI; Wang, Y | 1 |
Bonhomme, N; Casara, P; Dorey, G; Lestage, P; Lockhart, B; Roger, A | 1 |
Davidson, C; Ellinwood, EH; Gow, AJ; Lee, TH | 1 |
Kelsoe, JR; Niculescu, AB | 1 |
Dawirs, RR; Teuchert-Noodt, G | 1 |
Check, E | 1 |
Costain, WJ; Crocker, SF; Denovan-Wright, EM; Hamilton, LC; MacGibbon, GA; Murphy, KM; Robertson, HA | 1 |
Hashiguchi, H; Ishida, Y; Mitsuyama, Y; Nishimori, T; Takeda, R; Todaka, K | 1 |
Brown, VM; Cherry, SR; Khan, AH; Lacan, G; Leahy, RM; Melega, WP; Ossadtchi, A; Smith, DJ; Yee, S | 1 |
Hickey, MA; Morton, AJ; Reynolds, GP | 1 |
Gewin, V | 1 |
Ali, SF; Itzhak, Y | 1 |
Seltzer, V; Tonge, SR | 1 |
Sudilovsky, A | 1 |
Maeda, N; Matsuoka, N; Ohkubo, Y; Yamaguchi, I; Yamazaki, M | 1 |
Wagner, GC; Walsh, SL | 1 |
Machiyama, Y | 1 |
Carney, JM; Cheng, MS; Landrum, RW; Seale, TW | 1 |
Close, SP; Elliott, PJ; Hayes, AG; Marriott, AS; Walsh, DM | 1 |
Miyamoto, K | 1 |
Hada, H; Miyamoto, K | 1 |
Matsunaga, T; Morita, M; Takeda, N; Wada, H; Yamatodani, A | 1 |
Hashizume, K; Manaka, S; Sasaki, M; Takakura, K | 1 |
Barros, HM; Leite, JR | 1 |
Hatanaka, H; Ikeda, T; Matsui, Y; Miyao, Y; Mogami, H; Okamoto, Y; Shimizu, K; Tsuda, N; Yamada, M | 1 |
Ichikawa, J | 1 |
Kuribara, H; Tadokoro, S | 1 |
Ando, K; Hironaka, N; Yanagita, T | 1 |
Gomita, Y; Ogawa, N; Ueki, S | 1 |
Fujiwara, Y; Fukuda, K; Harada, T; Kashihara, K; Otsuki, S; Sato, M; Yasuda, J | 1 |
Fog, R | 1 |
Utena, H | 1 |
Ellinwood, EH; Grabowy, R; Sudilovsky, A | 1 |
Amarose, AP; Muller, TP; Schuster, CR | 1 |
Ellinwood, EH; Nelson, LM; Sudilovsky, A | 1 |
Ellinwood, EH; Nelson, L; Sudilovsky, A | 1 |
Machiyama, U; Utena, H | 1 |
32 review(s) available for methamphetamine and Disease Models, Animal
Article | Year |
---|---|
Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals.
Topics: Animals; Behavior, Animal; Brain; Cannabidiol; Cannabinoids; Disease Models, Animal; Dopamine; Humans; Methamphetamine; Piperidines; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptor, Serotonin, 5-HT1A; Recurrence; Reward; Self Administration; Substance-Related Disorders; TRPV Cation Channels | 2020 |
Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson's disease.
Topics: Animals; Apoptosis; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Humans; Methamphetamine; Mice; Mitochondrial Dynamics; Oxidative Stress; Parkinson Disease, Secondary; Rats | 2021 |
Mithramycin, an agent for developing new therapeutic drugs for neurodegenerative diseases.
Topics: Animals; Cell Death; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Endoplasmic Reticulum Stress; Hippocampus; Humans; Huntington Disease; Long-Term Potentiation; Methamphetamine; Mice; Molecular Targeted Therapy; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Oxidative Stress; Plicamycin; Reperfusion Injury | 2013 |
Transcriptional and epigenetic substrates of methamphetamine addiction and withdrawal: evidence from a long-access self-administration model in the rat.
Topics: Animals; Behavior, Addictive; Disease Models, Animal; Epigenesis, Genetic; Gene Regulatory Networks; Humans; Methamphetamine; Rats; Self Administration; Time Factors; Transcription Factors | 2015 |
Sources of variation in the design of preclinical studies assessing the effects of amphetamine-type stimulants in pregnancy and lactation.
Topics: Amphetamine; Amphetamines; Animals; Animals, Newborn; Central Nervous System Stimulants; Disease Models, Animal; Female; Lactation; Methamphetamine; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Rats, Wistar; Research Design | 2015 |
Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.
Topics: Acetylation; Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Disease Models, Animal; Epigenesis, Genetic; Gene Expression; Histone Deacetylases; Histones; Humans; Methamphetamine; Methylation; Mice; Neuronal Plasticity; Proto-Oncogene Mas; Rats | 2015 |
Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Corpus Striatum; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Humans; Methamphetamine; Rats | 2016 |
Identification of Treatment Targets in a Genetic Mouse Model of Voluntary Methamphetamine Drinking.
Topics: Animals; Central Nervous System Stimulants; Disease Models, Animal; Dopamine; Humans; Methamphetamine; Mice; Mice, Transgenic; Receptors, G-Protein-Coupled; Substance-Related Disorders; Vesicular Monoamine Transport Proteins | 2016 |
The Role of Oxidative Stress in Methamphetamine-induced Toxicity and Sources of Variation in the Design of Animal Studies.
Topics: Animals; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Methamphetamine; Neurotoxicity Syndromes; Oxidative Stress | 2017 |
Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Cognition Disorders; Disease Models, Animal; HIV Infections; HIV-1; Humans; Methamphetamine; Social Behavior Disorders | 2016 |
[Involvement of prefrontal serotonergic neurons in methamphetamine-induced behavioral sensitization].
Topics: Animals; Central Nervous System Stimulants; Disease Models, Animal; Humans; Methamphetamine; Mice; Motor Activity; Neurons; Prefrontal Cortex; Psychoses, Substance-Induced; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT2; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Stimulation, Chemical; Substance-Related Disorders | 2008 |
Neuroprotective actions of sex steroids in Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopamine; Dopamine Agents; Estrogens; Humans; Methamphetamine; Mitogen-Activated Protein Kinases; Neural Pathways; Neuroprotective Agents; Parkinson Disease; Phosphatidylinositol 3-Kinases; Progesterone; Receptors, Estrogen; Sex Characteristics; Signal Transduction; Steroids | 2009 |
[Establishment and evaluation of animal model with methamphetamine poisoning].
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Central Nervous System Stimulants; Cerebral Cortex; Disease Models, Animal; Forensic Toxicology; Humans; Injections, Intraperitoneal; Methamphetamine; Stereotyped Behavior | 2009 |
Animal models of neurological disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Amyloid beta-Protein Precursor; Animals; Antipsychotic Agents; Brain Ischemia; Central Nervous System; Central Nervous System Stimulants; Disease Models, Animal; Humans; Methamphetamine; Nervous System Diseases; Neurotoxins; Oxidopamine; Reserpine; Rotenone; Uncoupling Agents | 2010 |
[Molecular mechanism for methamphetamine-induced memory impairment].
Topics: Animals; Antipsychotic Agents; Central Nervous System Stimulants; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Humans; Memory Disorders; Methamphetamine; Mice; Mitogen-Activated Protein Kinase 3; Psychoses, Substance-Induced; Rats; Receptors, GABA; Substance-Related Disorders | 2010 |
Animal models of Parkinson's disease.
Topics: Animals; Disease Models, Animal; Humans; Insecticides; Methamphetamine; MPTP Poisoning; Oxidopamine; Parkinson Disease | 2012 |
Medication discovery for addiction: translating the dopamine D3 receptor hypothesis.
Topics: Animals; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Humans; Methamphetamine; Molecular Structure; Receptors, Dopamine D3; Substance-Related Disorders | 2012 |
Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption.
Topics: Animals; Biogenic Monoamines; Disease Models, Animal; Humans; Methamphetamine; Nervous System Diseases; Oxidative Stress; Research Design | 2003 |
[Stress sensitization induced by stressor and methamphetamine].
Topics: Amphetamine; Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Disease Models, Animal; Guinea Pigs; Hallucinations; Humans; Methamphetamine; Mice; Rats; Schizophrenia; Stress, Physiological; Substance-Related Disorders; Synaptic Transmission | 2004 |
The need for speed: an update on methamphetamine addiction.
Topics: Amphetamine-Related Disorders; Animals; Brain; Central Nervous System Stimulants; Cognition Disorders; Cross-Sectional Studies; Disease Models, Animal; Humans; Methamphetamine; Neurotoxicity Syndromes; Psychoses, Substance-Induced | 2006 |
MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Interactions; Hallucinogens; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Social Behavior; Substance Abuse, Intravenous; Substance-Related Disorders | 2007 |
Neuropsychotoxicity of abused drugs: involvement of matrix metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-2 in methamphetamine-induced behavioral sensitization and reward in rodents.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Disease Models, Animal; Dopamine; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Methamphetamine; Mice; Mice, Knockout; Nucleus Accumbens; Oligonucleotides, Antisense; Protease Inhibitors; Reward; Rodentia; Tissue Inhibitor of Metalloproteinase-2; Up-Regulation | 2008 |
Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Bridged Bicyclo Compounds, Heterocyclic; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Dioxanes; Dioxoles; Disease Models, Animal; Ligands; Methamphetamine; Mice; Motor Activity; Oxazines; Receptors, Serotonin; Ritanserin; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin 5-HT3 Receptor Antagonists; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists | 2008 |
[Minocycline as a therapeutic drug for methamphetamine use disorders].
Topics: Animals; Anti-Bacterial Agents; Brain; Disease Models, Animal; Humans; Methamphetamine; Minocycline; N-Methyl-3,4-methylenedioxyamphetamine; Positron-Emission Tomography; Psychoses, Substance-Induced; Schizophrenia; Substance-Related Disorders | 2008 |
[Context-dependent sensitization: reconsideration and a hypothesis].
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Classical; Disease Models, Animal; Methamphetamine; Rats; Schizophrenia; Substance-Related Disorders | 1997 |
Experimental models of Parkinson's disease: insights from many models.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopamine; Humans; Methamphetamine; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Reserpine | 1999 |
Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia.
Topics: Amphetamines; Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Humans; Japan; Methamphetamine; Psychoses, Substance-Induced; Research; Schizophrenia; Substance-Related Disorders | 2000 |
Methamphetamine dependence: medication development efforts based on the dual deficit model of stimulant addiction.
Topics: Animals; Behavior, Addictive; Biogenic Amines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Inhibitory Concentration 50; Methamphetamine; Neurotransmitter Uptake Inhibitors; Rats; Synaptosomes; Tritium | 2000 |
Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Disease Models, Animal; Humans; Methamphetamine; Rats | 2001 |
Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment.
Topics: Amphetamine-Related Disorders; Animals; Apoptosis; Central Nervous System; Disease Models, Animal; Drug Administration Schedule; Humans; Methamphetamine; Necrosis; Nerve Degeneration; Neurotoxins; Parkinson Disease | 2001 |
A novel pharmacological concept in an animal model of psychosis.
Topics: Adrenergic Uptake Inhibitors; Animals; Dentate Gyrus; Disease Models, Animal; Dopamine; Gerbillinae; Hippocampus; Immunohistochemistry; Inhibition, Psychological; Methamphetamine; Nerve Net; Prefrontal Cortex; Psychotic Disorders; Reaction Time | 2001 |
On stereotypy and catalepsy: studies on the effect of amphetamines and neuroleptics in rats.
Topics: Amphetamine; Animals; Basal Ganglia; Caffeine; Catalepsy; Cocaine; Compulsive Behavior; Corpus Striatum; Disease Models, Animal; Dopamine; Hippocampus; Humans; Lysergic Acid Diethylamide; Methamphetamine; Methylphenidate; Morphine; Norepinephrine; Pemoline; Phenmetrazine; Psychoses, Substance-Induced; Rats; Reserpine; Thalamus; Tranquilizing Agents | 1972 |
386 other study(ies) available for methamphetamine and Disease Models, Animal
Article | Year |
---|---|
Effect of PPM1F in dorsal raphe 5-HT neurons in regulating methamphetamine-induced conditioned place preference performance in mice.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Classical; Disease Models, Animal; Dorsal Raphe Nucleus; Methamphetamine; Mice; Mice, Knockout; Phosphoprotein Phosphatases; Serotonergic Neurons | 2022 |
Effects of synthetic cathinone naphyrone in the conditioned place preference test - Evidence of its addictive potential.
Topics: Alkaloids; Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Classical; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Methamphetamine; Pentanones; Pyrrolidines; Rats; Rats, Wistar; Substance-Related Disorders | 2022 |
The effects of alcohol drinking on subsequent methamphetamine self-administration and relapse in adolescent female rats.
Topics: Age Factors; Alcohol Drinking; Alcoholism; Amphetamine-Related Disorders; Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Female; Methamphetamine; Rats; Rats, Sprague-Dawley; Recurrence; Self Administration | 2022 |
Can prenatal methamphetamine exposure be considered a good animal model for ADHD?
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Cognition; Disease Models, Animal; Female; Fetal Hypoxia; Gestational Age; Locomotion; Maternal Exposure; Methamphetamine; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Wistar | 2021 |
Methamphetamine Enhances Cryptococcus neoformans Melanization, Antifungal Resistance, and Pathogenesis in a Murine Model of Drug Administration and Systemic Infection.
Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; HIV Infections; Humans; Levodopa; Mammals; Melanins; Methamphetamine; Mice; Saccharomyces cerevisiae; Sepsis | 2022 |
Targeting α6GABA
Topics: Animals; Disease Models, Animal; gamma-Aminobutyric Acid; Humans; Methamphetamine; Mice; Phencyclidine; Rats; Receptors, GABA-A; Schizophrenia | 2022 |
5-HT5A Receptor Antagonist ASP5736 Ameliorates Several Abnormal Behaviors in an Fmr1-Targeted Transgenic Male Rat Model of Fragile X Syndrome.
Topics: Animals; Disease Models, Animal; Fragile X Mental Retardation Protein; Fragile X Syndrome; Guanidines; Isoquinolines; Male; Memory Disorders; Methamphetamine; Mice; Mice, Knockout; Phencyclidine; Rats; Rats, Transgenic; Receptors, Serotonin; Scopolamine; Serotonin; Serotonin Antagonists | 2022 |
Chronic methamphetamine exposure exerts few effects on the iTat mouse model of HIV, but blocks Tat expression-induced slowed reward retrieval.
Topics: Amphetamine-Related Disorders; Animals; Calbindins; Disease Models, Animal; HIV Infections; Humans; Methamphetamine; Mice; Mice, Transgenic; Reward; tat Gene Products, Human Immunodeficiency Virus | 2023 |
Effects of adolescent methylphenidate administration on methamphetamine conditioned place preference in an animal model of attention-deficit/hyperactivity disorder: Examination of potential sex differences.
Topics: Adolescent; Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Disease Models, Animal; Female; Humans; Male; Methamphetamine; Methylphenidate; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sex Characteristics | 2023 |
Methylone produces antidepressant-relevant actions and prosocial effects.
Topics: Animals; Antidepressive Agents; Depression; Depressive Disorder, Major; Disease Models, Animal; Humans; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Rats; Stress, Psychological | 2024 |
Interaction of stress and stimulants in female rats: Role of chronic stress on later reactivity to methamphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Chronic Disease; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Female; Methamphetamine; Movement; Nucleus Accumbens; Rats, Sprague-Dawley; Stress, Psychological | 2019 |
Identification of the Differentially Expressed Genes Involved in the Synergistic Neurotoxicity of an HIV Protease Inhibitor and Methamphetamine.
Topics: Acquired Immunodeficiency Syndrome; Animals; Cell Line, Tumor; Central Nervous System Stimulants; Computational Biology; Disease Models, Animal; Drug Synergism; Gene Expression Profiling; Gene Expression Regulation; Gene Ontology; HIV Infections; HIV Protease Inhibitors; Humans; Male; Methamphetamine; Mice | 2019 |
Sex Differences in Escalated Methamphetamine Self-Administration and Altered Gene Expression Associated With Incubation of Methamphetamine Seeking.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Female; Gene Expression; Male; Methamphetamine; Nucleus Accumbens; Orexin Receptors; Rats; Rats, Long-Evans; Receptors, Opioid; RNA, Messenger; Sex Characteristics; Substance Withdrawal Syndrome; Vasopressins | 2019 |
Enhanced methamphetamine-induced conditioned place preference in risk-taking rats.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Choice Behavior; Conditioning, Psychological; Disease Models, Animal; Disease Susceptibility; Individuality; Male; Methamphetamine; Rats; Rats, Long-Evans; Reward; Risk-Taking; Substance-Related Disorders | 2020 |
Methamphetamine administration impairs behavior, memory and underlying signaling pathways in the hippocampus.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Gliosis; Hippocampus; Long-Term Potentiation; Male; Memory Disorders; Methamphetamine; Rats; Rats, Sprague-Dawley; Signal Transduction; Spatial Memory; Synaptic Transmission | 2020 |
Methamphetamine Induces Intestinal Inflammatory Injury via Nod-Like Receptor 3 Protein (NLRP3) Inflammasome Overexpression In Vitro and In Vivo.
Topics: Animals; Apoptosis; Carrier Proteins; Caspase 1; Cell Line; Disease Models, Animal; Inflammasomes; Inflammation; Intestinal Mucosa; Male; Methamphetamine; Mice; Mice, Inbred C57BL; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; Transcription Factor RelA | 2019 |
Acute changes in the retina and central retinal artery with methamphetamine.
Topics: Animals; Central Nervous System Stimulants; Disease Models, Animal; Electroretinography; Enzyme-Linked Immunosorbent Assay; Immunoblotting; In Situ Nick-End Labeling; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Retina; Retinal Artery; Retinal Degeneration | 2020 |
High ambient temperature increases the toxicity and lethality of 3,4-methylenedioxymethamphetamine and methcathinone.
Topics: Ammonia; Animals; Brain; Central Nervous System Stimulants; Disease Models, Animal; Female; Glutamic Acid; Hot Temperature; Male; Methamphetamine; Mice; Mice, Inbred C57BL; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Propiophenones; Signal Transduction; Substance-Related Disorders | 2020 |
An operant social self-administration and choice model in rats.
Topics: Animals; Choice Behavior; Conditioning, Operant; Disease Models, Animal; Drug-Seeking Behavior; Female; Heroin; Male; Methamphetamine; Models, Psychological; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Remifentanil; Self Administration; Social Behavior; Substance-Related Disorders | 2020 |
Abstinence-dependent dissociable central amygdala microcircuits control drug craving.
Topics: Animals; Behavior, Animal; Central Amygdaloid Nucleus; Craving; Disease Models, Animal; Drug-Seeking Behavior; Humans; Interpersonal Relations; Male; Methamphetamine; Neurons; Protein Kinase C-delta; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Self Administration; Somatostatin | 2020 |
Alpha-Synuclein deficiency ameliorates chronic methamphetamine induced neurodegeneration in mice.
Topics: alpha-Synuclein; Animals; Autophagy; Axons; Cells, Cultured; Cyclin-Dependent Kinase 5; Disease Models, Animal; Glycogen Synthase Kinase 3 beta; Hippocampus; Lysosomes; Male; Methamphetamine; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Nerve Degeneration; Neurons; Neurotoxicity Syndromes; Phosphorylation; Substantia Nigra; tau Proteins; Time Factors | 2020 |
Partial MHC/neuroantigen peptide constructs attenuate methamphetamine-seeking and brain chemokine (C-C motif) ligand 2 levels in rats.
Topics: Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Chemokine CCL2; Disease Models, Animal; Drug-Seeking Behavior; Extinction, Psychological; Immunotherapy; Male; Memory Disorders; Methamphetamine; Neuroprotective Agents; Rats, Inbred Lew; Recombinant Fusion Proteins; Self Administration; Substance-Related Disorders | 2020 |
Extended access self-administration of methamphetamine is associated with age- and sex-dependent differences in drug taking behavior and recognition memory in rats.
Topics: Age Factors; Animals; Behavior, Animal; Central Nervous System Stimulants; Cognitive Dysfunction; Disease Models, Animal; Female; Male; Methamphetamine; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Sex Factors; Substance-Related Disorders | 2020 |
The Molecular-Container Calabadion-2 Prevents Methamphetamine-Induced Reinstatement in Rats: A Potential Approach to Relapse Prevention?
Topics: Amphetamine-Related Disorders; Animals; Behavior, Addictive; Behavior, Animal; Disease Models, Animal; Drug-Seeking Behavior; Extinction, Psychological; Heterocyclic Compounds, 4 or More Rings; Male; Methamphetamine; Rats, Long-Evans; Recurrence; Self Administration; Sulfonic Acids; Time Factors | 2020 |
Lack of dopamine D4 receptor participation in mouse hyperdopaminergic locomotor response.
Topics: Amphetamine-Related Disorders; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Sensitization; Clozapine; Disease Models, Animal; Dopamine Agents; Locomotion; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Transgenic; Psychotic Disorders; Pyridines; Pyrroles; Receptors, Dopamine D4 | 2021 |
The motivational valence of methamphetamine relates inversely to subsequent methamphetamine self-administration in female C57BL/6J mice.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Classical; Conditioning, Operant; Disease Models, Animal; Female; Methamphetamine; Mice; Mice, Inbred C57BL; Motivation; Sex Characteristics | 2021 |
Naltrexone attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Central Nervous System Sensitization; Central Nervous System Stimulants; Conditioning, Classical; Disease Models, Animal; Extinction, Psychological; Male; Mental Recall; Methamphetamine; Mice; Motivation; Naltrexone; Narcotic Antagonists | 2021 |
Sign tracking predicts cue-induced but not drug-primed reinstatement to methamphetamine seeking in rats: Effects of oxytocin treatment.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Addictive; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Classical; Cues; Disease Models, Animal; Extinction, Psychological; Female; Male; Methamphetamine; Motivation; Oxytocin; Rats; Rats, Sprague-Dawley; Recurrence; Reinforcement, Psychology; Reward | 2020 |
Gut dysbiosis associated with the rats' responses in methamphetamine-induced conditioned place preference.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Classical; Disease Models, Animal; Dysbiosis; Gastrointestinal Microbiome; Male; Methamphetamine; Rats; Rats, Sprague-Dawley | 2021 |
URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels.
Topics: Amidohydrolases; Animals; Anxiety; Behavior, Animal; Benzamides; Cannabinoid Receptor Antagonists; Carbamates; Central Nervous System Stimulants; Depression; Disease Models, Animal; Endocannabinoids; Male; Methamphetamine; Mice; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Substance Withdrawal Syndrome; TRPV Cation Channels | 2021 |
Methamphetamine pre-exposure induces steeper escalation of methamphetamine self-administration with consequent alterations in hippocampal glutamate AMPA receptor mRNAs.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Central Nervous System Stimulants; Craving; Disease Models, Animal; Gene Expression Regulation; Hippocampus; Male; Methamphetamine; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Time Factors | 2020 |
Transcriptional Profiling of Whisker Follicles and of the Striatum in Methamphetamine Self-Administered Rats.
Topics: Alzheimer Disease; Amphetamine-Related Disorders; Animals; Corpus Striatum; Disease Models, Animal; Gene Expression Regulation; Hair Follicle; High-Throughput Nucleotide Sequencing; Humans; Huntington Disease; Methamphetamine; Neostriatum; Parkinson Disease; Rats; Self Administration; Signal Transduction; Transcriptome; Vibrissae | 2020 |
Sex-specific sensitivity to methamphetamine-induced schizophrenia-relevant behaviours in
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Female; Gene Expression Profiling; Locomotion; Male; Methamphetamine; Mice; Mice, Transgenic; Neuregulin-1; Prefrontal Cortex; Prepulse Inhibition; Psychotropic Drugs; Schizophrenia; Schizophrenic Psychology; Sex Factors; Substance-Related Disorders | 2021 |
Female rats display higher methamphetamine-primed reinstatement and c-Fos immunoreactivity than male rats.
Topics: Amphetamine-Related Disorders; Animals; Central Amygdaloid Nucleus; Central Nervous System Stimulants; Disease Models, Animal; Drug-Seeking Behavior; Extinction, Psychological; Female; Gyrus Cinguli; Immunohistochemistry; Male; Methamphetamine; Nucleus Accumbens; Prefrontal Cortex; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Recurrence; Self Administration; Sex Factors | 2021 |
Retinal hypoxia and angiogenesis with methamphetamine.
Topics: Animals; Disease Models, Animal; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Retinal Neovascularization; Retinal Vessels; Sympathomimetics | 2021 |
Brain transcriptomics of nonhuman primates: A review.
Topics: Aging; Animals; Brain; Brain Diseases; Disease Models, Animal; Ethanol; Humans; Methamphetamine; Neurosciences; Primates; RNA-Seq; Sevoflurane; Transcriptome; Valproic Acid | 2021 |
Methamphetamine facilitates pulmonary and splenic tissue injury and reduces T cell infiltration in C57BL/6 mice after antigenic challenge.
Topics: Amphetamine-Related Disorders; Animals; Antigens, Bacterial; Apoptosis; Chemotaxis, Leukocyte; Disease Models, Animal; Female; Humans; Inflammation; Jurkat Cells; Lipopolysaccharides; Lung; Lung Injury; Lymphocyte Activation; Methamphetamine; Mice; Mice, Inbred C57BL; Spleen; Splenic Diseases; T-Lymphocytes | 2021 |
Methamphetamine Enhances HIV-Induced Aberrant Proliferation of Neural Progenitor Cells via the FOXO3-Mediated Mechanism.
Topics: AIDS Dementia Complex; Animals; Brain; Cell Cycle; Cell Division; Cells, Cultured; Chemokine CXCL12; Chromones; Disease Models, Animal; Forkhead Box Protein O3; Gene Expression Regulation, Viral; HIV Infections; HIV-1; Humans; Lateral Ventricles; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Morpholines; Nerve Tissue Proteins; Neural Stem Cells; Proto-Oncogene Proteins c-akt; Receptors, CXCR4; RNA, Messenger; Signal Transduction; Substance-Related Disorders | 2021 |
Changes of
Topics: Adult; Amphetamine-Related Disorders; Animals; Base Sequence; Biomarkers; Brain-Derived Neurotrophic Factor; Corpus Striatum; Disease Models, Animal; DNA Methylation; Exons; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Hippocampus; Humans; Male; Methamphetamine; Rats; Sequence Analysis, DNA; Thailand; Young Adult | 2021 |
D1R/PP2A/p-CaMKIIα signaling in the caudate putamen is involved in acute methamphetamine-induced hyperlocomotion.
Topics: Animals; Benzazepines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Central Nervous System Stimulants; Disease Models, Animal; Humans; Locomotion; Male; Methamphetamine; Mice; Piperazines; Protein Phosphatase 2; Putamen; Receptors, Dopamine D1; Signal Transduction; Substance-Related Disorders | 2021 |
Effect of Chaihu-jia-Longgu-Muli decoction on withdrawal symptoms in rats with methamphetamine-induced conditioned place preference.
Topics: Animals; Behavior, Animal; beta-Endorphin; Central Nervous System Stimulants; Conditioning, Psychological; Corpus Striatum; Disease Models, Animal; Dopamine; Drugs, Chinese Herbal; Interleukin-1alpha; Interleukin-2; Male; Methamphetamine; Open Field Test; Rats, Sprague-Dawley; Serotonin; Substance Withdrawal Syndrome | 2021 |
Dopaminergic Neuron-Specific Deletion of p53 Gene Attenuates Methamphetamine Neurotoxicity.
Topics: Animals; bcl-2-Associated X Protein; Benzothiazoles; Central Nervous System Stimulants; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Enzyme Inhibitors; Exploratory Behavior; Fever; Glial Fibrillary Acidic Protein; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neurotoxicity Syndromes; rho GTP-Binding Proteins; Substantia Nigra; Toluene; Tumor Suppressor Protein p53; Tyrosine 3-Monooxygenase; Up-Regulation | 2017 |
Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia.
Topics: Analysis of Variance; Animals; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Ketamine; Locomotion; Methamphetamine; Methylazoxymethanol Acetate; Rats; Rats, Sprague-Dawley; Schizophrenia; Self Administration | 2017 |
Preclinical Evidence That 5-HT1B Receptor Agonists Show Promise as Medications for Psychostimulant Use Disorders.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Methamphetamine; Motor Activity; Oxazolidinones; Pyridines; Random Allocation; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Reinforcement Schedule; Serotonin 5-HT1 Receptor Agonists; Tryptamines | 2017 |
Methamphetamine-alcohol interactions in murine models of sequential and simultaneous oral drug-taking.
Topics: Administration, Oral; Alcohol Drinking; Amphetamine-Related Disorders; Animals; Choice Behavior; Conditioning, Operant; Disease Models, Animal; Drug Interactions; Ethanol; Female; Male; Methamphetamine; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Self Administration | 2017 |
HIV and drug abuse mediate astrocyte senescence in a β-catenin-dependent manner leading to neuronal toxicity.
Topics: AIDS Dementia Complex; Animals; Animals, Genetically Modified; Astrocytes; beta Catenin; Calcium-Binding Proteins; Cellular Senescence; Central Nervous System Stimulants; Cyclin-Dependent Kinase Inhibitor p16; Disease Models, Animal; DNA-Binding Proteins; Gene Expression Regulation; HIV-1; Humans; Male; Methamphetamine; Mice; Microfilament Proteins; Neurons; Primary Cell Culture; Rats; Signal Transduction; Substance-Related Disorders | 2017 |
Systemic PD149163, a neurotensin receptor 1 agonist, decreases methamphetamine self-administration in DBA/2J mice without causing excessive sedation.
Topics: Animals; Disease Models, Animal; Dopamine; Humans; Methamphetamine; Mice; Mice, Inbred DBA; Neurotensin; Receptors, Neurotensin; Self Administration; Substance-Related Disorders | 2017 |
Learning and memory effects of neonatal methamphetamine exposure in rats: Role of reactive oxygen species and age at assessment.
Topics: Animals; Animals, Newborn; Antioxidants; Cyclic N-Oxides; Disease Models, Animal; Female; Freezing Reaction, Cataleptic; Learning; Learning Disabilities; Male; Memory; Methamphetamine; Neuroprotective Agents; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Rats, Sprague-Dawley; Reactive Oxygen Species | 2017 |
How methamphetamine exposure during different neurodevelopmental stages affects social behavior of adult rats?
Topics: Animals; Animals, Newborn; Central Nervous System Stimulants; Disease Models, Animal; Estrous Cycle; Female; Male; Methamphetamine; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Rats, Wistar; Sex Characteristics; Social Behavior | 2017 |
Differential stimulus control of drug-seeking: multimodal reinstatement.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Cocaine-Related Disorders; Conditioning, Psychological; Cues; Disease Models, Animal; Drug-Seeking Behavior; Food; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Substance-Related Disorders | 2018 |
Persistent effects of acute stress on fear and drug-seeking in a novel model of the comorbidity between post-traumatic stress disorder and addiction.
Topics: Animals; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Corticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Electroshock; Fear; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Rats; Rats, Long-Evans; Self Administration; Stress Disorders, Post-Traumatic | 2017 |
Assessing the role of dopamine in the differential neurotoxicity patterns of methamphetamine, mephedrone, methcathinone and 4-methylmethamphetamine.
Topics: Analysis of Variance; Animals; Body Temperature; Brain; Designer Drugs; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Synergism; Female; Methamphetamine; Mice; Mice, Inbred C57BL; Neuroglia; Neurotoxicity Syndromes; Propiophenones; Tyrosine 3-Monooxygenase | 2018 |
Intranasal insulin treatment restores cognitive deficits and insulin signaling impairment induced by repeated methamphetamine exposure.
Topics: Administration, Intranasal; Amphetamine-Related Disorders; Animals; Cognition Disorders; Disease Models, Animal; Gene Expression Regulation; Gene Regulatory Networks; Insulin; Male; Memory, Short-Term; Methamphetamine; Mitochondria; Rats; Rats, Wistar; Signal Transduction | 2018 |
Are changes in excitability in the hippocampus of adult male rats induced by prenatal methamphetamine exposure or stress?
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy; Female; Hippocampus; Magnesium Deficiency; Male; Methamphetamine; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Rats, Wistar; Stress, Psychological; Tissue Culture Techniques | 2017 |
Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Body Temperature Regulation; Brain; Central Nervous System Stimulants; Disease Models, Animal; Female; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Homovanillic Acid; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurotoxicity Syndromes; Receptors, G-Protein-Coupled; Time Factors; Tyrosine 3-Monooxygenase | 2017 |
Differential effects of dopaminergic drugs on spontaneous motor activity in the common marmoset following pretreatment with a bilateral brain infusion of 6-hydroxydopamine.
Topics: Animals; Apomorphine; Area Under Curve; Callithrix; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Dopaminergic Neurons; Dose-Response Relationship, Drug; Immunohistochemistry; Levodopa; Male; Methamphetamine; Motor Activity; Oxidopamine; Parkinsonian Disorders; Substantia Nigra; Tyrosine 3-Monooxygenase | 2017 |
Methamphetamine-induced impulsivity during chronic methamphetamine treatment in rats: Effects of the TAAR 1 agonist RO5263397.
Topics: Animals; Central Nervous System Stimulants; Choice Behavior; Disease Models, Animal; Dose-Response Relationship, Drug; Impulsive Behavior; Locomotion; Male; Methamphetamine; Oxazoles; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Substance-Related Disorders; Time Factors | 2018 |
The antipsychotic-like effects in rodents of YQA31 involve dopamine D3 and 5-HT1A receptor.
Topics: Animals; Antipsychotic Agents; Benzothiazoles; Cognition Disorders; Disease Models, Animal; Dizocilpine Maleate; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Piperazines; Pyridines; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D3; Recognition, Psychology | 2017 |
Selective Activation of Striatal NGF-TrkA/p75NTR/MAPK Intracellular Signaling in Rats That Show Suppression of Methamphetamine Intake 30 Days following Drug Abstinence.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Electroshock; Extracellular Signal-Regulated MAP Kinases; Foot; Gene Expression; Male; Methamphetamine; Nerve Growth Factor; Nerve Tissue Proteins; Rats, Sprague-Dawley; Receptor, trkA; Receptors, Growth Factor; Receptors, Nerve Growth Factor; Self Administration; Signal Transduction | 2018 |
Chronic paroxetine treatment prevents disruption of methamphetamine-sensitive circadian oscillator in a transgenic mouse model of Huntington's disease.
Topics: Animals; Central Nervous System Stimulants; Circadian Clocks; Circadian Rhythm; Cocaine; Disease Models, Animal; Female; Huntington Disease; Male; Methamphetamine; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Motor Activity; Paroxetine; Receptors, Dopamine; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Vesicular Monoamine Transport Proteins | 2018 |
Downregulation of 5-hydroxytryptamine
Topics: Animals; Attention; Central Nervous System Stimulants; Cognition; Disease Models, Animal; Down-Regulation; Executive Function; Gene Knockdown Techniques; Impulsive Behavior; Male; Maze Learning; Memory; Methamphetamine; Mice, Inbred C57BL; Motor Activity; Phencyclidine; Prefrontal Cortex; Random Allocation; Receptors, Serotonin; Schizophrenia; Schizophrenic Psychology | 2018 |
Generalization of effects of environmental enrichment on seeking for different classes of drugs of abuse.
Topics: Amphetamine-Related Disorders; Animals; Craving; Cues; Disease Models, Animal; Drug-Seeking Behavior; Environment; Generalization, Psychological; Heroin; Heroin Dependence; Housing, Animal; Male; Methamphetamine; Nicotine; Psychotropic Drugs; Rats, Sprague-Dawley; Self Administration; Tobacco Use Disorder | 2018 |
"Ecstasy" to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Drug Combinations; Hallucinogens; HEK293 Cells; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Serotonin; Substance-Related Disorders | 2018 |
Parallel Effects of Methamphetamine on Anxiety and CCL3 in Humans and a Genetic Mouse Model of High Methamphetamine Intake.
Topics: Adult; Amphetamine-Related Disorders; Animals; Anxiety; Central Nervous System Stimulants; Chemokine CCL3; Disease Models, Animal; Female; Follow-Up Studies; Genetic Predisposition to Disease; Hippocampus; Humans; Male; Methamphetamine; Mice, Inbred C57BL; Mice, Inbred DBA; Middle Aged; RNA, Messenger; Treatment Outcome | 2017 |
Combined treatment with a selective PDE10A inhibitor TAK-063 and either haloperidol or olanzapine at subeffective doses produces potent antipsychotic-like effects without affecting plasma prolactin levels and cataleptic responses in rodents.
Topics: Administration, Oral; Akathisia, Drug-Induced; Animals; Antipsychotic Agents; Benzodiazepines; Catalepsy; Corpus Striatum; Dendritic Spines; Disease Models, Animal; Dopamine Antagonists; Drug Synergism; Drug Therapy, Combination; Haloperidol; Humans; Male; Methamphetamine; Mice; Mice, Inbred ICR; Neurons; Olanzapine; Phosphodiesterase Inhibitors; Prolactin; Pyrazoles; Pyridazines; Rats; Rats, Sprague-Dawley; Synaptic Potentials; Treatment Outcome | 2018 |
New Scaffold for Lead Compounds to Treat Methamphetamine Use Disorders.
Topics: Administration, Oral; Amphetamine-Related Disorders; Animals; Cardiotoxicity; Disease Models, Animal; Dopamine; Ether-A-Go-Go Potassium Channels; Humans; Lobeline; Locomotion; Male; Methamphetamine; Molecular Structure; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Treatment Outcome; Vesicular Monoamine Transport Proteins | 2018 |
A Single High Dose of Methamphetamine Reduces Monoamines and Impairs Egocentric and Allocentric Learning and Memory in Adult Male Rats.
Topics: Animals; Biogenic Monoamines; Body Temperature; Central Nervous System Stimulants; Disease Models, Animal; Male; Maze Learning; Memory Disorders; Methamphetamine; Rats; Rats, Sprague-Dawley; Spatial Navigation; Statistics, Nonparametric; Time Factors | 2018 |
Effects of N-Alkyl-4-Methylamphetamine Optical Isomers on Plasma Membrane Monoamine Transporters and Abuse-Related Behavior.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Calcium; Central Nervous System Agents; Disease Models, Animal; HEK293 Cells; Humans; Isomerism; Male; Methamphetamine; Molecular Structure; Rats, Sprague-Dawley; Symporters; Synaptosomes | 2018 |
The Effects of Exposure to Mephedrone During Adolescence on Brain Neurotransmission and Neurotoxicity in Adult Rats.
Topics: Age Factors; Analysis of Variance; Animals; Brain; Central Nervous System Stimulants; Comet Assay; Disease Models, Animal; Dopamine; Glutamic Acid; Male; Methamphetamine; Microdialysis; Neurotoxicity Syndromes; Rats; Rats, Wistar; Serotonin; Synaptic Transmission | 2018 |
Diazepam suppresses the stress-induced dopaminergic release in the amygdala of methamphetamine-sensitized rat.
Topics: Amygdala; Animals; Behavior, Animal; Conditioning, Operant; Diazepam; Disease Models, Animal; Dopamine; Fear; GABA Modulators; Humans; Male; Mental Disorders; Methamphetamine; Microdialysis; Rats; Rats, Sprague-Dawley; Stress, Psychological | 2018 |
Striatal Reinnervation Process after Acute Methamphetamine-Induced Dopaminergic Degeneration in Mice.
Topics: Animals; Calcium-Binding Proteins; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dopamine; GAP-43 Protein; Glial Fibrillary Acidic Protein; Locomotion; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microfilament Proteins; Neurodegenerative Diseases; Presynaptic Terminals; Psychomotor Disorders; Recovery of Function; Silver Staining; Time Factors; Tyrosine 3-Monooxygenase | 2018 |
Limited modulation of the abuse-related behavioral effects of d-methamphetamine by disulfiram.
Topics: Acetaldehyde Dehydrogenase Inhibitors; Amphetamine-Related Disorders; Animals; Behavioral Symptoms; Central Nervous System Stimulants; Cocaine; Discrimination, Psychological; Disease Models, Animal; Disulfiram; Dose-Response Relationship, Drug; Female; Macaca mulatta; Male; Methamphetamine; Reinforcement, Psychology; Treatment Outcome | 2018 |
Cerebrovascular Injury After Serial Exposure to Chronic Stress and Abstinence from Methamphetamine Self-Administration.
Topics: Animals; Central Nervous System Stimulants; Cerebral Cortex; Cerebrovascular Circulation; Cerebrovascular Disorders; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Humans; Male; Methamphetamine; Occludin; Rats; Rats, Sprague-Dawley; Self Administration; Stress, Psychological | 2018 |
Low-frequency repetitive transcranial magnetic stimulation inhibits the development of methamphetamine-induced conditioned place preference.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Conditioning, Psychological; Corpus Striatum; Disease Models, Animal; Gene Expression; Male; Methamphetamine; Random Allocation; Rats, Sprague-Dawley; Receptors, GABA-A; Spatial Behavior; Transcranial Magnetic Stimulation | 2018 |
Chemogenetic activation of the perirhinal cortex reverses methamphetamine-induced memory deficits and reduces relapse.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Cues; Disease Models, Animal; Genetic Techniques; Male; Memory Disorders; Methamphetamine; Perirhinal Cortex; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Recurrence | 2018 |
Drug-taking in a socio-sexual context enhances vulnerability for addiction in male rats.
Topics: Animals; Behavior, Addictive; Central Nervous System Stimulants; Disease Models, Animal; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Self Administration; Sexual Behavior, Animal; Social Behavior | 2019 |
Depression-like symptoms of withdrawal in a genetic mouse model of binge methamphetamine intake.
Topics: Animals; Central Nervous System Stimulants; Depression; Disease Models, Animal; Female; Male; Methamphetamine; Mice; Mice, Inbred DBA; Substance Withdrawal Syndrome | 2019 |
Involvement of NLRP3 inflammasome in methamphetamine-induced microglial activation through miR-143/PUMA axis.
Topics: Animals; Apoptosis Regulatory Proteins; Cell Line; Disease Models, Animal; Gene Expression Regulation; Genetic Vectors; Inflammasomes; Lentivirus; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microglia; MicroRNAs; NLR Family, Pyrin Domain-Containing 3 Protein; Tumor Suppressor Proteins | 2019 |
Withdrawal from chronic treatment with methamphetamine induces anxiety and depression-like behavior in mice.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; Behavior, Animal; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Depression; Disease Models, Animal; Hippocampus; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Prefrontal Cortex; Substance Withdrawal Syndrome | 2019 |
Oxytocin inhibits methamphetamine-associated learning and memory alterations by regulating DNA methylation at the Synaptophysin promoter.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Disease Models, Animal; DNA Methylation; Learning; Male; Memory; Methamphetamine; Mice; Mice, Inbred C57BL; Oxytocics; Oxytocin; Promoter Regions, Genetic; Synaptophysin | 2020 |
Differential gene expression and stereological analyses of the cerebellum following methamphetamine exposure.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cerebellum; Disease Models, Animal; Gene Expression; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Signal Transduction | 2020 |
Function of complement factor H and imaging of small molecules by MALDI-MSI in a methamphetamine behavioral sensitization model.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Addictive; Behavior, Animal; Brain; Complement C1q; Complement Factor H; Conditioning, Classical; Disease Models, Animal; Hippocampus; Learning; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Molecular Imaging; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2019 |
Cannabidiol modulates the expression of neuroinflammatory factors in stress- and drug-induced reinstatement of methamphetamine in extinguished rats.
Topics: Amphetamine-Related Disorders; Animals; Anticonvulsants; Brain; Cannabidiol; Central Nervous System Stimulants; Disease Models, Animal; Inflammation; Male; Methamphetamine; Rats; Rats, Wistar; Stress, Physiological | 2020 |
HDAC superfamily promoters acetylation is differentially regulated by modafinil and methamphetamine in the mouse medial prefrontal cortex.
Topics: Acetylation; Animals; Central Nervous System Stimulants; Disease Models, Animal; Histone Deacetylases; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Modafinil; Prefrontal Cortex | 2020 |
Sex influences susceptibility to methamphetamine cardiomyopathy in mice.
Topics: Amphetamine-Related Disorders; Animals; Cardiomyopathy, Dilated; Disease Models, Animal; Female; Male; Methamphetamine; Mice, Inbred C57BL; Myocytes, Cardiac; Risk Assessment; Risk Factors; RNA, Messenger; Sex Factors; Time Factors; Transcription, Genetic | 2019 |
Compulsive drug use is associated with imbalance of orbitofrontal- and prelimbic-striatal circuits in punishment-resistant individuals.
Topics: Animals; Central Nervous System Stimulants; Compulsive Behavior; Connectome; Corpus Striatum; Disease Models, Animal; Electroshock; Male; Methamphetamine; Prefrontal Cortex; Punishment; Rats; Rats, Sprague-Dawley; Self Administration; Substance-Related Disorders | 2019 |
Preclinical characterization of AMPA receptor potentiator TAK-137 as a therapeutic drug for schizophrenia.
Topics: Animals; Cognition; Disease Models, Animal; Dizocilpine Maleate; Drug Evaluation, Preclinical; Excitatory Amino Acid Agonists; Gene Expression Regulation; Haplorhini; Male; Maze Learning; Methamphetamine; Mice; Phencyclidine; Rats; Receptors, AMPA; Schizophrenia; Thiadiazines | 2019 |
Genetics of cocaine and methamphetamine consumption and preference in Drosophila melanogaster.
Topics: Animals; Central Nervous System Stimulants; Cocaine; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Drosophila melanogaster; Drosophila Proteins; Feeding Behavior; Female; Gene Expression Profiling; Gene Expression Regulation; Gene Regulatory Networks; Genome, Insect; Male; Methamphetamine; Mushroom Bodies; RNA, Small Interfering; Sex Characteristics; Substance-Related Disorders | 2019 |
Diffusion Kurtosis Imaging Detects Microstructural Changes in a Methamphetamine-Induced Mouse Model of Parkinson's Disease.
Topics: Animals; Behavior, Animal; Brain; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Dopamine Agents; Male; Methamphetamine; Mice, Inbred C57BL; Parkinson Disease, Secondary | 2019 |
Investigation of betaine as a novel psychotherapeutic for schizophrenia.
Topics: Animals; Betaine; Brain; Choline Dehydrogenase; Dietary Supplements; Disease Models, Animal; DNA Methylation; Genotype; Humans; Japan; Liver; Male; Methamphetamine; Mice; Oxidative Stress; Psychotropic Drugs; Quantitative Trait Loci; Schizophrenia | 2019 |
Rodent Models of Methamphetamine Misuse: Mechanisms of Methamphetamine Action and Comparison of Different Rodent Paradigms.
Topics: Animals; Blood-Brain Barrier; Central Nervous System Stimulants; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Humans; Methamphetamine; Receptors, Dopamine; Rodentia; Substance-Related Disorders | 2019 |
Distinct gene alterations between Fos-expressing striatal and thalamic neurons after withdrawal from methamphetamine self-administration.
Topics: Animals; Corpus Striatum; Craving; Disease Models, Animal; Gene Expression Regulation; Male; Methamphetamine; Neurons; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Self Administration; Substance Withdrawal Syndrome; Thalamus | 2019 |
Intrastriatal gene delivery of GDNF persistently attenuates methamphetamine self-administration and relapse in mice.
Topics: Analysis of Variance; Animals; Central Nervous System Stimulants; Corpus Striatum; Cues; Dependovirus; Disease Models, Animal; Drug-Seeking Behavior; Environment; Extinction, Psychological; Genetic Therapy; Glial Cell Line-Derived Neurotrophic Factor; Green Fluorescent Proteins; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microinjections; Reinforcement, Psychology; Self Administration; Substance-Related Disorders | 2013 |
Chronic wheel running reduces maladaptive patterns of methamphetamine intake: regulation by attenuation of methamphetamine-induced neuronal nitric oxide synthase.
Topics: Analysis of Variance; Animals; Bromodeoxyuridine; Caspase 3; Cell Proliferation; Central Nervous System Stimulants; Disease Models, Animal; Hippocampus; Ki-67 Antigen; Male; Methamphetamine; Neural Stem Cells; Neurons; Neurotoxicity Syndromes; Nitric Oxide Synthase; Oncogene Proteins v-fos; Rats; Rats, Wistar; Reward; Running; Self Administration; Time Factors | 2014 |
Role of melanin-concentrating hormone in the nucleus accumbens shell in rats behaviourally sensitized to methamphetamine.
Topics: Analysis of Variance; Animals; Behavior, Addictive; Central Nervous System Stimulants; Disease Models, Animal; Drug Interactions; Hypothalamic Hormones; Male; MAP Kinase Signaling System; Melanins; Methamphetamine; Motor Activity; Nucleus Accumbens; Piperidines; Pituitary Hormones; Rats; Rats, Sprague-Dawley | 2013 |
NMR-based metabonomic in hippocampus, nucleus accumbens and prefrontal cortex of methamphetamine-sensitized rats.
Topics: Animals; Brain; Central Nervous System Sensitization; Central Nervous System Stimulants; Discriminant Analysis; Disease Models, Animal; Hippocampus; Magnetic Resonance Spectroscopy; Male; Metabolomics; Methamphetamine; Motor Activity; Neurotransmitter Agents; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Wistar; Tritium | 2013 |
Effect of an mGlu2/3 receptor antagonist on depressive behavior induced by withdrawal from chronic treatment with methamphetamine.
Topics: Amino Acids; Analysis of Variance; Animals; Central Nervous System Stimulants; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Interactions; Excitatory Amino Acid Antagonists; Immobility Response, Tonic; Male; Methamphetamine; Motor Activity; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Swimming; Xanthenes | 2013 |
A sex- and region-specific role of Akt1 in the modulation of methamphetamine-induced hyperlocomotion and striatal neuronal activity: implications in schizophrenia and methamphetamine-induced psychosis.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Disease Models, Animal; Estradiol; Estrogens; Female; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Neostriatum; Neurons; Proto-Oncogene Proteins c-akt; Psychoses, Substance-Induced; Raclopride; Schizophrenia; Sex Factors | 2014 |
The role of the neuropeptide somatostatin on methamphetamine and glutamate-induced neurotoxicity in the striatum of mice.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Fluoresceins; Glutamic Acid; Male; Methamphetamine; Mice; Mice, Inbred ICR; Microinjections; Neurotoxicity Syndromes; Neurotoxins; Nitric Oxide; Octreotide; Somatostatin; Tyrosine; Tyrosine 3-Monooxygenase | 2013 |
Unique pharmacological actions of atypical neuroleptic quetiapine: possible role in cell cycle/fate control.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Astrocytes; Cell Cycle; Dibenzothiazepines; Disease Models, Animal; Frontal Lobe; Gene Expression; Haloperidol; In Situ Hybridization; Male; Methamphetamine; Mice; Neurons; Oligodendroglia; p21-Activated Kinases; Principal Component Analysis; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Schizophrenia | 2013 |
New Meth vaccine shows promise in animals.
Topics: Animals; Disease Models, Animal; Methamphetamine; Rats; Substance-Related Disorders; Treatment Outcome; Vaccination; Vaccines | 2013 |
Cyclooxygenase activity contributes to the monoaminergic damage caused by serial exposure to stress and methamphetamine.
Topics: Analysis of Variance; Animals; Biogenic Monoamines; Body Temperature; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Gene Expression Regulation; Hippocampus; Hydrazines; Male; Methamphetamine; Oxazepines; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Stress, Psychological | 2013 |
CREB phosphorylation regulates striatal transcriptional responses in the self-administration model of methamphetamine addiction in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Central Nervous System Stimulants; Conditioning, Operant; Corpus Striatum; CREB-Binding Protein; Disease Models, Animal; Dopamine; Gene Expression Profiling; Gene Expression Regulation; Hydroxyindoleacetic Acid; Male; Methamphetamine; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Self Administration; Serotonin; Substance-Related Disorders; Time Factors | 2013 |
Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex.
Topics: Adenosine A2 Receptor Antagonists; Animals; Cognition; Cognition Disorders; Disease Models, Animal; Donepezil; Dopamine; Indans; Male; Memory Disorders; Memory, Short-Term; Methamphetamine; Oxidopamine; Piperidines; Prefrontal Cortex; Purines; Rats; Rats, Sprague-Dawley | 2013 |
Cuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis.
Topics: Animals; Astrocytes; Brain; Central Nervous System Stimulants; Chelating Agents; Copper; Cuprizone; Disease Models, Animal; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hallucinogens; Hyperkinesis; Interleukin-6; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Phencyclidine; Psychotic Disorders; Time Factors | 2013 |
Methamphetamine enhances Cryptococcus neoformans pulmonary infection and dissemination to the brain.
Topics: Animals; Biofilms; Cell Adhesion; Central Nervous System Fungal Infections; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Female; Lung Diseases, Fungal; Methamphetamine; Mice; Mice, Inbred C57BL; Polysaccharides; Substance-Related Disorders | 2013 |
Metabolic profiling of urine and blood plasma in rat models of drug addiction on the basis of morphine, methamphetamine, and cocaine-induced conditioned place preference.
Topics: Animals; Cocaine; Conditioning, Operant; Disease Models, Animal; Gas Chromatography-Mass Spectrometry; Male; Metabolic Networks and Pathways; Metabolome; Methamphetamine; Morphine; Narcotics; Rats; Rats, Sprague-Dawley; Reward; Substance-Related Disorders | 2014 |
96-hour methamphetamine self-administration in male and female rats: a novel model of human methamphetamine addiction.
Topics: Amphetamine-Related Disorders; Animals; Body Weight; Disease Models, Animal; Female; Humans; Male; Methamphetamine; Rats; Rats, Wistar; Self Administration | 2013 |
Effect of prenatal methamphetamine exposure and challenge dose of the same drug in adulthood on epileptiform activity induced by electrical stimulation in female rats.
Topics: Animals; Animals, Newborn; Central Nervous System Stimulants; Disease Models, Animal; Electric Stimulation; Electroencephalography; Epilepsy; Estrous Cycle; Female; Head Movements; Male; Methamphetamine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Statistics, Nonparametric | 2014 |
Administration of low dose methamphetamine 12 h after a severe traumatic brain injury prevents neurological dysfunction and cognitive impairment in rats.
Topics: Animals; Brain Injuries; Central Nervous System Stimulants; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Hippocampus; Humans; Male; Maze Learning; Methamphetamine; Nervous System Diseases; Neurofilament Proteins; Neurons; Rats; Rats, Wistar; Space Perception; Time Factors | 2014 |
Serotonin depletion can enhance the cerebrovascular responses induced by cortical spreading depression via the nitric oxide pathway.
Topics: Analysis of Variance; Animals; Cerebrovascular Circulation; Cortical Spreading Depression; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation; Intercellular Adhesion Molecule-1; Male; Methamphetamine; Microscopy, Electron, Transmission; Microvessels; Migraine Disorders; NG-Nitroarginine Methyl Ester; Potassium Chloride; Rats; Rats, Wistar; Serotonin; Vascular Cell Adhesion Molecule-1 | 2015 |
The effect of methamphetamine on an animal model of erectile function.
Topics: Animals; Carbolines; Disease Models, Animal; Erectile Dysfunction; Male; Methamphetamine; Penile Erection; Phosphodiesterase 5 Inhibitors; Rats, Sprague-Dawley; Tadalafil | 2014 |
CC-chemokine ligand 2 facilitates conditioned place preference to methamphetamine through the activation of dopamine systems.
Topics: Animals; Benzoxazines; Central Nervous System Stimulants; Chemokine CCL2; Disease Models, Animal; Dopaminergic Neurons; Dose-Response Relationship, Drug; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Nucleus Accumbens; Prefrontal Cortex; Receptors, CCR2; Spiro Compounds; Substance Abuse Detection; Substance-Related Disorders; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2014 |
Minocycline, an antibiotic with inhibitory effect on microglial activation, attenuates the maintenance and reinstatement of methamphetamine-seeking behavior in rat.
Topics: Animals; Anti-Bacterial Agents; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Extinction, Psychological; Male; Methamphetamine; Minocycline; Rats; Rats, Wistar; Reinforcement, Psychology; Substance-Related Disorders | 2014 |
Involvement of sigma 1 receptor in the SSRI-induced suppression of the methamphetamine-induced behavioral sensitization and rewarding effects in mice.
Topics: Animals; Anisoles; Behavior, Animal; Disease Models, Animal; Fluvoxamine; Methamphetamine; Mice; Propylamines; Rats; Receptors, sigma; Reward; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sigma-1 Receptor | 2013 |
Effects of social interaction and warm ambient temperature on brain hyperthermia induced by the designer drugs methylone and MDPV.
Topics: Animals; Benzodioxoles; Body Temperature; Brain; Designer Drugs; Disease Models, Animal; Dose-Response Relationship, Drug; Fever; Homeostasis; Interpersonal Relations; Locomotion; Methamphetamine; Psychotropic Drugs; Pyrrolidines; Rats, Long-Evans; Synthetic Cathinone; Temperature; Vasoconstriction | 2015 |
Chronic stress may facilitate the recruitment of habit- and addiction-related neurocircuitries through neuronal restructuring of the striatum.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Addictive; Central Nervous System Stimulants; Chronic Disease; Corpus Striatum; Dendrites; Disease Models, Animal; Habits; Learning; Male; Methamphetamine; Motor Activity; Neural Pathways; Neuronal Plasticity; Neurons; Nucleus Accumbens; Rats, Sprague-Dawley; Stress, Psychological | 2014 |
The disruptive effects of methamphetamine on delayed-matching-to-sample performance reflect proactive interference and are reduced by SCH23390.
Topics: Amphetamine-Related Disorders; Animals; Benzazepines; Central Nervous System Stimulants; Disease Models, Animal; Dopamine Antagonists; Male; Memory Disorders; Memory, Short-Term; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 2015 |
The central amygdala nucleus is critical for incubation of methamphetamine craving.
Topics: Amphetamine-Related Disorders; Animals; Baclofen; Basolateral Nuclear Complex; Central Amygdaloid Nucleus; Central Nervous System Stimulants; Craving; Cues; Disease Models, Animal; Drug-Seeking Behavior; Frontal Lobe; GABA Agonists; Methamphetamine; Muscimol; Rats, Sprague-Dawley; Self Administration; Substance Withdrawal Syndrome | 2015 |
Cognitive deficits associated with combined HIV gp120 expression and chronic methamphetamine exposure in mice.
Topics: Adaptation, Ocular; Analysis of Variance; Animals; Body Weight; Central Nervous System Stimulants; Cognition Disorders; Disease Models, Animal; Gene Expression Regulation; Glial Fibrillary Acidic Protein; HIV Envelope Protein gp120; Male; Maze Learning; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Reaction Time; Recognition, Psychology | 2015 |
Pharmacological effects of two anti-methamphetamine monoclonal antibodies. Supporting data for lead candidate selection for clinical development.
Topics: Animals; Antibodies, Monoclonal; Disease Models, Animal; Drug Overdose; Locomotion; Male; Methamphetamine; Placebos; Rats, Sprague-Dawley; Time Factors; Treatment Outcome | 2014 |
Effects of background mutations and single nucleotide polymorphisms (SNPs) on the Disc1 L100P behavioral phenotype associated with schizophrenia in mice.
Topics: Animals; Central Nervous System Stimulants; Disease Models, Animal; Exome; Female; Interpersonal Relations; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Motor Activity; Mutation; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Schizophrenia; Schizophrenic Psychology | 2014 |
Persistent palatable food preference in rats with a history of limited and extended access to methamphetamine self-administration.
Topics: Animals; Behavior, Addictive; Behavior, Animal; Central Nervous System Stimulants; Choice Behavior; Conditioning, Operant; Disease Models, Animal; Food Preferences; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Reward; Self Administration | 2015 |
Methamphetamine decreases CD4 T cell frequency and alters pro-inflammatory cytokine production in a model of drug abuse.
Topics: Animals; CD4-Positive T-Lymphocytes; Cell Count; Cytokines; Disease Models, Animal; Humans; Inflammation; Intracellular Space; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Self Administration; Spleen; Substance-Related Disorders | 2015 |
Methamphetamine-sensitized rats show augmented dopamine release to methylphenidate stimulation: a positron emission tomography using [18F]fallypride.
Topics: Animals; Benzamides; Biomarkers; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dopamine; Humans; Male; Methamphetamine; Methylphenidate; Positron-Emission Tomography; Rats; Receptors, Dopamine D2; Schizophrenia | 2015 |
Persistent conditioned place preference to cocaine and withdrawal hypo-locomotion to mephedrone in the flatworm planaria.
Topics: Animals; Cocaine; Conditioning, Psychological; Disease Models, Animal; Locomotion; Methamphetamine; Planarians; Psychotropic Drugs; Substance Withdrawal Syndrome; Substance-Related Disorders | 2015 |
Effect of the Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor 2 AZD8529 on Incubation of Methamphetamine Craving After Prolonged Voluntary Abstinence in a Rat Model.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Craving; Cues; Disease Models, Animal; Drug-Seeking Behavior; Excitatory Amino Acid Agents; Extinction, Psychological; Food; Indoles; Methamphetamine; Oxadiazoles; Rats; Receptors, Metabotropic Glutamate; Self Administration; Substance Withdrawal Syndrome; Time Factors; Volition | 2015 |
Reduced prefrontal dopaminergic activity in valproic acid-treated mouse autism model.
Topics: Animals; Autistic Disorder; Biogenic Monoamines; Corpus Striatum; Disease Models, Animal; Dopamine; Female; Male; Methamphetamine; Mice; Mice, Inbred ICR; Motor Activity; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Proto-Oncogene Proteins c-fos; Receptors, Dopamine; Valproic Acid | 2015 |
The effect of prenatal methamphetamine exposure on recognition memory in adult rats.
Topics: Animals; Animals, Newborn; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Female; Male; Memory; Methamphetamine; Pregnancy; Pregnancy, Animal; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Recognition, Psychology | 2015 |
A critical role of striatal A2A R-mGlu5 R interactions in modulating the psychomotor and drug-seeking effects of methamphetamine.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Drug-Seeking Behavior; Male; Methamphetamine; Mice; Mice, Knockout; Psychomotor Performance; Receptor, Adenosine A2A; Receptor, Metabotropic Glutamate 5 | 2016 |
Do the effects of prenatal exposure and acute treatment of methamphetamine on anxiety vary depending on the animal model used?
Topics: Animals; Anxiety; Disease Models, Animal; Female; Interpersonal Relations; Male; Methamphetamine; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Vocalization, Animal | 2015 |
Early life stress and chronic variable stress in adulthood interact to influence methamphetamine self-administration in male rats.
Topics: Animals; Animals, Newborn; Central Nervous System Stimulants; Conditioning, Operant; Cues; Disease Models, Animal; Extinction, Psychological; Female; Male; Maternal Deprivation; Methamphetamine; Pregnancy; Rats; Rats, Long-Evans; Reinforcement, Psychology; Self Administration; Stress, Psychological; Time Factors | 2016 |
Striatal and extrastriatal dopamine release in the common marmoset brain measured by positron emission tomography and [(18)F]fallypride.
Topics: Animals; Benzamides; Brain; Callithrix; Central Nervous System Stimulants; Cerebellum; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Fluorodeoxyglucose F18; Male; Methamphetamine; Methylphenidate; Positron-Emission Tomography; Prefrontal Cortex; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia | 2015 |
Nonmuscle myosin IIB as a therapeutic target for the prevention of relapse to methamphetamine use.
Topics: Amphetamine-Related Disorders; Amygdala; Animals; Central Nervous System Agents; Conditioning, Psychological; Disease Models, Animal; Drug-Seeking Behavior; Exploratory Behavior; Fear; Gene Knockdown Techniques; Heterocyclic Compounds, 4 or More Rings; Male; Memory; Methamphetamine; Mice; Motor Activity; Nonmuscle Myosin Type IIB; Rats; Secondary Prevention; Self Administration; Spatial Behavior | 2016 |
Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation.
Topics: Animals; Biogenic Monoamines; Body Temperature; Calcium-Binding Proteins; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Electrochemical Techniques; Encephalitis; Glial Fibrillary Acidic Protein; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microfilament Proteins; Motor Activity; Neurotoxicity Syndromes; Time Factors; Tyrosine 3-Monooxygenase | 2015 |
The consequences of prenatal and/or postnatal methamphetamine exposure on neonatal development and behaviour in rat offspring.
Topics: Age Factors; Animals; Animals, Newborn; Behavior, Animal; Biogenic Monoamines; Catalepsy; Central Nervous System Stimulants; Developmental Disabilities; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Male; Maze Learning; Methamphetamine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Sex Factors; Stereotyped Behavior; Swimming | 2015 |
Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2.
Topics: Animals; Apoptosis; Behavior, Animal; Blotting, Western; Cell Proliferation; Cells, Cultured; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dopamine; Fever; Glial Fibrillary Acidic Protein; Humans; Immunoenzyme Techniques; Methamphetamine; Mice; Mice, Knockout; Neurotoxicity Syndromes; NF-E2-Related Factor 2; Oxidative Stress; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tyrosine 3-Monooxygenase | 2015 |
Olfactory bulbectomy increases reinstatement of methamphetamine seeking after a forced abstinence in rats.
Topics: Administration, Intravenous; Amphetamine-Related Disorders; Animals; Catheters, Indwelling; Central Nervous System Stimulants; Conditioning, Operant; Depressive Disorder; Disease Models, Animal; Drug-Seeking Behavior; Male; Methamphetamine; Olfactory Bulb; Random Allocation; Rats, Sprague-Dawley; Recurrence; Self Administration | 2016 |
l-Scoulerine attenuates behavioural changes induced by methamphetamine in zebrafish and mice.
Topics: Amphetamine-Related Disorders; Animals; Anxiety Disorders; Berberine Alkaloids; Central Nervous System Agents; Central Nervous System Stimulants; Disease Models, Animal; Female; Male; Methamphetamine; Mice; Motor Activity; Random Allocation; Spatial Behavior; Zebrafish | 2016 |
Reward related neurotransmitter changes in a model of depression: An in vivo microdialysis study.
Topics: Animals; Depression; Disease Models, Animal; Dopamine; Dopamine Agents; gamma-Aminobutyric Acid; Glutamic Acid; Male; Methamphetamine; Microdialysis; Neurotransmitter Agents; Nucleus Accumbens; Rats; Rats, Wistar; Reward; Self Administration; Serotonin | 2015 |
BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic Methamphetamine.
Topics: Amphetamine-Related Disorders; Animals; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Male; Methamphetamine; Mice, Transgenic; Motor Activity; Psychoses, Substance-Induced | 2016 |
The rewarding properties of methamphetamine in an invertebrate model of drug addiction.
Topics: Animals; Astacoidea; Conditioning, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Methamphetamine; Microdialysis; Motivation; Reward; Spatial Behavior; Substance-Related Disorders | 2016 |
Combined behavioral studies and in vivo imaging of inflammatory response and expression of mGlu5 receptors in schnurri-2 knockout mice.
Topics: Acetamides; Amphetamine; Animals; Brain; Carbon Radioisotopes; Central Nervous System Stimulants; Cerebral Cortex; Disease Models, Animal; DNA-Binding Proteins; Exploratory Behavior; Fluorine Radioisotopes; Hippocampus; Inflammation; Methamphetamine; Mice, Knockout; Motor Activity; Nitriles; Positron-Emission Tomography; Pyridines; Radiopharmaceuticals; Receptor, Metabotropic Glutamate 5; Schizophrenia | 2015 |
BDNF-TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Blotting, Western; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Nucleus Accumbens; Protein Kinases; Signal Transduction; Substance Withdrawal Syndrome | 2015 |
Methamphetamine Alters the Antimicrobial Efficacy of Phagocytic Cells during Methicillin-Resistant Staphylococcus aureus Skin Infection.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Humans; Immunosuppressive Agents; Methamphetamine; Methicillin-Resistant Staphylococcus aureus; Mice; Phagocytes; Skin; Staphylococcal Skin Infections | 2015 |
Pulling habits out of rats: adenosine 2A receptor antagonism in dorsomedial striatum rescues meth-amphetamine-induced deficits in goal-directed action.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Choice Behavior; Corpus Striatum; Cues; Disease Models, Animal; Goals; Habits; Methamphetamine; Purinergic P1 Receptor Antagonists; Rats; Rats, Long-Evans; Sodium Chloride | 2017 |
The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in female rats.
Topics: Amphetamine-Related Disorders; Animals; Catheters, Indwelling; Central Nervous System Stimulants; Conditioning, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Extinction, Psychological; Female; Methamphetamine; Motor Activity; Nicotinic Agonists; Psychotropic Drugs; Random Allocation; Rats, Sprague-Dawley; Self Administration; Treatment Outcome; Varenicline | 2016 |
Methamphetamine-, d-Amphetamine-, and p-Chloroamphetamine-Induced Neurotoxicity Differentially Effect Impulsive Responding on the Stop-Signal Task in Rats.
Topics: Animals; Body Temperature; Brain; Central Nervous System Stimulants; Dextroamphetamine; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Impulsive Behavior; Male; Methamphetamine; Motor Activity; Neuropsychological Tests; Neurotoxicity Syndromes; p-Chloroamphetamine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins; Time Factors | 2016 |
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration.
Topics: Animals; Central Nervous System Stimulants; Deep Brain Stimulation; Disease Models, Animal; Infusions, Intravenous; Methamphetamine; Rats; Rats, Wistar; Self Administration; Substance-Related Disorders | 2016 |
Methamphetamine abstinence induces changes in μ-opioid receptor, oxytocin and CRF systems: Association with an anxiogenic phenotype.
Topics: Amphetamine-Related Disorders; Amygdala; Animals; Anxiety; Central Nervous System Stimulants; Corpus Striatum; Corticosterone; Corticotropin-Releasing Hormone; Disease Models, Animal; Male; Methamphetamine; Mice, Inbred C57BL; Neurons; Proto-Oncogene Proteins c-fos; Random Allocation; Receptors, Dopamine D2; Receptors, Opioid, mu; Receptors, Oxytocin; Septum of Brain; Substance Withdrawal Syndrome | 2016 |
Behavioral flexibility predicts increased ability to resist excessive methamphetamine self-administration.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Self Administration | 2017 |
Peripheral ammonia and blood brain barrier structure and function after methamphetamine.
Topics: Ammonia; Animals; Blood-Brain Barrier; Capillaries; Capillary Permeability; Central Nervous System Stimulants; Cerebral Cortex; Claudin-5; Disease Models, Animal; Fever; Gastrointestinal Agents; Lactulose; Male; Matrix Metalloproteinase 9; Methamphetamine; Occludin; Rats, Sprague-Dawley | 2016 |
Incubation of extinction responding and cue-induced reinstatement, but not context- or drug priming-induced reinstatement, after withdrawal from methamphetamine.
Topics: Animals; Central Nervous System Stimulants; Conditioning, Operant; Craving; Cues; Disease Models, Animal; Extinction, Psychological; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2017 |
Inhibiting effects of rhynchophylline on zebrafish methamphetamine dependence are associated with amelioration of neurotransmitters content and down-regulation of TH and NR2B expression.
Topics: Amphetamine-Related Disorders; Animals; Animals, Genetically Modified; Behavior, Animal; Brain; Conditioning, Psychological; Disease Models, Animal; Dopamine; Glutamic Acid; Indole Alkaloids; Methamphetamine; Oxindoles; Receptors, N-Methyl-D-Aspartate; Tyrosine 3-Monooxygenase; Zebrafish | 2016 |
Chronic methamphetamine exposure prior to middle cerebral artery occlusion increases infarct volume and worsens cognitive injury in Male mice.
Topics: Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Cognition; Cognition Disorders; Disease Models, Animal; Infarction, Middle Cerebral Artery; Male; Memory; Methamphetamine; Mice | 2016 |
Methamphetamine abuse affects gene expression in brain-derived microglia of SIV-infected macaques to enhance inflammation and promote virus targets.
Topics: Animals; Brain; Cells, Cultured; Chemotaxis; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; HIV Infections; HIV-1; Humans; Inflammation; Macaca; Methamphetamine; Microglia; Receptors, CCR5; Receptors, CXCR4; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Substance-Related Disorders; Viral Load | 2016 |
Methamphetamine alters microglial immune function through P2X7R signaling.
Topics: Amphetamine-Related Disorders; Animals; Blotting, Western; Central Nervous System Stimulants; Disease Models, Animal; Gene Knockdown Techniques; Immunohistochemistry; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microglia; Real-Time Polymerase Chain Reaction; Receptors, Purinergic P2X7; Signal Transduction | 2016 |
Methamphetamine reduces expression of caveolin-1 in the dorsal striatum: Implication for dysregulation of neuronal function.
Topics: Amphetamine-Related Disorders; Animals; Caveolin 1; Central Nervous System Stimulants; Conditioning, Operant; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression; Male; Methamphetamine; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neurons; Phosphorylation; Rats, Wistar; Receptors, Dopamine D1; Reinforcement, Psychology; Self Administration | 2016 |
Alteration of catecholamine concentrations in rat testis after methamphetamine exposure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine-Related Disorders; Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Illicit Drugs; Male; Methamphetamine; Methoxyhydroxyphenylglycol; Norepinephrine; Rats; Reproduction; Testis | 2017 |
Effect of Methamphetamine Exposure on Expression of Calcium Binding Proteins in Rat Frontal Cortex and Hippocampus.
Topics: Amphetamine-Related Disorders; Animals; Calbindin 2; Calbindins; Central Nervous System Stimulants; Disease Models, Animal; Frontal Lobe; GABAergic Neurons; Gene Expression; Hippocampus; Immunohistochemistry; Male; Methamphetamine; Parvalbumins; Rats, Sprague-Dawley | 2016 |
Sex-related differences in striatal dopaminergic system after traumatic brain injury.
Topics: Animals; Brain Injuries, Traumatic; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Female; Functional Laterality; Gene Expression Regulation; In Vitro Techniques; Locomotion; Male; Methamphetamine; Mice; Potassium; RNA, Messenger; Sex Characteristics; Vesicular Monoamine Transport Proteins | 2016 |
Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats.
Topics: Alcohol Drinking; Animals; Behavior, Animal; Disease Models, Animal; Female; Male; Methamphetamine; Methylazoxymethanol Acetate; Pregnancy; Rats; Rats, Sprague-Dawley; Schizophrenia; Sex Characteristics | 2017 |
Developmental stress elicits preference for methamphetamine in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.
Topics: Animals; Attention; Attention Deficit Disorder with Hyperactivity; Disease Models, Animal; Female; Genetic Predisposition to Disease; Hypertension; Learning; Male; Maternal Deprivation; Methamphetamine; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Rats, Wistar; Stress, Psychological | 2016 |
Intermittent bilateral deep brain stimulation of the nucleus accumbens shell reduces intravenous methamphetamine intake and seeking in Wistar rats.
Topics: Administration, Intravenous; Amphetamine-Related Disorders; Animals; Catheters, Indwelling; Central Nervous System Stimulants; Conditioning, Operant; Deep Brain Stimulation; Disease Models, Animal; Drug-Seeking Behavior; Feeding Behavior; Male; Methamphetamine; Nucleus Accumbens; Rats, Wistar; Self Administration | 2017 |
Mir143-BBC3 cascade reduces microglial survival via interplay between apoptosis and autophagy: Implications for methamphetamine-mediated neurotoxicity.
Topics: 3' Untranslated Regions; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Cell Survival; Disease Models, Animal; Heterozygote; Hippocampus; Humans; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microglia; MicroRNAs; Proto-Oncogene Proteins; Transcription, Genetic; Tumor Suppressor Proteins; Up-Regulation | 2016 |
Selective Enhancement of Dopamine Release in the Ventral Pallidum of Methamphetamine-Sensitized Mice.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Disease Models, Animal; Dopamine; Dopamine Agents; Globus Pallidus; Immunohistochemistry; Male; Methamphetamine; Mice, Inbred C57BL; Motor Activity; Neuronal Plasticity; Presynaptic Terminals | 2016 |
The Clock Gene Rev-Erbα Regulates Methamphetamine Actions on Circadian Timekeeping in the Mouse Brain.
Topics: Animals; Circadian Rhythm; CLOCK Proteins; Disease Models, Animal; Hypothalamus; Methamphetamine; Mice, Knockout; Nuclear Receptor Subfamily 1, Group D, Member 1; Suprachiasmatic Nucleus | 2017 |
Progressive gene dose-dependent disruption of the methamphetamine-sensitive circadian oscillator-driven rhythms in a knock-in mouse model of Huntington's disease.
Topics: Age Factors; Animals; Central Nervous System Stimulants; Chronobiology Disorders; Circadian Rhythm; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Humans; Huntingtin Protein; Huntington Disease; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Mutation | 2016 |
Step Sequence Is a Critical Gait Parameter of Unilateral 6-OHDA Parkinson's Rat Models.
Topics: Animals; Disease Models, Animal; Gait; Locomotion; Male; Mesencephalon; Methamphetamine; Neurons; Oxidopamine; Parkinson Disease; Rats, Long-Evans; Rotation; Tyrosine 3-Monooxygenase | 2017 |
Impaired Subset Progression and Polyfunctionality of T Cells in Mice Exposed to Methamphetamine during Chronic LCMV Infection.
Topics: Animals; Central Nervous System Stimulants; Cytokines; Disease Models, Animal; Gene Expression Regulation; Lymphocyte Activation; Lymphocytic Choriomeningitis; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Programmed Cell Death 1 Receptor; Spleen; T-Lymphocyte Subsets; Up-Regulation | 2016 |
Methamphetamine Induces Anhedonic-Like Behavior and Impairs Frontal Cortical Energetics in Mice.
Topics: Anhedonia; Animals; Aspartic Acid; Brain Injuries; Central Nervous System Stimulants; Cerebral Cortex; Disease Models, Animal; Exploratory Behavior; Food Preferences; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 3; Glutamic Acid; Grooming; Male; Maze Learning; Methamphetamine; Mice; Mice, Inbred C57BL; Motor Activity | 2017 |
Effects of alcohol on c-Myc protein in the brain.
Topics: Alcoholism; Animals; Brain; Central Nervous System Depressants; Central Nervous System Stimulants; Chlorocebus aethiops; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Ethanol; Gene Expression Regulation; Genetic Predisposition to Disease; Methamphetamine; Mice; Mice, Knockout; Proto-Oncogene Proteins c-myc; Receptors, Metabotropic Glutamate | 2017 |
Long-term cognitive, emotional and neurogenic alterations induced by alcohol and methamphetamine exposure in adolescent rats.
Topics: Animals; Anxiety; Central Nervous System Depressants; Central Nervous System Stimulants; Cognition Disorders; Disease Models, Animal; Doublecortin Domain Proteins; Doublecortin Protein; Drug Combinations; Ethanol; Exploratory Behavior; Hippocampus; Immobility Response, Tonic; Male; Maze Learning; Methamphetamine; Microtubule-Associated Proteins; Neurogenesis; Neuropeptides; Rats; Rats, Long-Evans; Statistics, Nonparametric; Time | 2017 |
The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in male rats.
Topics: Amphetamine-Related Disorders; Analysis of Variance; Animals; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Extinction, Psychological; Locomotion; Male; Methamphetamine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Reward; Self Administration; Varenicline | 2017 |
Frequency-dependent, transient effects of subthalamic nucleus deep brain stimulation on methamphetamine-induced circling and neuronal activity in the hemiparkinsonian rat.
Topics: Analysis of Variance; Animals; Central Nervous System Stimulants; Deep Brain Stimulation; Disease Models, Animal; Dose-Response Relationship, Radiation; Linear Models; Male; Methamphetamine; Neurons; Parkinsonian Disorders; Rats; Rats, Long-Evans; Subthalamic Nucleus; Time Factors | 2017 |
Active vaccination attenuates the psychostimulant effects of α-PVP and MDPV in rats.
Topics: Administration, Intravesical; Animals; Benzodioxoles; Body Temperature; Central Nervous System Stimulants; Designer Drugs; Disease Models, Animal; Dose-Response Relationship, Drug; Immunoconjugates; Male; Methamphetamine; Motor Activity; Pentanones; Psychotropic Drugs; Pyrrolidines; Rats, Sprague-Dawley; Self Administration; Substance-Related Disorders; Synthetic Cathinone; Vaccination; Vaccines | 2017 |
Maladaptive Sexual Behavior Following Concurrent Methamphetamine and Sexual Experience in Male Rats is Associated with Altered Neural Activity in Frontal Cortex.
Topics: Animals; Avoidance Learning; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Central Nervous System Stimulants; Conditioning, Psychological; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Frontal Lobe; Glutamate Decarboxylase; Immunohistochemistry; Limbic System; Male; Methamphetamine; Phosphorylation; Rats, Sprague-Dawley; Sexual Behavior, Animal; Sexual Dysfunctions, Psychological | 2017 |
Optimized temporal pattern of brain stimulation designed by computational evolution.
Topics: Animals; Basal Ganglia; Behavior, Animal; Brain; Computer Simulation; Deep Brain Stimulation; Disease Models, Animal; Electrophysiology; Female; Humans; Male; Methamphetamine; Oscillometry; Parkinson Disease; Rats; Rats, Long-Evans; Software; Time Factors; Treatment Outcome | 2017 |
Acute behavioral effects of co-administration of mephedrone and MDMA in mice.
Topics: Animals; Antidepressive Agents; Anxiety; Cognition; Depression; Disease Models, Animal; Drug Interactions; Male; Maze Learning; Memory; Methamphetamine; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Swimming | 2017 |
Pharmacological activation of the neurotensin receptor 1 abrogates the methamphetamine-induced striatal apoptosis in the mouse brain.
Topics: Animals; Apoptosis; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Drug Evaluation, Preclinical; Fever; Male; Methamphetamine; Mice, Inbred ICR; Neurons; Neuroprotective Agents; Neurotensin; Neurotransmitter Agents; Protein Precursors; Receptors, Neurotensin; RNA, Messenger; Tyrosine 3-Monooxygenase | 2017 |
Locomotor activity and discriminative stimulus effects of a novel series of synthetic cathinone analogs in mice and rats.
Topics: Alkaloids; Amphetamines; Animals; Discrimination Learning; Disease Models, Animal; Dose-Response Relationship, Drug; Illicit Drugs; Locomotion; Male; Methamphetamine; Mice; Propiophenones; Psychotropic Drugs; Pyrrolidines; Rats; Rats, Sprague-Dawley; Thiophenes | 2017 |
Modeling human methamphetamine use patterns in mice: chronic and binge methamphetamine exposure, reward function and neurochemistry.
Topics: Amphetamine-Related Disorders; Animals; Brain; Central Nervous System Stimulants; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Dopamine; Glutamine; Methamphetamine; Mice; Reward; Self Stimulation; Serotonin | 2018 |
Compulsive methamphetamine taking under punishment is associated with greater cue-induced drug seeking in rats.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Central Nervous System Stimulants; Craving; Cues; Disease Models, Animal; Male; Methamphetamine; Phenotype; Punishment; Rats; Rats, Sprague-Dawley | 2017 |
Nigrostriatal alterations in bone morphogenetic protein receptor II dominant negative mice.
Topics: Analysis of Variance; Animals; Behavior, Animal; Bone Morphogenetic Protein Receptors, Type II; Cell Death; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; In Situ Nick-End Labeling; Male; Methamphetamine; Mice; Mice, Knockout; Motor Activity; Neurons; Parkinson Disease; Substantia Nigra; Tyrosine 3-Monooxygenase | 2008 |
Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis.
Topics: Amphetamine-Related Disorders; Animals; Astrocytes; Biomarkers; Brain; Cell Compartmentation; Cells, Cultured; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Down-Regulation; Fever; Gliosis; Methamphetamine; Mice; Mice, Knockout; Nerve Degeneration; Neurons; Oxidative Stress; Synaptic Vesicles; Vesicular Monoamine Transport Proteins | 2008 |
Acute inhalation exposure to vaporized methamphetamine causes lung injury in mice.
Topics: Acute Disease; Administration, Inhalation; Albumins; Animals; Bronchoalveolar Lavage Fluid; Central Nervous System Stimulants; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; L-Lactate Dehydrogenase; Lung; Lung Diseases; Methamphetamine; Mice; Mice, Inbred BALB C; Organ Size; Reactive Oxygen Species | 2008 |
Mice lacking the schizophrenia-associated protein FEZ1 manifest hyperactivity and enhanced responsiveness to psychostimulants.
Topics: Animals; Base Sequence; Brain; Central Nervous System Stimulants; Disease Models, Animal; Dizocilpine Maleate; DNA Primers; DNA-Binding Proteins; Dopamine; gamma-Aminobutyric Acid; Humans; Interneurons; Learning; Male; Memory; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Nerve Tissue Proteins; Phenotype; RNA, Messenger; Schizophrenia; Synaptic Transmission | 2008 |
Differential expression of Fos and Zif268 in the nigrostriatal system after methamphetamine administration in a rat model of Parkinson's disease.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Early Growth Response Protein 1; Gene Expression Regulation; Genes, fos; Male; Methamphetamine; Parkinson Disease; Rats; Rats, Wistar; Substantia Nigra | 2008 |
Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Electron Spin Resonance Spectroscopy; Functional Laterality; Galantamine; Gene Expression Regulation; Male; Mecamylamine; Methamphetamine; Motor Activity; Neuroprotective Agents; Nicotine; Nicotinic Antagonists; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, Nicotinic; RNA, Messenger; Rotarod Performance Test; Tyrosine 3-Monooxygenase | 2008 |
Effect of methamphetamine exposure and cross-fostering on sensorimotor development of male and female rat pups.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Female; Locomotion; Male; Methamphetamine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Reflex; Sodium Chloride; Substance-Related Disorders | 2009 |
Neonatal status epilepticus alters prefrontal-striatal circuitry and enhances methamphetamine-induced behavioral sensitization in adolescence.
Topics: Age Factors; Animals; Animals, Newborn; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Female; Gene Expression Regulation, Developmental; Glutamic Acid; Lithium Compounds; Male; Methamphetamine; Motor Activity; Neural Pathways; Pilocarpine; Prefrontal Cortex; Pregnancy; Rats; Rats, Sprague-Dawley; RGS Proteins; Status Epilepticus | 2009 |
Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease.
Topics: Animals; Carbon Radioisotopes; Cells, Cultured; Cocaine; Disease Models, Animal; Dopamine; Dopamine Agents; Embryonic Stem Cells; Levodopa; Macaca fascicularis; Methamphetamine; Movement Disorders; Neurons; Parkinson Disease; Positron-Emission Tomography; Putamen; Raclopride; Tyrosine 3-Monooxygenase | 2009 |
Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease.
Topics: Administration, Oral; Adrenergic Agents; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Hydrogen; Immunohistochemistry; Injections, Intraperitoneal; Male; Methamphetamine; Microinjections; Nerve Degeneration; Neurons; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase | 2009 |
Increases in cytoplasmic dopamine compromise the normal resistance of the nucleus accumbens to methamphetamine neurotoxicity.
Topics: Animals; Clorgyline; Cytosol; Disease Models, Animal; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Female; Levodopa; Methamphetamine; Mice; Mice, Inbred C57BL; Microglia; Monoamine Oxidase Inhibitors; Neurons; Neurotoxicity Syndromes; Nucleus Accumbens; Plant Lectins; Reserpine; Ribosome Inactivating Proteins; Time Factors; Tyrosine 3-Monooxygenase | 2009 |
Methamphetamine treatment causes delayed decrease in novelty-induced locomotor activity in mice.
Topics: Age Factors; Aging; Amphetamine-Related Disorders; Animals; Brain; Central Nervous System Stimulants; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Dopamine; Exploratory Behavior; Male; Methamphetamine; Mice; Mice, Inbred BALB C; Motor Activity; Nerve Degeneration; Presynaptic Terminals | 2009 |
Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge.
Topics: Amphetamine-Related Disorders; Animals; Brain; Central Nervous System Stimulants; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Humans; Male; Methamphetamine; Motor Activity; Norepinephrine; Random Allocation; Rats; Rats, Sprague-Dawley; Serotonin; Sleep; Time Factors; Vesicular Monoamine Transport Proteins | 2009 |
Prenatal methamphetamine exposure affects the mesolimbic dopaminergic system and behavior in adult offspring.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Homovanillic Acid; Male; Methamphetamine; Motor Activity; Neural Pathways; Nucleus Accumbens; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Time; Ventral Tegmental Area | 2009 |
Genetically correlated effects of selective breeding for high and low methamphetamine consumption.
Topics: Administration, Oral; Amphetamine-Related Disorders; Animals; Apoptosis; Avoidance Learning; Breeding; Central Nervous System Stimulants; Conditioning, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Genotype; Immune System; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Motivation; Phenotype; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-rel; Receptors, Serotonin, 5-HT3; Self Administration; Serotonin Plasma Membrane Transport Proteins | 2009 |
Reversal-specific learning impairments after a binge regimen of methamphetamine in rats: possible involvement of striatal dopamine.
Topics: Analysis of Variance; Animals; Attention; Body Temperature; Central Nervous System Stimulants; Cocaine; Corpus Striatum; Discrimination, Psychological; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Learning Disabilities; Male; Methamphetamine; Neuropsychological Tests; Photic Stimulation; Protein Binding; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Long-Evans; Recognition, Psychology; Reversal Learning | 2010 |
Proteomic analysis reveals differentially expressed proteins in the rat frontal cortex after methamphetamine treatment.
Topics: Adaptor Proteins, Vesicular Transport; Amphetamine-Related Disorders; Animals; beta-Synuclein; Brain Chemistry; Cell Membrane; Cytosol; Disease Models, Animal; Dopamine Uptake Inhibitors; Heat-Shock Proteins; Intercellular Signaling Peptides and Proteins; Male; Methamphetamine; Nerve Tissue Proteins; Neuronal Plasticity; Phosphopyruvate Hydratase; Prefrontal Cortex; Proteomics; Rats; Rats, Sprague-Dawley; Synapsins; Synaptic Transmission; Ubiquitin Thiolesterase | 2009 |
Alteration of Methamphetamine-induced stereotypic behaviour in transgenic mice expressing HIV-1 envelope protein gp120.
Topics: AIDS-Associated Nephropathy; Analysis of Variance; Animals; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Female; HIV Envelope Protein gp120; HIV-1; Male; Methamphetamine; Mice; Mice, Transgenic; Motor Activity; Stereotyped Behavior | 2010 |
Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
Topics: 5,7-Dihydroxytryptamine; Animals; Area Under Curve; Benzylamines; Brain; Central Nervous System Stimulants; Disease Models, Animal; Female; Gene Expression; Hallucinogens; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Neurotransmitter Uptake Inhibitors; Pregnancy; Protein Binding; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins; Synaptosomes; Time Factors; Vesicular Monoamine Transport Proteins | 2010 |
Attention-like deficit and hyperactivity in a Drosophila memory mutant.
Topics: Animals; Animals, Genetically Modified; Attention; Attention Deficit Disorder with Hyperactivity; Bias; Brain; Central Nervous System Stimulants; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; Evoked Potentials, Visual; Maze Learning; Memory; Methamphetamine; Mutation; Orientation; Phosphoproteins; Photic Stimulation; Signal Detection, Psychological; Spectrum Analysis | 2010 |
Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction.
Topics: Actin Cytoskeleton; Animals; Antioxidants; Cardiac Catheterization; Cyclic N-Oxides; Disease Models, Animal; Male; Methamphetamine; Mitochondrial Proteins; Myocardial Contraction; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Spin Labels; Stroke Volume; Time Factors; Tyrosine; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2010 |
Withdrawal from fixed-dose injection of methamphetamine decreases cerebral levels of 3-methoxy-4-hydroxyphenylglycol and induces the expression of anxiety-related behavior in mice.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; Behavior, Animal; Brain Chemistry; Disease Models, Animal; Male; Methamphetamine; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred ICR; Substance Withdrawal Syndrome | 2010 |
Upregulation of L-type Ca(v)1 channels in the development of psychological dependence.
Topics: Animals; Brain; Brain Chemistry; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Cocaine; Disease Models, Animal; Frontal Lobe; Limbic System; Male; Methamphetamine; Mice; Morphine; Nifedipine; Substance-Related Disorders; Up-Regulation | 2010 |
Modafinil effects on reinstatement of methamphetamine seeking in a rat model of relapse.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Addictive; Benzhydryl Compounds; Disease Models, Animal; Male; Methamphetamine; Modafinil; Rats; Rats, Long-Evans; Secondary Prevention; Self Administration | 2010 |
Effect of an electronic control device exposure on a methamphetamine-intoxicated animal model.
Topics: Animals; Arrhythmias, Cardiac; Body Size; Body Weight; Disease Models, Animal; Electric Injuries; Electrocardiography; Electroshock; Heart Rate; Law Enforcement; Methamphetamine; Probability; Random Allocation; Reference Values; Risk Factors; Severity of Illness Index; Sheep; Tachycardia, Sinus; Tachycardia, Ventricular; Time Factors; Vital Signs; Weapons | 2010 |
Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB₁ cannabinoid receptors.
Topics: Acoustic Stimulation; Amygdala; Animals; Behavior, Animal; Benzoxazines; Brain; CA1 Region, Hippocampal; Cannabinoid Receptor Agonists; Caudate Nucleus; Central Nervous System Stimulants; Disease Models, Animal; Exploratory Behavior; Male; Memory; Methamphetamine; Morpholines; Motor Activity; Naphthalenes; Neurotoxicity Syndromes; Prefrontal Cortex; Putamen; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reflex, Startle; Up-Regulation | 2010 |
Dopamine is not essential for the development of methamphetamine-induced neurotoxicity.
Topics: Adrenergic Agents; alpha-Methyltyrosine; Amphetamine-Related Disorders; Animals; Body Temperature; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Functional Laterality; Male; Methamphetamine; Mice; Mice, Transgenic; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Synaptic Transmission | 2010 |
Prenatal exposure to methamphetamine alters the mechanical withdrawal threshold and tonic hyperalgesia in the offspring.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Birth Weight; Body Temperature; Body Weight; Disease Models, Animal; Female; Formaldehyde; Hyperalgesia; Male; Methamphetamine; Pain Measurement; Pain Threshold; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Reaction Time; Sex Characteristics | 2010 |
The different performance among motor tasks during the increasing current intensity of deep brain stimulation of the subthalamic nucleus in rats with different degrees of the unilateral striatal lesion.
Topics: Animals; Central Nervous System Stimulants; Corpus Striatum; Deep Brain Stimulation; Disease Models, Animal; Male; Methamphetamine; Microinjections; Motor Skills; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Subthalamic Nucleus | 2010 |
Lamotrigine blocks the initiation and expression of repeated high-dose methamphetamine-induced prepulse inhibition deficit in rats.
Topics: Animals; Anticonvulsants; Central Nervous System Stimulants; Disease Models, Animal; Lamotrigine; Male; Methamphetamine; Neural Inhibition; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia; Triazines | 2010 |
Challenge dose of methamphetamine affects kainic acid-induced seizures differently depending on prenatal methamphetamine exposure, sex, and estrous cycle.
Topics: Analysis of Variance; Animals; Central Nervous System Stimulants; Disease Models, Animal; Estrous Cycle; Female; Incidence; Kainic Acid; Male; Methamphetamine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Reaction Time; Seizures; Sex Factors | 2010 |
5-HT(1A)-like receptor activation inhibits abstinence-induced methamphetamine withdrawal in planarians.
Topics: Analysis of Variance; Animals; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Methamphetamine; Movement; Piperazines; Planarians; Pyridines; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Substance Withdrawal Syndrome | 2010 |
Methods in systems biology of experimental methamphetamine drug abuse.
Topics: Animals; Cerebral Cortex; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Gene Expression Profiling; Immunoblotting; Injections; Male; Methamphetamine; Proteomics; Rats; Rats, Sprague-Dawley; Rosaniline Dyes; Substance-Related Disorders; Systems Biology | 2010 |
Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioural abnormalities and apoptosis in rodents.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Antipsychotic Agents; Apoptosis; Aripiprazole; Behavioral Symptoms; Disease Models, Animal; Dizocilpine Maleate; Haloperidol; In Situ Nick-End Labeling; Inhibition, Psychological; Male; Methamphetamine; Microdialysis; Motor Activity; Neuroprotective Agents; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia | 2011 |
Methamphetamine potentiates behavioral and electrochemical responses after mild traumatic brain injury in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Injuries; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Methamphetamine; Mice; Motor Activity; Severity of Illness Index | 2011 |
Methamphetamine causes persistent immune dysregulation: a cross-species, translational report.
Topics: Adult; Amphetamine-Related Disorders; Animals; Brain; Chemokine CCL2; Chemokines; Cognition Disorders; Cytokines; Disease Models, Animal; Female; Humans; Immune System Diseases; Immunologic Factors; Intercellular Adhesion Molecule-1; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neuropsychological Tests; Random Allocation | 2011 |
Reinforcing effects of methamphetamine in an animal model of attention-deficit/hyperactivity disorder--the spontaneously hypertensive rat.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Male; Methamphetamine; Rats; Rats, Inbred SHR; Rats, Wistar; Reinforcement, Psychology; Species Specificity | 2010 |
Nicotine ameliorates impairment of working memory in methamphetamine-treated rats.
Topics: Animals; Attention; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Food Deprivation; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Methamphetamine; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Spatial Behavior; Sympathomimetics; Time Factors | 2011 |
Developmental GABAergic deficit enhances methamphetamine-induced apoptosis.
Topics: Animals; Apoptosis; Central Nervous System Stimulants; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Glutamic Acid; In Situ Nick-End Labeling; Male; Methamphetamine; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Schizophrenia; Sensory Gating; Time Factors | 2011 |
Does prenatal methamphetamine exposure affect the drug-seeking behavior of adult male rats?
Topics: Amphetamine; Analysis of Variance; Animals; Body Weight; Cocaine; Conditioning, Operant; Disease Models, Animal; Dopamine Agents; Female; Male; Methamphetamine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Substance-Related Disorders | 2011 |
Brain region-selective cellular redistribution of mGlu5 but not GABA(B) receptors following methamphetamine-induced associative learning.
Topics: Amphetamine-Related Disorders; Animals; Association Learning; Brain; Central Nervous System Stimulants; Disease Models, Animal; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, GABA-B; Receptors, Metabotropic Glutamate | 2011 |
Mouse strain- and age-dependent effects of binge methamphetamine on dopaminergic signaling.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Amphetamine-Related Disorders; Animals; Basal Ganglia; Central Nervous System Stimulants; Disease Models, Animal; Dopamine; Dopamine Agents; Down-Regulation; Genotype; Male; Methamphetamine; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Inbred DBA; Phenotype; Prefrontal Cortex; Signal Transduction; Species Specificity; Time Factors; Tyrosine 3-Monooxygenase | 2011 |
4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.
Topics: Administration, Oral; Animals; Central Nervous System Stimulants; Corpus Striatum; Designer Drugs; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Hippocampus; Male; Methamphetamine; Public Health; Rats; Rats, Sprague-Dawley; Reward; Serotonin | 2011 |
The methamphetamine-sensitive circadian oscillator is dysfunctional in a transgenic mouse model of Huntington's disease.
Topics: Animals; Behavior, Animal; Biological Clocks; Central Nervous System Stimulants; Circadian Rhythm; Disease Models, Animal; Female; Huntington Disease; Male; Methamphetamine; Mice; Mice, Transgenic; Motor Activity; Suprachiasmatic Nucleus | 2012 |
Differences between dextroamphetamine and methamphetamine: behavioral changes and oxidative damage in brain of Wistar rats.
Topics: Animals; Brain; Central Nervous System Stimulants; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Male; Methamphetamine; Motor Activity; Oxidative Stress; Protein Carbonylation; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Time Factors | 2012 |
Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatum.
Topics: Adrenergic Uptake Inhibitors; Animals; Axons; Corpus Striatum; Disease Models, Animal; Dopamine; Gliosis; Inflammation Mediators; Male; Methamphetamine; Mice; Mice, Knockout; NF-E2-Related Factor 2; Wallerian Degeneration | 2011 |
Sex differences in anxiety-like behavior and locomotor activity following prenatal and postnatal methamphetamine exposure in adult rats.
Topics: Analysis of Variance; Animals; Animals, Newborn; Anxiety; Disease Models, Animal; Dopamine Uptake Inhibitors; Estrous Cycle; Exploratory Behavior; Female; Immobility Response, Tonic; Male; Maternal Behavior; Maze Learning; Methamphetamine; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Sex Characteristics; Video Recording | 2012 |
Novel cocaine vaccine linked to a disrupted adenovirus gene transfer vector blocks cocaine psychostimulant and reinforcing effects.
Topics: Adenoviridae; Analysis of Variance; Animals; Brain; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Disease Models, Animal; Dopamine Uptake Inhibitors; Extinction, Psychological; Genetic Vectors; Haptens; Immunoglobulin G; Male; Methamphetamine; Motor Activity; Radioimmunoassay; Rats; Rats, Wistar; Reinforcement, Psychology; Self Administration; Time Factors; Transfer, Psychology; Tritium; Vaccination | 2012 |
Antidepressant-like effects of 3,4-methylenedioxymethamphetamine in an animal model of depression.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Brain; Central Nervous System Stimulants; Depressive Disorder; Disease Models, Animal; Hydroxyindoleacetic Acid; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin; Swimming | 2011 |
Altered learning and Arc-regulated consolidation of learning in striatum by methamphetamine-induced neurotoxicity.
Topics: Adrenergic Uptake Inhibitors; Amphetamine-Related Disorders; Animals; Cytoskeletal Proteins; Disease Models, Animal; Genes, Immediate-Early; Learning Disabilities; Male; Methamphetamine; Neostriatum; Nerve Tissue Proteins; Neurotoxins; Organ Culture Techniques; Rats; Rats, Sprague-Dawley | 2012 |
Methamphetamine-induced changes in the striatal dopamine pathway in μ-opioid receptor knockout mice.
Topics: Animals; Behavior, Animal; Central Nervous System Sensitization; Corpus Striatum; Disease Models, Animal; Dopamine; Gene Expression Regulation; GTP-Binding Protein alpha Subunits; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Dopamine D1; Receptors, Opioid, mu; RGS Proteins; Stereotyped Behavior | 2011 |
The effects of methamphetamine self-administration on behavioural sensitization in the olfactory bulbectomy rat model of depression.
Topics: Animals; Behavior, Addictive; Depression; Disease Models, Animal; Male; Methamphetamine; Olfactory Bulb; Rats; Rats, Wistar; Self Administration; Treatment Outcome | 2012 |
ADHD animal model characterization: transcriptomics and proteomics analyses.
Topics: Animals; Animals, Newborn; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Brain; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Female; Hyperkinesis; Methamphetamine; Oligonucleotide Array Sequence Analysis; Oxidopamine; Pregnancy; Proteomics; Rats; Rats, Wistar; Transcriptome | 2012 |
Behavioral inhibition in mice bred for high vs. low levels of methamphetamine consumption or sensitization.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Breeding; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Male; Methamphetamine; Mice; Motor Activity; Risk; Self Administration; Sex Factors | 2012 |
Differential behavioral responses of the spontaneously hypertensive rat to methylphenidate and methamphetamine: lack of a rewarding effect of repeated methylphenidate treatment.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Psychological; Disease Models, Animal; Male; Methamphetamine; Methylphenidate; Rats; Rats, Inbred SHR; Rats, Wistar; Reward | 2012 |
Altered locomotor and stereotyped responses to acute methamphetamine in adolescent, maternally separated rats.
Topics: Animals; Animals, Newborn; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Male; Maternal Deprivation; Methamphetamine; Motor Activity; Rats; Rats, Long-Evans; Sex Factors; Stereotyped Behavior; Stress, Psychological | 2012 |
Effects of lithium and valproate on oxidative stress and behavioral changes induced by administration of m-AMPH.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Lithium Compounds; Male; Methamphetamine; Motor Activity; Oxidative Stress; Protein Carbonylation; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Valproic Acid | 2012 |
The effects of vasopressin and oxytocin on methamphetamine-induced place preference behaviour in rats.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Disease Models, Animal; Male; Methamphetamine; Oxytocin; Rats; Rats, Sprague-Dawley; Vasopressins | 2012 |
Cannabinoid receptors mediate methamphetamine induction of high frequency gamma oscillations in the nucleus accumbens.
Topics: Animals; Brain Waves; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Interneurons; Male; Methamphetamine; Nerve Tissue Proteins; Neurotoxicity Syndromes; Nucleus Accumbens; Piperidines; Psychomotor Performance; Psychotic Disorders; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Rimonabant | 2012 |
Chemosensory cue conditioning with stimulants in a Caenorhabditis elegans animal model of addiction.
Topics: Animals; Behavior, Addictive; Caenorhabditis elegans; Chemotaxis; Cocaine; Conditioning, Psychological; Cues; Disease Models, Animal; Methamphetamine | 2012 |
Pharmacological modulation of amphetamine-induced dyskinesia in transplanted hemi-parkinsonian rats.
Topics: Animals; Anti-Dyskinesia Agents; Cell Transplantation; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Dyskinesias; Excitatory Amino Acid Antagonists; Female; Mesencephalon; Methamphetamine; Neostriatum; Nerve Tissue Proteins; Neurons; Parkinson Disease; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Neurotransmitter; Serotonin Receptor Agonists | 2012 |
Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Association Learning; Benzothiazoles; Conditioning, Operant; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Forelimb; Male; Methamphetamine; Motor Activity; Nucleus Accumbens; Oxidopamine; Parkinson Disease; Pramipexole; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reward; Tyrosine 3-Monooxygenase | 2012 |
Chronic exposure to corticosterone enhances the neuroinflammatory and neurotoxic responses to methamphetamine.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Body Weight; Brain; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Corticosterone; Cytokines; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Electrochemical Techniques; Encephalitis; Enzyme-Linked Immunosorbent Assay; Glial Fibrillary Acidic Protein; Lectins; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microglia; Time Factors; Tyrosine 3-Monooxygenase; Up-Regulation | 2012 |
Attenuated response to methamphetamine sensitization and deficits in motor learning and memory after selective deletion of β-catenin in dopamine neurons.
Topics: Action Potentials; Animals; beta Catenin; Biophysics; Disease Models, Animal; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Electric Stimulation; GABA Plasma Membrane Transport Proteins; Hand Strength; In Vitro Techniques; Learning Disabilities; Locomotion; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microdissection; Motor Activity; Neuronal Plasticity; Rotarod Performance Test; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2012 |
Influence of methamphetamine on genital herpes simplex virus type 2 infection in a mouse model.
Topics: Animals; Antibodies, Viral; Cytokines; Disease Models, Animal; Disease Susceptibility; Enzyme-Linked Immunosorbent Assay; Female; Herpes Genitalis; Herpesvirus 2, Human; Immunity, Innate; Methamphetamine; Mice; Real-Time Polymerase Chain Reaction; Vagina | 2012 |
The evaluation of AZ66, an optimized sigma receptor antagonist, against methamphetamine-induced dopaminergic neurotoxicity and memory impairment in mice.
Topics: Analysis of Variance; Animals; Avoidance Learning; Benzothiazoles; Body Temperature; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Male; Memory Disorders; Methamphetamine; Mice; Neurotoxicity Syndromes; Neurotransmitter Agents; Piperazines; Protein Binding; Receptors, sigma; Recognition, Psychology; Tritium | 2013 |
Peripheral ammonia as a mediator of methamphetamine neurotoxicity.
Topics: Alanine Transaminase; Ammonia; Analysis of Variance; Animals; Aspartate Aminotransferases; Benzodiazepines; Biogenic Monoamines; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Fever; Gene Expression Regulation; Lactulose; Liver Diseases; Male; Mass Spectrometry; Methamphetamine; Microdialysis; Neuroprotective Agents; Neurotoxicity Syndromes; Rats; Rats, Sprague-Dawley; Time Factors | 2012 |
Lithium and valproate modulate energy metabolism in an animal model of mania induced by methamphetamine.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Brain; Citric Acid Cycle; Creatine Kinase; Disease Models, Animal; Electron Transport Chain Complex Proteins; Energy Metabolism; Lithium Compounds; Male; Methamphetamine; Motor Activity; Rats; Rats, Wistar; Valproic Acid | 2013 |
Long-term cognitive and neurochemical effects of "bath salt" designer drugs methylone and mephedrone.
Topics: Animals; Anxiety; Brain; Depression; Designer Drugs; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Hindlimb Suspension; Male; Maze Learning; Memory Disorders; Methamphetamine; Mice; Mice, Inbred C57BL; Norepinephrine; Radioligand Assay; Rats; Rats, Wistar; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2013 |
Role of convergent activation of glutamatergic and dopaminergic systems in the nucleus accumbens in the development of methamphetamine psychosis and dependence.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Conditioning, Operant; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Dopamine; Dopamine Agents; Gene Expression Regulation; Glutamic Acid; Inhibition, Psychological; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Mutation; Nucleus Accumbens; Psychotic Disorders; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Tyrosine 3-Monooxygenase | 2013 |
Expression of HIV gp120 protein increases sensitivity to the rewarding properties of methamphetamine in mice.
Topics: Amphetamine-Related Disorders; Analysis of Variance; Animals; Association Learning; Behavior, Animal; Central Nervous System Stimulants; Choice Behavior; Conditioning, Classical; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gene Expression; HIV Envelope Protein gp120; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Motivation; Quinine; Reward; Saccharin; Sex Distribution | 2014 |
Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity.
Topics: Analysis of Variance; Animals; Body Temperature; Chymotrypsin; Corpus Striatum; Dependovirus; Disease Models, Animal; Dopamine; Dopamine Agents; Male; Methamphetamine; Neurotoxicity Syndromes; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Substantia Nigra; Synaptosomes; Tyrosine 3-Monooxygenase; Ubiquitin-Protein Ligases | 2013 |
Caspase-3 is not activated in seizure-induced neuronal necrosis with internucleosomal DNA cleavage.
Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Brain; Caspase 3; Caspases; Disease Models, Animal; DNA; DNA Fragmentation; Enzyme Activation; Enzyme Inhibitors; In Situ Nick-End Labeling; Male; Methamphetamine; Microdialysis; Necrosis; Neurons; Pilocarpine; Rats; Rats, Wistar; Seizures; Status Epilepticus; Thymus Gland; Time Factors | 2002 |
Controversial HIV study puts whole-cat work on pause.
Topics: Animal Rights; Animals; Brain; Cats; Cell Line; Disease Models, Animal; HIV Infections; Immunodeficiency Virus, Feline; Methamphetamine; Research Design; Substance-Related Disorders | 2002 |
Animal rights pressure on scientists.
Topics: AIDS Dementia Complex; Animal Experimentation; Animal Rights; Animals; Brain; Cats; Disease Models, Animal; Financing, Government; HIV; Humans; Immunodeficiency Virus, Feline; Methamphetamine; National Institutes of Health (U.S.); Research Support as Topic; United States; Virus Replication | 2002 |
Obesity exacerbates chemically induced neurodegeneration.
Topics: Animals; Astrocytes; Brain; Disease Models, Animal; Dopamine; Female; Glial Fibrillary Acidic Protein; Hippocampus; Immunohistochemistry; Ion Channels; Kainic Acid; Membrane Transport Proteins; Methamphetamine; Mice; Mice, Obese; Microtubule-Associated Proteins; Mitochondrial Proteins; Neostriatum; Neurodegenerative Diseases; Neurons; Neurotoxicity Syndromes; Neurotoxins; Obesity; Presynaptic Terminals; Proteins; Uncoupling Protein 2 | 2002 |
[Effects of chronic alcohol administration on changes of extracellular dopamine and serotonin concentration induced by methamphetamine--comparison of two different alcohol preference rat lines].
Topics: Alcoholism; Animals; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Dopamine; Ethanol; Male; Methamphetamine; Microdialysis; Neurotransmitter Agents; Rats; Serotonin | 2002 |
Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; alpha-Synuclein; Animals; Antibodies; Blastomeres; Blotting, Southern; Corpus Striatum; Disease Models, Animal; DNA Primers; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; Hippocampus; Homovanillic Acid; Humans; Immunoblotting; Immunohistochemistry; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; MPTP Poisoning; Nerve Tissue Proteins; Neurons; Parkinsonian Disorders; Piperazines; Rats; Reserpine; Serotonin; Stem Cells; Subcellular Fractions; Substantia Nigra; Synucleins; Tyrosine 3-Monooxygenase | 2003 |
Neurodegeneration of substantia nigra accompanied with macrophage/microglia infiltration after intrastriatal hemorrhage.
Topics: Animals; Apomorphine; Behavior, Animal; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Cerebral Hemorrhage; Collagenases; Disease Models, Animal; Dopamine Agonists; Ectodysplasins; Enzyme-Linked Immunosorbent Assay; Functional Laterality; Immunohistochemistry; In Situ Hybridization; Macrophages; Male; Membrane Proteins; Methamphetamine; Microglia; Mitogen-Activated Protein Kinases; Nerve Degeneration; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Wistar; RNA, Messenger; Rotation; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase | 2003 |
Presence of beta-arrestin in cellular inclusions in metamphetamine-treated PC12 cells.
Topics: Animals; Arrestins; beta-Arrestins; Central Nervous System Stimulants; Disease Models, Animal; Inclusion Bodies; Methamphetamine; Neurodegenerative Diseases; PC12 Cells; Rats; Signal Transduction; Time Factors; Ubiquitin | 2003 |
Methamphetamine and AIDS: 1HMRS studies in a feline model of human disease.
Topics: Acquired Immunodeficiency Syndrome; Animals; Brain; Brain Chemistry; Cats; Choline; Creatine; Disease Models, Animal; gamma-Aminobutyric Acid; Immunodeficiency Virus, Feline; Infections; Magnetic Resonance Spectroscopy; Methamphetamine; Random Allocation | 2004 |
Chronic stress augments the long-term and acute effects of methamphetamine.
Topics: Amphetamine-Related Disorders; Animals; Body Weight; Chronic Disease; Corpus Striatum; Corticosterone; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Down-Regulation; Drug Tolerance; Fever; Male; Methamphetamine; Nerve Degeneration; Neurons; Neurotoxins; Organ Size; Rats; Rats, Sprague-Dawley; Reaction Time; Stress, Physiological | 2004 |
Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity.
Topics: Animals; Antigens, CD; Corpus Striatum; Discrimination Learning; Disease Models, Animal; Dopamine; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Microinjections; Motor Activity; Neurotoxicity Syndromes; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Reward; RNA, Messenger; Spatial Behavior; Substance-Related Disorders; Tumor Necrosis Factor-alpha | 2004 |
Enhancement of central dopaminergic activity in the kainate model of temporal lobe epilepsy: implication for the mechanism of epileptic psychosis.
Topics: Analysis of Variance; Animals; Behavior, Animal; Brain Chemistry; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Electrochemistry; Epilepsy, Temporal Lobe; Haloperidol; In Vitro Techniques; Kainic Acid; Male; Methamphetamine; Microdialysis; Motor Activity; Psychotic Disorders; Rats; Rats, Sprague-Dawley | 2004 |
Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Administration, Oral; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Catalepsy; Chlorpromazine; Dibenzothiazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Haloperidol; Hyperkinesis; Injections, Intraperitoneal; Male; Methamphetamine; Mice; Piperazines; Pyridines; Quetiapine Fumarate; Receptor, Serotonin, 5-HT1A; Risperidone; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists | 2004 |
Enhanced locomotor activity in rats with excitotoxic lesions of the entorhinal cortex, a neurodevelopmental animal model of schizophrenia: behavioral and in vivo microdialysis studies.
Topics: Animals; Behavior, Animal; Brain Chemistry; Disease Models, Animal; Dopamine; Dopamine Agents; Entorhinal Cortex; Male; Methamphetamine; Microdialysis; Motor Activity; Nucleus Accumbens; Quinolinic Acid; Rats; Rats, Wistar; Schizophrenic Psychology; Stereotyped Behavior; Synaptic Transmission | 2004 |
Extrapyramidal motor symptoms versus striatal infarction volume after focal ischemia in mongolian gerbils.
Topics: Animals; Basal Ganglia Diseases; Brain Infarction; Brain Ischemia; Corpus Striatum; Disease Models, Animal; Dopamine; Female; Functional Laterality; Gerbillinae; Hippocampus; Infarction, Middle Cerebral Artery; Male; Methamphetamine; Movement Disorders; Neurons; Rotation; Substantia Nigra | 2004 |
Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach.
Topics: Animals; Antimanic Agents; Bayes Theorem; Bipolar Disorder; Brain; Central Nervous System Stimulants; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Enkephalins; Gene Expression Profiling; Genetic Linkage; Genetic Predisposition to Disease; Genetic Testing; Genomics; Humans; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microarray Analysis; Nerve Tissue Proteins; Pharmacogenetics; Phosphoproteins; Protein Precursors; Substance P; Tachykinins; Valproic Acid | 2004 |
Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease.
Topics: Adrenergic Agents; Animals; Behavior, Animal; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Cell Count; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electrochemistry; Immunohistochemistry; Male; Methamphetamine; Nerve Growth Factors; Oxidopamine; Parkinson Disease; Potassium; Rats; Rats, Inbred F344; Tyrosine 3-Monooxygenase | 2004 |
Motor activity and gene expression in rats with neonatal 6-hydroxydopamine lesions.
Topics: Animals; Animals, Newborn; Brain Chemistry; Catecholamines; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Disease Models, Animal; Electrochemistry; Gene Expression; Gene Expression Regulation, Developmental; Hyperkinesis; Immunohistochemistry; Ion Channels; Male; Methamphetamine; Motor Activity; Neurons; Neuropeptides; Oligonucleotide Array Sequence Analysis; Oxidopamine; Rats; Receptors, Cell Surface; Tyrosine 3-Monooxygenase | 2004 |
Modeling human methamphetamine exposure in nonhuman primates: chronic dosing in the rhesus macaque leads to behavioral and physiological abnormalities.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Body Temperature; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Hydrocortisone; Macaca mulatta; Male; Methamphetamine; Substance Withdrawal Syndrome | 2005 |
Neurotoxic regimens of methamphetamine induce persistent expression of phospho-c-Jun in somatosensory cortex and substantia nigra.
Topics: Afferent Pathways; Animals; Apoptosis; Biomarkers; Cell Survival; Denervation; Disease Models, Animal; Down-Regulation; Fluoresceins; Fluorescent Dyes; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Male; Methamphetamine; Nerve Degeneration; Neurotoxins; Organic Chemicals; Phosphorylation; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Somatosensory Cortex; Substantia Nigra; Time Factors; Vibrissae | 2005 |
Effects of neonatal and prepubertal hormonal manipulations upon estrogen neuroprotection of the nigrostriatal dopaminergic system within female and male mice.
Topics: Aging; Animals; Animals, Newborn; Disease Models, Animal; Dopamine; Estrogens; Female; Gonads; Male; Methamphetamine; Mice; Neostriatum; Neural Pathways; Neuroprotective Agents; Orchiectomy; Ovariectomy; Sex Characteristics; Sexual Maturation; Substantia Nigra; Testosterone | 2005 |
6-Hydroxydopamine-induced lesions in a rat model of hemi-Parkinson's disease monitored by magnetic resonance imaging.
Topics: Animals; Brain; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Immunohistochemistry; Magnetic Resonance Imaging; Male; Methamphetamine; Neurotoxins; Oxidopamine; Parkinsonian Disorders; Predictive Value of Tests; Rats; Rats, Wistar; Rotation; Substantia Nigra; Tyrosine 3-Monooxygenase | 2005 |
Long-lasting change in brain dynamics induced by methamphetamine: enhancement of protein kinase C-dependent astrocytic response and behavioral sensitization.
Topics: Amphetamine-Related Disorders; Animals; Animals, Newborn; Astrocytes; Behavior, Animal; Brain; Cells, Cultured; Central Nervous System Stimulants; Coculture Techniques; Disease Models, Animal; Gyrus Cinguli; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred ICR; Morphine; Narcotics; Nerve Degeneration; Neuronal Plasticity; Nucleus Accumbens; Protein Kinase C; Up-Regulation | 2005 |
Learning in the Place navigation task, not the New-learning task, is altered by prenatal methamphetamine exposure.
Topics: Amphetamine-Related Disorders; Animals; Brain; Central Nervous System Stimulants; Disease Models, Animal; Female; Learning Disabilities; Male; Maze Learning; Memory; Memory Disorders; Methamphetamine; Orientation; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Sex Characteristics; Sex Factors | 2005 |
Methamphetamine modulation of gene expression in the brain: analysis using customized cDNA microarray system with the mouse homologues of KIAA genes.
Topics: Amphetamine-Related Disorders; Animals; Cell Cycle Proteins; Central Nervous System Stimulants; Circadian Rhythm; Disease Models, Animal; DNA, Complementary; Drug Administration Schedule; Gene Expression Profiling; Gene Expression Regulation; Hippocampus; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Period Circadian Proteins; Transcription Factors; Up-Regulation | 2005 |
Isolation rearing or methamphetamine traumatisation induce a "dysconnection" of prefrontal efferents in gerbils: implications for schizophrenia.
Topics: Animals; Central Nervous System Stimulants; Cerebral Cortex; Disease Models, Animal; Dopamine; Efferent Pathways; Gerbillinae; Glutamic Acid; Lysine; Male; Methamphetamine; Models, Neurological; Parietal Lobe; Prefrontal Cortex; Presynaptic Terminals; Schizophrenia; Social Isolation; Synaptic Transmission | 2006 |
Selective disruption of nucleus accumbens gating mechanisms in rats behaviorally sensitized to methamphetamine.
Topics: Animals; Central Nervous System Stimulants; Disease Models, Animal; Drug Administration Schedule; Electric Stimulation; Electrodes, Implanted; Locomotion; Male; Methamphetamine; Microelectrodes; Neurons; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Substance-Related Disorders; Ventral Tegmental Area | 2005 |
Transplantation of mouse embryonic stem cell-derived neurons into the striatum, subthalamic nucleus and substantia nigra, and behavioral recovery in hemiparkinsonian rats.
Topics: Animals; Basal Ganglia; Behavior, Animal; Brain Tissue Transplantation; Cell Count; Corpus Striatum; Denervation; Disease Models, Animal; Graft Survival; Growth Cones; Hyperkinesis; Male; Methamphetamine; Mice; Neurons; Oxidopamine; Parkinsonian Disorders; Pluripotent Stem Cells; Rats; Rats, Wistar; Recovery of Function; Stem Cell Transplantation; Substantia Nigra; Subthalamic Nucleus | 2005 |
Increased proportion of high-affinity dopamine D2 receptors in rats with excitotoxic damage of the entorhinal cortex, an animal model of schizophrenia.
Topics: Animals; Benzazepines; Disease Models, Animal; Dopamine Antagonists; Entorhinal Cortex; Functional Laterality; Male; Methamphetamine; Rats; Rats, Wistar; Receptors, Dopamine D2; Schizophrenia | 2005 |
Human methamphetamine pharmacokinetics simulated in the rat: single daily intravenous administration reveals elements of sensitization and tolerance.
Topics: Amphetamine-Related Disorders; Anesthesia, Intravenous; Animals; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Drug Administration Schedule; Drug Tolerance; Extracellular Fluid; Humans; Male; Methamphetamine; Microdialysis; Motor Activity; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Synaptic Transmission | 2006 |
Concurrent calpain and caspase-3 mediated proteolysis of alpha II-spectrin and tau in rat brain after methamphetamine exposure: a similar profile to traumatic brain injury.
Topics: Animals; Blotting, Western; Brain; Brain Injuries; Calpain; Caspase 3; Caspases; Cysteine Endopeptidases; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Male; Methamphetamine; Nerve Tissue Proteins; Neurotoxicity Syndromes; Rats; Rats, Sprague-Dawley; Spectrin; tau Proteins | 2005 |
Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Methamphetamine; Mice; Naltrexone; Narcotic Antagonists | 2005 |
Changes in renal function and oxidative damage in methamphetamine-treated rat.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Biomarkers; Body Temperature; Body Weight; Calcium; Central Nervous System Stimulants; Creatinine; Deoxyguanosine; Disease Models, Animal; Immunohistochemistry; Kidney; Male; Methamphetamine; Myoglobin; Phosphorus; Potassium; Rats; Rats, Wistar; Ubiquitin | 2006 |
Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in rats.
Topics: Animals; Antibodies, Monoclonal; Antibody Affinity; Antibody Specificity; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Drug Overdose; Female; Immunoglobulin G; Male; Methamphetamine; Mice; Mice, Inbred BALB C; Motor Activity; Rats; Rats, Sprague-Dawley; Time Factors | 2005 |
Methamphetamine causes alterations in the MAP kinase-related pathways in the brains of mice that display increased aggressiveness.
Topics: Aggression; Amphetamine-Related Disorders; Animals; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Frontal Lobe; Glycogen Synthase Kinase 3; Male; MAP Kinase Kinase 1; MAP Kinase Signaling System; Mental Disorders; Methamphetamine; Mice; Motor Activity; Phosphorylation | 2006 |
Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia.
Topics: Animals; Animals, Newborn; Antibodies, Viral; Brain; Clozapine; Cognition; Cytokines; Disease Models, Animal; Exploratory Behavior; Female; Form Perception; Mental Recall; Methamphetamine; Mice; Mice, Inbred BALB C; Motor Activity; Neural Inhibition; Neuroimmunomodulation; Orientation; Poly I-C; Pregnancy; Pregnancy Complications, Infectious; Pregnancy, Animal; Prenatal Exposure Delayed Effects; Reflex, Startle; Schizophrenia; Virus Diseases | 2006 |
Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease.
Topics: Age Factors; Animals; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electrochemistry; Huntingtin Protein; Huntington Disease; In Vitro Techniques; Methamphetamine; Mice; Mice, Transgenic; Microelectrodes; Motor Activity; Nerve Tissue Proteins; Nuclear Proteins; Time Factors | 2006 |
Differences in extinction responding and reinstatement of methamphetamine-seeking behavior between Fischer 344 and Lewis rats.
Topics: Animals; Central Nervous System Stimulants; Disease Models, Animal; Extinction, Psychological; Methamphetamine; Rats; Rats, Inbred F344; Rats, Inbred Lew; Self Administration; Species Specificity; Substance-Related Disorders | 2006 |
Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice.
Topics: Amphetamine-Related Disorders; Animals; Apoptosis; Biomarkers; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; DNA-Binding Proteins; Drug Resistance; Immunohistochemistry; In Situ Nick-End Labeling; Interneurons; Male; Methamphetamine; Mice; Mice, Inbred ICR; Nerve Degeneration; Nerve Tissue Proteins; Neural Pathways; Neurons; Neurotoxins; Neurotransmitter Agents; Nuclear Proteins | 2006 |
Nigral injection of antisense oligonucleotides to synaptotagmin I using HVJ-liposome vectors causes disruption of dopamine release in the striatum and impaired skill learning.
Topics: Analysis of Variance; Animals; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dopamine; Gene Transfer Techniques; Immunohistochemistry; Male; Methamphetamine; Microdialysis; Motor Activity; Motor Skills; Motor Skills Disorders; Oligonucleotides, Antisense; Oxidopamine; Rats; Rats, Wistar; Reaction Time; Rotarod Performance Test; Substantia Nigra; Synaptotagmin I | 2006 |
Selective serotonin reuptake inhibitors, fluoxetine and paroxetine, attenuate the expression of the established behavioral sensitization induced by methamphetamine.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Fluoxetine; Head Movements; Locomotion; Methamphetamine; Mice; Paroxetine; Psychoses, Substance-Induced; Secondary Prevention; Selective Serotonin Reuptake Inhibitors | 2007 |
Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists.
Topics: Acetylcysteine; Animals; Behavior, Animal; Brain Chemistry; Cocaine; Conditioning, Operant; Disease Models, Animal; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Free Radical Scavengers; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glutathione; Learning Disabilities; Male; Methamphetamine; Mice; Neurotoxicity Syndromes; Tyrosine 3-Monooxygenase | 2007 |
Inhibition of tumor necrosis factor-alpha signaling prevents human immunodeficiency virus-1 protein Tat and methamphetamine interaction.
Topics: AIDS Dementia Complex; Amphetamine-Related Disorders; Animals; Basal Ganglia; Cells, Cultured; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Encephalitis; Gene Products, tat; Humans; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Presynaptic Terminals; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; tat Gene Products, Human Immunodeficiency Virus; Tumor Necrosis Factor-alpha; Up-Regulation | 2006 |
Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Estrogens; Female; Male; Methamphetamine; Mice; Nerve Degeneration; Neural Pathways; Neuroprotective Agents; Neurotoxins; Orchiectomy; Ovariectomy; Parkinsonian Disorders; Substantia Nigra | 2006 |
Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine.
Topics: Animals; Disease Models, Animal; Male; Methamphetamine; Mice; Mice, Inbred BALB C; Minocycline; Motor Activity; Movement; Substance-Related Disorders | 2006 |
Reinforcing effects of smoked methamphetamine in rhesus monkeys.
Topics: Amphetamine-Related Disorders; Animals; Cocaine; Disease Models, Animal; Dose-Response Relationship, Drug; Macaca mulatta; Male; Methamphetamine; Reinforcement, Psychology; Self Administration; Smoking | 2006 |
High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus.
Topics: Amphetamine-Related Disorders; Amygdala; Animals; Blood-Brain Barrier; Body Temperature; Central Nervous System Stimulants; Cerebral Arteries; Disease Models, Animal; Fever; Fluoresceins; Gliosis; Hippocampus; Immunoglobulin G; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microglia; Nerve Degeneration; Neurons; Organic Chemicals; Phagocytosis; Plant Lectins; Seizures | 2006 |
Peroxisome proliferator-activated receptor gamma activation relieves expression of behavioral sensitization to methamphetamine in mice.
Topics: Amphetamine-Related Disorders; Anilides; Animals; Behavior, Animal; Brain; Brain Chemistry; Cell Nucleus; Disease Models, Animal; Dopamine Uptake Inhibitors; Electrophoretic Mobility Shift Assay; Encephalitis; Hypoglycemic Agents; Male; Methamphetamine; Mice; Mice, Inbred ICR; Motor Activity; Nucleus Accumbens; Pioglitazone; PPAR gamma; Psychoses, Substance-Induced; Retinoid X Receptors; Reward; Thiazolidinediones | 2007 |
Nifedipine suppresses self-injurious behaviors in animals.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Behavior, Animal; Calcium Channel Agonists; Calcium Channel Blockers; Central Nervous System Stimulants; Disease Models, Animal; Female; Male; Methamphetamine; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nifedipine; Oxidopamine; Pemoline; Pregnancy; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Self-Injurious Behavior; Sympatholytics | 2007 |
Effects of prenatal exposure to methamphetamine on the development of the rat retina.
Topics: Animals; Body Weight; Disease Models, Animal; Dopamine Agents; Female; Immunohistochemistry; Male; Maternal-Fetal Exchange; Methamphetamine; Pregnancy; Pregnancy, Animal; Prenatal Exposure Delayed Effects; Rats; Retina; Tyrosine 3-Monooxygenase | 2006 |
Effects of postnatal exposure to methamphetamine on the development of the rat retina.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Size; Disease Models, Animal; Dopamine; Female; Male; Methamphetamine; Postnatal Care; Rats; Rats, Inbred BB; Retina; Tyrosine 3-Monooxygenase | 2006 |
Nrf2 gene deletion fails to alter psychostimulant-induced behavior or neurotoxicity.
Topics: Amino Acid Transport System y+; Animals; Brain; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Gene Expression Regulation; Glutamic Acid; Methamphetamine; Mice; Mice, Knockout; Nerve Degeneration; NF-E2-Related Factor 2; Nucleus Accumbens; Oxidative Stress; Regulatory Elements, Transcriptional | 2007 |
Quantitative measurement of neurological deficit after mild (30 min) transient middle cerebral artery occlusion in rats.
Topics: Animals; Behavioral Research; Brain Damage, Chronic; Brain Ischemia; Disease Models, Animal; Endpoint Determination; Infarction, Middle Cerebral Artery; Male; Methamphetamine; Motor Skills; Movement Disorders; Rats; Rats, Wistar; Rotation; Severity of Illness Index | 2007 |
Alteration in the GABAergic network of the prefrontal cortex in a potential animal model of psychosis.
Topics: Aging; Animals; Cell Differentiation; Disease Models, Animal; Dopamine Uptake Inhibitors; Environment Design; gamma-Aminobutyric Acid; Gerbillinae; Interneurons; Male; Methamphetamine; Nerve Net; Prefrontal Cortex; Presynaptic Terminals; Psychotic Disorders; Pyramidal Cells; Sensory Deprivation; Synapses; Synaptic Transmission | 2007 |
Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration.
Topics: Amphetamine-Related Disorders; Animals; Antipsychotic Agents; Aripiprazole; Brain; Brain Chemistry; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Drug Interactions; Male; Methamphetamine; Nucleus Accumbens; Piperazines; Quinolones; Rats; Rats, Wistar; Receptors, Dopamine D2; Self Administration | 2007 |
Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine
Topics: Age Factors; Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Male; Methamphetamine; Motor Activity; Neurons; Parvalbumins; Phencyclidine; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2007 |
Effect of prefrontal cortex inactivation on behavioral and neurochemical abnormalities in rats with excitotoxic lesions of the entorhinal cortex.
Topics: Amygdala; Anesthetics, Local; Animals; Denervation; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Entorhinal Cortex; Lidocaine; Limbic System; Male; Methamphetamine; Motor Activity; Neural Inhibition; Neural Pathways; Nucleus Accumbens; Prefrontal Cortex; Quinolinic Acid; Rats; Rats, Wistar; Schizophrenia; Synaptic Transmission | 2007 |
Effects of behavioral and neurochemical changes on adult excitotoxic lesion of the ventral hippocampus.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Hippocampus; Male; Methamphetamine; Motor Activity; Neurodegenerative Diseases; Neurotoxins; Rats; Rats, Sprague-Dawley; Schizophrenia | 2007 |
Anxiety-like and exploratory behaviors of isolation-reared mice in the staircase test.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Carbolines; Central Nervous System Stimulants; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; GABA Antagonists; GABA Modulators; Male; Methamphetamine; Mice; Motor Activity; Phenobarbital; Social Isolation | 2007 |
Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles.
Topics: Analysis of Variance; Animals; Autoradiography; Behavior, Animal; Benzazepines; Brain; Brain Chemistry; Central Nervous System Stimulants; Chlorocebus aethiops; Cocaine; Disease Models, Animal; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Methamphetamine; Neurotoxicity Syndromes; Protein Binding; Raclopride; Social Behavior; Tritium | 2008 |
The guinea pig forced swim test as a new behavioral despair model to characterize potential antidepressants.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Clozapine; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drugs, Investigational; Fluoxetine; Guinea Pigs; Injections, Intraperitoneal; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Paroxetine; Piperidines; Selective Serotonin Reuptake Inhibitors; Swimming; Tranylcypromine | 2007 |
Nitric oxide-containing neurons in long-term grafts in a rat model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Brain Tissue Transplantation; Choline; Disease Models, Animal; Female; Indazoles; Methamphetamine; NADPH Dehydrogenase; Neostriatum; Neurons; Nitric Oxide; Parkinson Disease; Pedunculopontine Tegmental Nucleus; Pregnancy; Rats; Rats, Sprague-Dawley; Rotation; Somatostatin; Time Factors; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2007 |
Changes in leptin, ghrelin, growth hormone and neuropeptide-Y after an acute model of MDMA and methamphetamine exposure in rats.
Topics: Adrenergic Uptake Inhibitors; Amphetamine-Related Disorders; Animals; Appetite; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Ghrelin; Growth Hormone; Leptin; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neuropeptide Y; Radioimmunoassay; Rats; Rats, Sprague-Dawley | 2008 |
Methamphetamine increases basal ganglia iron to levels observed in aging.
Topics: Aging; Animals; Basal Ganglia; Basal Ganglia Diseases; Central Nervous System Stimulants; Chlorocebus aethiops; Disease Models, Animal; Dopamine; Ferritins; Globus Pallidus; Iron; Iron Metabolism Disorders; Male; Methamphetamine; Oxidative Stress; Species Specificity; Substantia Nigra; Tyrosine 3-Monooxygenase | 2007 |
Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure.
Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dopamine; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microglia; Myelin Sheath; Neostriatum; Nerve Degeneration; Serotonin; Time Factors; Tyrosine 3-Monooxygenase | 2008 |
The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity.
Topics: Adrenergic Uptake Inhibitors; Amphetamine-Related Disorders; Animals; Body Temperature; Brain; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Enzyme Inhibitors; Extracellular Space; Female; Gliosis; Levodopa; Methamphetamine; Mice; Mice, Inbred C57BL; Microglia; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Presynaptic Terminals; Reserpine; Tyrosine 3-Monooxygenase | 2008 |
Olanzapine and risperidone block a high dose of methamphetamine-induced schizophrenia-like behavioral abnormalities and accompanied apoptosis in the medial prefrontal cortex.
Topics: Animals; Antipsychotic Agents; Apoptosis; Behavior, Animal; Benzodiazepines; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; In Situ Nick-End Labeling; Male; Methamphetamine; Motor Activity; Neural Inhibition; Neuroprotective Agents; Olanzapine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Risperidone; Schizophrenia; Time Factors | 2008 |
Effects of methamphetamine on single unit activity in rat medial prefrontal cortex in vivo.
Topics: Action Potentials; Animals; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Male; Methamphetamine; Neurons; Prefrontal Cortex; Psychoses, Substance-Induced; Rats; Rats, Sprague-Dawley; Schizophrenia; Stochastic Processes; Synaptic Transmission | 2007 |
Developmental lead exposure attenuates methamphetamine dose-effect self-administration performance and progressive ratio responding in the male rat.
Topics: Animals; Disease Models, Animal; Female; Lead Poisoning, Nervous System; Male; Methamphetamine; Motivation; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Substance-Related Disorders | 2008 |
Methamphetamine-induced neurotoxicity and microglial activation are not mediated by fractalkine receptor signaling.
Topics: Animals; Body Temperature; Central Nervous System Stimulants; Corpus Striatum; CX3C Chemokine Receptor 1; Disease Models, Animal; Dopamine; Green Fluorescent Proteins; Lectins; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Neurotoxicity Syndromes; Receptors, Chemokine; Signal Transduction; Time Factors | 2008 |
Enhanced methamphetamine self-administration in a neurodevelopmental rat model of schizophrenia.
Topics: Amphetamine-Related Disorders; Animals; Animals, Newborn; Behavior, Addictive; Behavior, Animal; Central Nervous System Stimulants; Diagnosis, Dual (Psychiatry); Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hippocampus; Male; Methamphetamine; Pregnancy; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Schizophrenia; Self Administration | 2008 |
[Effect of central effective substances on alcohol preference].
Topics: Alcohol Drinking; Alcoholism; Animals; Arecoline; Atropine; Central Nervous System Stimulants; Cyproheptadine; Disease Models, Animal; Drinking Behavior; Food Preferences; Haloperidol; Humans; Isoproterenol; Male; Methamphetamine; Mice; Phenoxybenzamine; Picrotoxin; Propranolol | 1983 |
[The effects of chronic methamphetamine and single haloperidol injections on thiamine and its phosphate ester levels in the rat brain].
Topics: Animals; Brain; Disease Models, Animal; Haloperidol; Humans; Male; Methamphetamine; Rats; Rats, Inbred Strains; Schizophrenia; Thiamine; Thiamine Monophosphate; Thiamine Pyrophosphate; Thiamine Triphosphate; Time Factors | 1984 |
Effect of a single injection of psychoactive drugs on CCK mRNA in rat brain.
Topics: Animals; Brain Chemistry; Cholecystokinin; Disease Models, Animal; Male; Methamphetamine; Phencyclidine; Psychoses, Substance-Induced; Rats; Rats, Wistar; RNA, Messenger | 1994 |
Methamphetamine toxicity prevented by activated charcoal in a mouse model.
Topics: Animals; Charcoal; Disease Models, Animal; Male; Methamphetamine; Mice; Poisoning; Prospective Studies; Random Allocation | 1994 |
Dissimilar patterns of degeneration in brain following four different addictive stimulants.
Topics: Animals; Brain; Cocaine; Dextroamphetamine; Disease Models, Animal; Drug Implants; Methamphetamine; Nerve Degeneration; Phencyclidine; Rats; Substance-Related Disorders | 1993 |
[Reverse-tolerance phenomenon in methamphetamine-induced behavioral stereotypy and impairment of cliff avoidance reaction after subchronic methamphetamine administration in rats].
Topics: Animals; Avoidance Learning; Central Nervous System Stimulants; Cognition Disorders; Disease Models, Animal; Male; Methamphetamine; Psychoses, Substance-Induced; Rats; Rats, Sprague-Dawley; Stereotyped Behavior | 1995 |
Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia.
Topics: Animals; Antipsychotic Agents; Central Nervous System Stimulants; Chronic Disease; Depressive Disorder; Disease Models, Animal; Hallucinogens; Male; Methamphetamine; Mice; Mice, Inbred Strains; Motor Activity; Phencyclidine; Schizophrenic Psychology; Swimming | 1995 |
Early cytopathic features in rat ischemia model and reconstruction by neural graft.
Topics: Animals; Behavior, Animal; Brain Ischemia; Brain Tissue Transplantation; Cell Death; Disease Models, Animal; Electric Stimulation; Immunohistochemistry; Male; Methamphetamine; Neurons; Rats; Rats, Wistar | 1996 |
Hair analysis for drug abuse. XIV. Identification of substances causing acute poisoning using hair root. I. Methamphetamine.
Topics: Acute Disease; Adult; Animals; Central Nervous System Stimulants; Chromatography; Disease Models, Animal; Drug Overdose; Hair Follicle; Humans; Male; Methamphetamine; Middle Aged; Rats; Substance Abuse Detection | 1997 |
Cortical and hippocampal EEG power spectra in animal models of schizophrenia produced with methamphetamine, cocaine, and phencyclidine.
Topics: Adrenergic Agents; Animals; Cerebral Cortex; Cocaine; Disease Models, Animal; Electroencephalography; Hallucinogens; Hippocampus; Male; Methamphetamine; Phencyclidine; Rabbits; Schizophrenia | 1997 |
Methamphetamine induces fos expression in the striatum and the substantia nigra pars reticulata in a rat model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Benzazepines; Brain Chemistry; Brain Tissue Transplantation; Corpus Striatum; Disease Models, Animal; Dizocilpine Maleate; Dopamine Agents; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Female; Mesencephalon; Methamphetamine; Neurons; Oxidopamine; Parkinson Disease, Secondary; Proto-Oncogene Proteins c-fos; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Salicylamides; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase | 1998 |
Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.
Topics: Animals; Antihypertensive Agents; Behavior, Animal; Benzazepines; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Antagonists; Drug Interactions; Female; Huntington Disease; Methamphetamine; Microglia; Nerve Degeneration; Neurons; Nitro Compounds; Oxidopamine; Propionates; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sympatholytics; Sympathomimetics | 1998 |
The role of gamma-aminobutyric acid (GABA)-benzodiazepine neurotransmission in an animal model of methamphetamine-induced psychosis.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Clonazepam; Depression, Chemical; Disease Models, Animal; Flumazenil; GABA Modulators; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Rats; Rats, Wistar; Receptors, GABA-A; Synaptic Transmission | 1999 |
Effects of repeated administration of methamphetamine on P3-like potentials in rats.
Topics: Animals; Central Nervous System Stimulants; Cerebral Cortex; Conditioning, Operant; Disease Models, Animal; Drug Administration Schedule; Event-Related Potentials, P300; Male; Methamphetamine; Motor Activity; Psychoses, Substance-Induced; Rats; Rats, Sprague-Dawley; Schizophrenia; Stereotypic Movement Disorder; Time Factors | 1999 |
Chroman amide and nicotinyl amide derivatives: inhibition of lipid peroxidation and protection against head trauma.
Topics: Animals; Brain Injuries; Chromans; Craniocerebral Trauma; Disease Models, Animal; Dopamine; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Hydroxyl Radical; Hypoxia; Lipid Peroxidation; Male; Methamphetamine; Mice; Molecular Structure; Motor Activity; Neuroprotective Agents; Niacinamide | 2000 |
Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats.
Topics: Animals; Behavior, Animal; Discrimination Learning; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Substance-Related Disorders | 2000 |
Neonatal lesions of the left entorhinal cortex affect dopamine metabolism in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amygdala; Animals; Animals, Newborn; Brain; Caudate Nucleus; Disease Models, Animal; Dopamine; Dopamine Agonists; Entorhinal Cortex; Female; Homovanillic Acid; Methamphetamine; Microdialysis; Neurotoxins; Nucleus Accumbens; Prefrontal Cortex; Quinolinic Acid; Rats; Rats, Wistar; Schizophrenia; Temporal Lobe | 2000 |
Relation between hippocampal gamma waves and behavioral disturbances induced by phencyclidine and methamphetamine.
Topics: Animals; Arousal; Brain Mapping; Central Nervous System Stimulants; Disease Models, Animal; Electroencephalography; Evoked Potentials; Hallucinogens; Hippocampus; Male; Methamphetamine; Motor Activity; Phencyclidine; Psychomotor Performance; Rats; Rats, Long-Evans; Schizophrenia; Septum of Brain | 2000 |
Involvement of sigma 1 receptors in methamphetamine-induced behavioral sensitization in rats.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Haloperidol; Injections, Intraperitoneal; Male; Methamphetamine; Piperazines; Pyrrolidines; Rats; Rats, Wistar; Receptors, sigma; Schizophrenia; Sigma-1 Receptor; Stereotyped Behavior; Tartrates | 2000 |
Age-dependent differential responses of monoaminergic systems to high doses of methamphetamine.
Topics: Age Factors; Aging; Amphetamine-Related Disorders; Animals; Biogenic Monoamines; Brain; Carrier Proteins; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Administration Schedule; Fever; Frontal Lobe; Hippocampus; Injections, Subcutaneous; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Synaptosomes; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase | 2000 |
Prevention of dopaminergic neurotoxicity by targeting nitric oxide and peroxynitrite: implications for the prevention of methamphetamine-induced neurotoxic damage.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Cyclic N-Oxides; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Drug Administration Schedule; Drug Interactions; Electrochemistry; Free Radical Scavengers; Homovanillic Acid; Imidazoles; Indazoles; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Models, Biological; Neuroprotective Agents; Neurotoxicity Syndromes; Nitric Oxide; Peroxynitrous Acid; Tyrosine | 2000 |
Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Area Under Curve; Body Temperature; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Female; Homovanillic Acid; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Models, Biological; Neurotoxicity Syndromes; Sex Factors; Time Factors | 2000 |
Glycine reduces novelty- and methamphetamine-induced locomotor activity in neonatal ventral hippocampal damaged rats.
Topics: Animals; Disease Models, Animal; Glycine; Hippocampus; Hyperkinesis; Ibotenic Acid; Methamphetamine; Motor Activity; Rats; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2001 |
IGF-I and bFGF improve dopamine neuron survival and behavioral outcome in parkinsonian rats receiving cultured human fetal tissue strands.
Topics: Abortion, Induced; Animals; Apomorphine; Brain; Brain Tissue Transplantation; Cell Survival; Cells, Cultured; Disease Models, Animal; Dopamine; Female; Fetal Tissue Transplantation; Fibroblast Growth Factor 2; Homovanillic Acid; Humans; Insulin-Like Growth Factor I; Male; Methamphetamine; Motor Activity; Neurons; Oxidopamine; Parkinsonian Disorders; Pregnancy; Rats; Rats, Sprague-Dawley; Rotation; Transplantation, Heterologous; Tyrosine 3-Monooxygenase | 2001 |
Dopaminergic role in stimulant-induced wakefulness.
Topics: Amphetamine; Animals; Benzhydryl Compounds; Caffeine; Carrier Proteins; Caudate Nucleus; Central Nervous System Stimulants; Disease Models, Animal; Dogs; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electroencephalography; Electromyography; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Mice, Knockout; Microdialysis; Modafinil; Motor Activity; Narcolepsy; Nerve Tissue Proteins; Orexin Receptors; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Wakefulness | 2001 |
Methamphetamine potentiates ischemia/reperfusion insults after transient middle cerebral artery ligation.
Topics: Animals; Blood Flow Velocity; Blood Gas Analysis; Blood Pressure; Calcium; Cerebral Cortex; Cerebrovascular Circulation; Corpus Striatum; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glial Cell Line-Derived Neurotrophic Factor; Heart Rate; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Ligation; Male; Methamphetamine; Mice; Nerve Growth Factors; Nerve Tissue Proteins; Reactive Oxygen Species; Reperfusion Injury; RNA, Messenger; Tumor Suppressor Protein p53 | 2001 |
Protective effect of the antioxidant 6-ethoxy-2,2-pentamethylen-1,2-dihydroquinoline (S 33113) in models of cerebral neurodegeneration.
Topics: Alloxan; Animals; Antioxidants; Body Temperature; Brain Ischemia; Cell Survival; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Hippocampus; Hyperglycemia; Injections, Intraventricular; Kainic Acid; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Nerve Degeneration; Neurons; Quinolines; Rats; Rats, Wistar; Rectum; Survival Rate; tert-Butylhydroperoxide | 2001 |
The human genome: genetic testing and animal models.
Topics: Animals; Bipolar Disorder; Chromosome Mapping; Disease Models, Animal; Gene Expression; Genome, Human; Humans; Methamphetamine; Oligonucleotide Array Sequence Analysis; Rats | 2001 |
NIH faces action over HIV cat study.
Topics: Animal Experimentation; Animal Welfare; Animals; Animals, Laboratory; Cats; Disease Models, Animal; Feline Acquired Immunodeficiency Syndrome; Humans; Methamphetamine; National Institutes of Health (U.S.); Research; Substance-Related Disorders; United States | 2002 |
Immediate-early gene response to methamphetamine, haloperidol, and quinolinic acid is not impaired in Huntington's disease transgenic mice.
Topics: Animals; Anti-Dyskinesia Agents; Central Nervous System Stimulants; Corpus Callosum; Corpus Striatum; Disease Models, Animal; DNA-Binding Proteins; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Antagonists; Early Growth Response Protein 1; Gene Expression; Genes, Immediate-Early; Glial Fibrillary Acidic Protein; Haloperidol; Huntington Disease; Immediate-Early Proteins; Methamphetamine; Mice; Mice, Transgenic; Nerve Tissue Proteins; Phosphoproteins; Proto-Oncogene Proteins c-fos; Quinolinic Acid; RNA, Messenger; Transcription Factors | 2002 |
Students protest use of cats in HIV research; lawsuit filed.
Topics: Animal Rights; Animals; Cats; Disease Models, Animal; Feline Acquired Immunodeficiency Syndrome; Methamphetamine; Ohio; Research; Students; Substance-Related Disorders; Universities | 2002 |
Morphological changes in immunopositive cells of ionotropic glutamate receptor subunits during the development of transplanted fetal ventral mesencephalic neurons.
Topics: Animals; Behavior, Animal; Brain Tissue Transplantation; Cell Differentiation; Disease Models, Animal; Female; Fetal Tissue Transplantation; Graft Survival; Immunohistochemistry; Mesencephalon; Methamphetamine; Neurons; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Tyrosine 3-Monooxygenase | 2002 |
Multiplex three-dimensional brain gene expression mapping in a mouse model of Parkinson's disease.
Topics: Animals; Brain Chemistry; Brain Mapping; Central Nervous System Stimulants; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Multigene Family; Parkinson Disease; Parkinson Disease, Secondary | 2002 |
The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease.
Topics: Aging; Animals; Behavior, Animal; Brain; Brain Chemistry; Central Nervous System Stimulants; Cocaine; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Disease Progression; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Female; Glucose Tolerance Test; Huntington Disease; Levodopa; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Spatial Behavior; Survival Rate | 2002 |
Drug researcher quits controversial cat study.
Topics: Animal Experimentation; Animal Rights; Animals; Brain; Cats; Disease Models, Animal; HIV; Humans; Immunodeficiency Virus, Feline; Methamphetamine; Research; Research Design; Research Personnel; Virus Replication; Workforce | 2002 |
Behavioral consequences of methamphetamine-induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine-Related Disorders; Animals; Behavior, Animal; Binding Sites; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Homovanillic Acid; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Motor Activity; Nerve Tissue Proteins; Neurotoxins | 2002 |
Proceedings: Methylamphetamine withdrawal as a model for the depressive state: antagonism of post-amphetamine depression by imipramine.
Topics: Animals; Brain Chemistry; Depression; Disease Models, Animal; Humans; Imipramine; Male; Methamphetamine; Norepinephrine; Rats; Substance Withdrawal Syndrome | 1975 |
Effects of disulfiram on the amphetamine-induced behavioral syndrome in the cat as a model of psychosis.
Topics: Animals; Behavior, Animal; Cats; Disease Models, Animal; Disulfiram; Drug Interactions; Female; Humans; Methamphetamine; Motor Activity; Psychotic Disorders; Stereotyped Behavior; Time Factors | 1975 |
Effect of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks.
Topics: Aging; Animals; Avoidance Learning; Brain; Choline O-Acetyltransferase; Cognition Disorders; Dementia; Discrimination Learning; Disease Models, Animal; Male; Memory Disorders; Methamphetamine; Motor Activity; Physostigmine; Piperazines; Rats; Rats, Inbred F344; Rats, Wistar; Scopolamine; Sulfonamides | 1992 |
Motor impairments after methamphetamine-induced neurotoxicity in the rat.
Topics: Animals; Avoidance Learning; Disease Models, Animal; Dopamine; Fenfluramine; Levodopa; Male; Methamphetamine; Motor Activity; Nervous System Diseases; Parkinson Disease; Rats; Serotonin | 1992 |
Chronic methamphetamine intoxication model of schizophrenia in animals.
Topics: Animals; Behavior, Animal; Cats; Disease Models, Animal; Female; Guinea Pigs; Male; Methamphetamine; Mice; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology | 1992 |
Establishment of chronic intravenous drug self-administration in the C57BL/6J mouse.
Topics: Animals; Cocaine; Disease Models, Animal; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Morphine; Pentobarbital; Self Administration; Species Specificity; Substance-Related Disorders | 1991 |
Neuroleptic-induced catalepsy as a model of Parkinson's disease. I. Effect of dopaminergic agents.
Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Fluphenazine; Levodopa; Male; Methamphetamine; Microinjections; Parkinson Disease; Rats; Sulpiride | 1990 |
Conditioned drug effects of pimozide, haloperidol and chlorpromazine on methamphetamine-induced behavior.
Topics: Animals; Arousal; Chlorpromazine; Conditioning, Classical; Disease Models, Animal; Dose-Response Relationship, Drug; Haloperidol; Male; Methamphetamine; Motor Activity; Neurocognitive Disorders; Orientation; Pimozide; Rats; Rats, Inbred Strains; Schizophrenic Psychology; Stereotyped Behavior | 1990 |
Enhancing effects of sound on methamphetamine-induced behavioral aberrations in the rat: a model of relapse of schizophrenia-like symptoms.
Topics: Acoustic Stimulation; Animals; Arousal; Association Learning; Behavior, Animal; Conditioning, Classical; Disease Models, Animal; Male; Methamphetamine; Motor Activity; Neurocognitive Disorders; Orientation; Rats; Rats, Inbred Strains; Schizophrenic Psychology; Stereotyped Behavior | 1990 |
Catecholaminergic responses to rotational stress in rat brain stem: implications for amphetamine therapy of motion sickness.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Brain Stem; Disease Models, Animal; Homovanillic Acid; Male; Methamphetamine; Methoxyhydroxyphenylglycol; Motion Sickness; Norepinephrine; Pica; Rats; Rats, Inbred Strains; Restraint, Physical; Rotation; Stress, Physiological | 1990 |
[The influences of neurotransmitters on the traumatic unconsciousness, immediate convulsion and mortality in the experimental mice model].
Topics: Animals; Atropine; Craniocerebral Trauma; Disease Models, Animal; Haloperidol; Male; Methamphetamine; Mice; Neurotransmitter Agents; Physostigmine; Scopolamine; Seizures; Unconsciousness | 1987 |
The effects of carbamazepine on two animal models of depression.
Topics: Animals; Carbamazepine; Depressive Disorder; Disease Models, Animal; Haloperidol; Imipramine; Male; Methamphetamine; Motivation; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1987 |
[Transplant-induced recovery from 6-OHDA lesions of the nigro-striatal dopamine neurons in mice].
Topics: Animals; Disease Models, Animal; Dopamine; Female; Hydroxydopamines; Methamphetamine; Mice; Mice, Inbred C57BL; Neurons; Parkinson Disease, Secondary; Substantia Nigra; Transplantation, Homologous | 1988 |
[Changes in behavior and central monoaminergic systems in the rat after repeated methamphetamine pretreatment: presynaptic regulatory mechanism].
Topics: Animals; Behavior, Animal; Biogenic Monoamines; Brain; Corpus Striatum; Disease Models, Animal; Dopamine; Male; Methamphetamine; Psychoses, Substance-Induced; Rats; Rats, Inbred Strains | 1988 |
Reverse tolerance to the ambulation-increasing effect of methamphetamine in mice as an animal model of amphetamine-psychosis.
Topics: Animals; Disease Models, Animal; Drug Tolerance; Humans; Methamphetamine; Mice; Mice, Inbred Strains; Motor Activity; Psychoses, Substance-Induced; Rats | 1986 |
Psychotic manifestations in amphetamine abuse--experimental study on the mechanism of psychotic recurrence.
Topics: Animals; Conditioning, Operant; Dextroamphetamine; Disease Models, Animal; Male; Methamphetamine; Mice; Mice, Inbred ICR; Motor Activity; Psychoses, Substance-Induced; Rats; Rats, Inbred Strains; Recurrence | 1986 |
Effects of psychotropic drugs on discrimination conditioning in olfactory bulbectomized rats.
Topics: Amitriptyline; Animals; Avoidance Learning; Chlordiazepoxide; Chlorpromazine; Discrimination Learning; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Male; Mental Disorders; Methamphetamine; Olfactory Bulb; Psychotropic Drugs; Rats; Rats, Inbred Strains | 1985 |
[Chronological change in abnormal behavior produced by long-term methamphetamine administration in the rat].
Topics: Animals; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Injections, Intraperitoneal; Male; Methamphetamine; Motor Activity; Rats; Rats, Inbred Strains; Reflex, Startle; Spiperone; Stereotyped Behavior; Substance-Related Disorders | 1985 |
[Experimental psychopathy].
Topics: Animals; Behavior, Animal; Disease Models, Animal; Haplorhini; Humans; Mental Disorders; Methamphetamine; Social Isolation; Substance-Related Disorders | 1972 |
Olfactory forebrain seizures induced by methamphetamine and disulfiram.
Topics: Amphetamine; Animals; Brain; Brain Chemistry; Cats; Disease Models, Animal; Disulfiram; Dopamine; Electroencephalography; Epilepsy, Temporal Lobe; Female; Humans; Limbic System; Methamphetamine; Norepinephrine; Olfactory Bulb; Pattern Recognition, Automated; Psychoses, Substance-Induced; Seizures; Substantia Nigra | 1973 |
An animal model for the evaluation of drug-induced chromosome damage.
Topics: Animals; Chromosome Aberrations; Chromosomes; Disease Models, Animal; Fever; Lysergic Acid Diethylamide; Methamphetamine; Mitomycins; Rabbits | 1973 |
Behavior and EEG analysis of chronic amphetamine effect.
Topics: Amphetamine; Amygdala; Animals; Arousal; Behavior, Animal; Cats; Disease Models, Animal; Electroencephalography; Hallucinations; Humans; Limbic System; Methamphetamine; Motor Activity; Olfactory Bulb; Psychoses, Substance-Induced; Seizures | 1974 |
Behavioral analysis of chronic amphetamine intoxication.
Topics: Animals; Attitude; Behavior, Animal; Cats; Disease Models, Animal; Electroencephalography; Humans; Methamphetamine; Motor Activity; Movement Disorders; Paranoid Disorders; Posture; Psychoses, Substance-Induced | 1972 |
[Schizophrenia model in animals].
Topics: Animals; Behavior, Animal; Disease Models, Animal; Humans; Macaca; Male; Methamphetamine; Schizophrenia | 1971 |